<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum - Papers of the Week: 24-30 Apr 2026</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>MMP9 as a shared immune-related gene in Alzheimer&#039;s and Huntington&#039;s diseases: a cross-tissue transcriptomic analysis.</title>
 <link>https://www.alzforum.org/papers/mmp9-shared-immune-related-gene-alzheimers-and-huntingtons-diseases-cross-tissue</link>
 <description>Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):316-331.  Epub 2026 Apr 24&lt;br&gt;Authors: Li X, Zhang C, Ni H, Sun P, Ren J, Huang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030987&quot;&gt;42030987&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mmp9-shared-immune-related-gene-alzheimers-and-huntingtons-diseases-cross-tissue#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mmp9-shared-immune-related-gene-alzheimers-and-huntingtons-diseases-cross-tissue#comments</comments>
</item>
<item>
 <title>Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/therapeutic-effects-40-hz-light-stimulation-clinical-and-pathological-features-alzheimers</link>
 <description>Dialogues Clin Neurosci. 2026 Dec;28(1):177-187.  Epub 2026 Apr 26&lt;br&gt;Authors: Chou PS, Chien CF, Huang LC, Yang YH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035365&quot;&gt;42035365&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-effects-40-hz-light-stimulation-clinical-and-pathological-features-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-effects-40-hz-light-stimulation-clinical-and-pathological-features-alzheimers#comments</comments>
</item>
<item>
 <title>Convergent transcriptomic signature in iPSC-dopaminergic neurons of hereditary Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/convergent-transcriptomic-signature-ipsc-dopaminergic-neurons-hereditary-parkinsons-disease</link>
 <description>Life Sci Alliance. 2026 Jul;9(7) Print 2026 Jul&lt;br&gt;Authors: Kopylova IV, Ivanov AB, Eidelman LR, Zaitseva EN, Kulikova ED, Grehnyov DA, Bogomazova AN, Vigont VA, Kaznacheyeva EV, Lagarkova MA, Lebedeva OS, Olekhnovich EI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031673&quot;&gt;42031673&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/convergent-transcriptomic-signature-ipsc-dopaminergic-neurons-hereditary-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/convergent-transcriptomic-signature-ipsc-dopaminergic-neurons-hereditary-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Sex-dependent impact of Il6 deficiency in Parkinson&#039;s disease mice.</title>
 <link>https://www.alzforum.org/papers/sex-dependent-impact-il6-deficiency-parkinsons-disease-mice</link>
 <description>Genes Dis. 2026 Jul;13(4):101986.  Epub 2025 Dec 15&lt;br&gt;Authors: Chen F, Duan Y, Wang M, Liu Z, Zhao J, Fan G, He Y, Dong H, Zhang X, Fang R, Zhang Y, Yan X, Shen C, Tang X, Ma Y, Yu M, Zhou R, Fei J, Huang F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027807&quot;&gt;42027807&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-dependent-impact-il6-deficiency-parkinsons-disease-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-dependent-impact-il6-deficiency-parkinsons-disease-mice#comments</comments>
</item>
<item>
 <title>P2X7 receptor or TNAP genetic blockade prevents the reduction of neuronal CTCF detected in tauopathy.</title>
 <link>https://www.alzforum.org/papers/p2x7-receptor-or-tnap-genetic-blockade-prevents-reduction-neuronal-ctcf-detected-tauopathy</link>
 <description>Neuropharmacology. 2026 Jul 1;292:110948.  Epub 2026 Mar 24&lt;br&gt;Authors: Aivar P, Sebastián-Serrano Á, Vincelle-Nieto Á, Collado-Cantero AC, Ouro-Corredera D, Soria-Tobar L, Reyes-Palomares A, Díaz-Hernández M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/41881298&quot;&gt;41881298&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/p2x7-receptor-or-tnap-genetic-blockade-prevents-reduction-neuronal-ctcf-detected-tauopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/p2x7-receptor-or-tnap-genetic-blockade-prevents-reduction-neuronal-ctcf-detected-tauopathy#comments</comments>
</item>
<item>
 <title>Comparative Analysis of Deep Learning Techniques in Alzheimer&#039;s Disease Diagnosis: Trends, Challenges, and Future Directions.</title>
 <link>https://www.alzforum.org/papers/comparative-analysis-deep-learning-techniques-alzheimers-disease-diagnosis-trends-challenges</link>
 <description>MethodsX. 2026 Jun;16:103844.  Epub 2026 Feb 21&lt;br&gt;Authors: Naik DR, Savyanavar DA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027884&quot;&gt;42027884&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-analysis-deep-learning-techniques-alzheimers-disease-diagnosis-trends-challenges#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-analysis-deep-learning-techniques-alzheimers-disease-diagnosis-trends-challenges#comments</comments>
</item>
<item>
 <title>Comment on &quot;AlzStack: Forecasting early-onset Alzheimer&#039;s with an explainable AI system using multiple data balancing techniques&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-alzstack-forecasting-early-onset-alzheimers-explainable-ai-system-using-multiple-data</link>
 <description>Glob Epidemiol. 2026 Jun;11:100260.  Epub 2026 Apr 20&lt;br&gt;Authors: Ailani T, Jauhari R, Rani A, Singh R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051542&quot;&gt;42051542&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-alzstack-forecasting-early-onset-alzheimers-explainable-ai-system-using-multiple-data#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-alzstack-forecasting-early-onset-alzheimers-explainable-ai-system-using-multiple-data#comments</comments>
</item>
<item>
 <title>Kaempferol Improves Alzheimer&#039;s Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4/AKR1C3 Signaling Pathway.</title>
 <link>https://www.alzforum.org/papers/kaempferol-improves-alzheimers-disease-inhibiting-neuronal-ferroptosis-activating-gpx4akr1c3</link>
 <description>Pharmacol Res Perspect. 2026 Jun;14(3):e70255. &lt;br&gt;Authors: Li L, Yang M, Tao J, Zhao Y, Zhao N, Sun S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062795&quot;&gt;42062795&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/kaempferol-improves-alzheimers-disease-inhibiting-neuronal-ferroptosis-activating-gpx4akr1c3#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/kaempferol-improves-alzheimers-disease-inhibiting-neuronal-ferroptosis-activating-gpx4akr1c3#comments</comments>
</item>
<item>
 <title>Cellular Senescence of Patient-derived Fibroblasts Reveals the Mid-old Stage as a Critical Window for Transcriptomic Signatures Linked to Alzheimer&#039;s Disease Biomarkers and Classification.</title>
 <link>https://www.alzforum.org/papers/cellular-senescence-patient-derived-fibroblasts-reveals-mid-old-stage-critical-window</link>
 <description>Clin Psychopharmacol Neurosci. 2026 May 31;24(2):353-367.  Epub 2025 Dec 16&lt;br&gt;Authors: Cho YJ, Yoon S, Kim Y, Song HM, Nam YJ, Lee SH, Lee S, Shin D, Lee SM, Moon SY, Kim EJ, Cho SH, Kim BC, Choi SH, Seo SW, Kim JC, Park YJ, Kang HY, Lee SR, Hong S, Son SJ, Hong CH, Roh HW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036745&quot;&gt;42036745&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-senescence-patient-derived-fibroblasts-reveals-mid-old-stage-critical-window#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-senescence-patient-derived-fibroblasts-reveals-mid-old-stage-critical-window#comments</comments>
</item>
<item>
 <title>What Is the Potential Relevance of Hippocampal Area CA2 in Neurologic Disorders?</title>
 <link>https://www.alzforum.org/papers/what-potential-relevance-hippocampal-area-ca2-neurologic-disorders</link>
 <description>Neurology. 2026 May 26;106(10):e218096.  Epub 2026 Apr 28&lt;br&gt;Authors: Benarroch E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42048628&quot;&gt;42048628&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/what-potential-relevance-hippocampal-area-ca2-neurologic-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/what-potential-relevance-hippocampal-area-ca2-neurologic-disorders#comments</comments>
</item>
<item>
 <title>Phosphorylated TDP-43 Pathology in Skin and Muscle Tissue of Patients With Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/phosphorylated-tdp-43-pathology-skin-and-muscle-tissue-patients-amyotrophic-lateral-sclerosis</link>
 <description>Neurology. 2026 May 26;106(10):e214940.  Epub 2026 Apr 30&lt;br&gt;Authors: Nolano M, Provitera V, Caporaso G, Areniello AR, Borreca I, Stancanelli A, Senerchia G, Iuzzolino VV, Fasolino I, Vitale F, Ciccarelli G, Dell&amp;#039;Aversana D, Masciarelli F, Tozza S, Iodice R, Santoro L, Manganelli F, Dubbioso R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060881&quot;&gt;42060881&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/phosphorylated-tdp-43-pathology-skin-and-muscle-tissue-patients-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/phosphorylated-tdp-43-pathology-skin-and-muscle-tissue-patients-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Association of MRI-Visible Perivascular Spaces With Longitudinal Cognitive Decline Over a Decade.</title>
 <link>https://www.alzforum.org/papers/association-mri-visible-perivascular-spaces-longitudinal-cognitive-decline-over-decade</link>
 <description>Neurology. 2026 May 12;106(9):e214803.  Epub 2026 Apr 24&lt;br&gt;Authors: Kohno K, Sun Y, LeFevre JD, Robb WH, Jackson TB, Liu D, Vyas Y, Sweely B, Pechman KR, Shashikumar N, Peterson A, Landman B, Davis LT, Hohman TJ, Jefferson AL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030516&quot;&gt;42030516&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-mri-visible-perivascular-spaces-longitudinal-cognitive-decline-over-decade#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-mri-visible-perivascular-spaces-longitudinal-cognitive-decline-over-decade#comments</comments>
</item>
<item>
 <title>Unveiling the glymphatic system&#039;s role in brain aging: A comprehensive biomarker and modifiable intervention target.</title>
 <link>https://www.alzforum.org/papers/unveiling-glymphatic-systems-role-brain-aging-comprehensive-biomarker-and-modifiable</link>
 <description>Proc Natl Acad Sci U S A. 2026 May 5;123(18):e2516601123.  Epub 2026 Apr 27&lt;br&gt;Authors: Fang Y, Luo W, Huang H, Ran L, He Y, Cheng C, Yao Y, Hou Y, Zheng H, Pan D, Xu S, Luo X, Qin T, Hao X, Lu F, Wang W, Wang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044335&quot;&gt;42044335&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unveiling-glymphatic-systems-role-brain-aging-comprehensive-biomarker-and-modifiable#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unveiling-glymphatic-systems-role-brain-aging-comprehensive-biomarker-and-modifiable#comments</comments>
</item>
<item>
 <title>Exploring PrPC unfolding as a critical step preceding its refolding in the context of PrPSc propagation.</title>
 <link>https://www.alzforum.org/papers/exploring-prpc-unfolding-critical-step-preceding-its-refolding-context-prpsc-propagation</link>
 <description>Proc Natl Acad Sci U S A. 2026 May 5;123(18):e2529837123.  Epub 2026 Apr 29&lt;br&gt;Authors: Sabzehei S, Rigoli M, Cacheiro R, Díaz-Arias I, Eraña H, Lago RP, Guerra A, Rezaei H, Castilla J, Biasini E, Sánchez-Pedregal VM, Martín-Pastor M, Requena JR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054361&quot;&gt;42054361&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-prpc-unfolding-critical-step-preceding-its-refolding-context-prpsc-propagation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-prpc-unfolding-critical-step-preceding-its-refolding-context-prpsc-propagation#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives&quot; [Pharmacol. Res. 227 (2026) 108185].</title>
 <link>https://www.alzforum.org/papers/corrigendum-role-cannabinoid-ligands-neurodegenerative-diseases-emerging-anti-inflammatory</link>
 <description>Pharmacol Res. 2026 May;227:108206.  Epub 2026 Apr 23&lt;br&gt;Authors: Baldasso GM, Paes RS, Moreira AG, Salvadori SG, Limberger C, Roviezzo F, Capasso R, Dutra RC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031635&quot;&gt;42031635&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-role-cannabinoid-ligands-neurodegenerative-diseases-emerging-anti-inflammatory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-role-cannabinoid-ligands-neurodegenerative-diseases-emerging-anti-inflammatory#comments</comments>
</item>
<item>
 <title>Changes in Regional T1/T2-Weighted Ratio Index in Patients With Semantic Dementia.</title>
 <link>https://www.alzforum.org/papers/changes-regional-t1t2-weighted-ratio-index-patients-semantic-dementia</link>
 <description>Psychogeriatrics. 2026 May;26(3):e70170. &lt;br&gt;Authors: Ota M, Koshibe Y, Kitabatake A, Takahashi T, Nemoto K, Arai T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029577&quot;&gt;42029577&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/changes-regional-t1t2-weighted-ratio-index-patients-semantic-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/changes-regional-t1t2-weighted-ratio-index-patients-semantic-dementia#comments</comments>
</item>
<item>
 <title>The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer&#039;s Disease and Neurogenesis.</title>
 <link>https://www.alzforum.org/papers/myokine-irisin-represents-indirect-pathway-linking-exercise-hippocampal-subfields-relevant</link>
 <description>Aging Cell. 2026 May;25(5):e70497. &lt;br&gt;Authors: Pace T, Levenstein JM, Quigley BL, Houston R, Bouças AP, Andrews SC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033046&quot;&gt;42033046&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/myokine-irisin-represents-indirect-pathway-linking-exercise-hippocampal-subfields-relevant#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/myokine-irisin-represents-indirect-pathway-linking-exercise-hippocampal-subfields-relevant#comments</comments>
</item>
<item>
 <title>Simultaneous Representation Learning of Multi-Omics and Clinical Outcome Data via a Supervised Knowledge-Guided Bayesian Factor Model.</title>
 <link>https://www.alzforum.org/papers/simultaneous-representation-learning-multi-omics-and-clinical-outcome-data-supervised</link>
 <description>Stat Med. 2026 May;45(10-12):e70570. &lt;br&gt;Authors: Zhang Q, Chang C, Jin C, Shen L, Long Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035335&quot;&gt;42035335&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/simultaneous-representation-learning-multi-omics-and-clinical-outcome-data-supervised#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/simultaneous-representation-learning-multi-omics-and-clinical-outcome-data-supervised#comments</comments>
</item>
<item>
 <title>Structural Volumetric Alterations in Parkinson&#039;s Disease With Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/structural-volumetric-alterations-parkinsons-disease-mild-cognitive-impairment</link>
 <description>Brain Behav. 2026 May;16(5):e71410. &lt;br&gt;Authors: Hu J, Lei P, Zhang J, Wu Q, Zhang Z, Zhu X, Li B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043968&quot;&gt;42043968&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-volumetric-alterations-parkinsons-disease-mild-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-volumetric-alterations-parkinsons-disease-mild-cognitive-impairment#comments</comments>
</item>
<item>
 <title>GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/gpnd-ai-nulisa-15-protein-ai-classifier-diagnosis-and-co-pathology-profiling-across</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71420. &lt;br&gt;Authors: Xu Y, Denkinger MN, Liu M, Gong K, Chen Y, Western D, Timsina J, Cheng Y, Xie Y, Mu R, Budde J, Beach TG, Serrano GE, Reiman EM, Singh A, Alfradique-Dunham I, Benzinger TL, Schindler SE, Morris JC, Holtzman DM, Perlumtter JS, Snider BJ, Campbell MC, Kotzbauer PT, Ashton NJ, Cruchaga C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050390&quot;&gt;42050390&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gpnd-ai-nulisa-15-protein-ai-classifier-diagnosis-and-co-pathology-profiling-across#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gpnd-ai-nulisa-15-protein-ai-classifier-diagnosis-and-co-pathology-profiling-across#comments</comments>
</item>
<item>
 <title>Designing a communication strategy to promote Alzheimer&#039;s disease prevention: The CULTIVAMENTE campaign.</title>
 <link>https://www.alzforum.org/papers/designing-communication-strategy-promote-alzheimers-disease-prevention-cultivamente-campaign</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71448. &lt;br&gt;Authors: Aravena JM, Castro H, Poblete R, Saavedra G, Briceño R, Torres W, Vecchi M, Budinich M, Fuentes P, Albala C, Levy BR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050370&quot;&gt;42050370&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/designing-communication-strategy-promote-alzheimers-disease-prevention-cultivamente-campaign#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/designing-communication-strategy-promote-alzheimers-disease-prevention-cultivamente-campaign#comments</comments>
</item>
<item>
 <title>Peripheral vascular function, including endothelium-dependent measures, and dementia risk: The Framingham Heart Study.</title>
 <link>https://www.alzforum.org/papers/peripheral-vascular-function-including-endothelium-dependent-measures-and-dementia-risk</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71396. &lt;br&gt;Authors: Tao Q, Han J, Ang TF, Hou L, Liu C, Murabito JM, Lunetta KL, Mez J, Alosco ML, Stein TD, Zhang X, Au R, Farrer L, Palmisano JN, Hamburg NM, Qiu WQ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050369&quot;&gt;42050369&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/peripheral-vascular-function-including-endothelium-dependent-measures-and-dementia-risk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/peripheral-vascular-function-including-endothelium-dependent-measures-and-dementia-risk#comments</comments>
</item>
<item>
 <title>Reduced risk of dementia with recombinant zoster vaccine in US adults age 65 or older.</title>
 <link>https://www.alzforum.org/papers/reduced-risk-dementia-recombinant-zoster-vaccine-us-adults-age-65-or-older</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71407. &lt;br&gt;Authors: Dos Reis S, Tran P, Mohanty K, Amill-Rosario A, Johnson A, Ryan K, Alsdurf H, Oraichi D, Yun H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050365&quot;&gt;42050365&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-risk-dementia-recombinant-zoster-vaccine-us-adults-age-65-or-older#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-risk-dementia-recombinant-zoster-vaccine-us-adults-age-65-or-older#comments</comments>
</item>
<item>
 <title>Identification of Alzheimer&#039;s disease subtypes and biomarkers from human multi-omics data using subspace merging algorithm.</title>
 <link>https://www.alzforum.org/papers/identification-alzheimers-disease-subtypes-and-biomarkers-human-multi-omics-data-using</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71292. &lt;br&gt;Authors: Song Z, Huang X, Jannu AJ, Johnson TS, Zhang J, Huang K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056682&quot;&gt;42056682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identification-alzheimers-disease-subtypes-and-biomarkers-human-multi-omics-data-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identification-alzheimers-disease-subtypes-and-biomarkers-human-multi-omics-data-using#comments</comments>
</item>
<item>
 <title>Bibliometric analysis of Alzheimer&#039;s and dementia research in Latin America.</title>
 <link>https://www.alzforum.org/papers/bibliometric-analysis-alzheimers-and-dementia-research-latin-america</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71395. &lt;br&gt;Authors: Vazquez-Guajardo M, Mimenza-Alvarado AJ, Martinez-Zamora CA, Lee A, Padilla Solis OA, Parodi JF, Custodio Capuñay NS, Aguilar-Navarro SG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056639&quot;&gt;42056639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bibliometric-analysis-alzheimers-and-dementia-research-latin-america#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bibliometric-analysis-alzheimers-and-dementia-research-latin-america#comments</comments>
</item>
<item>
 <title>Activities of daily living and their neural correlates across the Alzheimer&#039;s disease continuum: Evidence from a Latin American cohort.</title>
 <link>https://www.alzforum.org/papers/activities-daily-living-and-their-neural-correlates-across-alzheimers-disease-continuum</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71445. &lt;br&gt;Authors: Henríquez F, Riquelme P, Forno G, Migeot J, Henríquez R, Lillo P, Thumala-Dockendorff D, Okuma C, Campo CG, Hornberger M, Aboitiz F, Slachevsky A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056392&quot;&gt;42056392&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/activities-daily-living-and-their-neural-correlates-across-alzheimers-disease-continuum#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/activities-daily-living-and-their-neural-correlates-across-alzheimers-disease-continuum#comments</comments>
</item>
<item>
 <title>Characterizing circadian rest-activity rhythm patterns across Alzheimer&#039;s disease continuum in Down syndrome.</title>
 <link>https://www.alzforum.org/papers/characterizing-circadian-rest-activity-rhythm-patterns-across-alzheimers-disease-continuum</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71409. &lt;br&gt;Authors: Giménez S, Vaqué-Alcázar L, Clos S, Benejam B, Carmona-Iragui M, Maure-Blesa L, Videla L, Zhu N, Altuna M, Arranz J, Barroeta I, Rodríguez-Baz Í, Bejanin A, Bueno A, Fernandez S, Del Hoyo Soriano L, Pertierra L, Alcolea D, Miller B, Grinberg LT, Ruiz J, Lisgaras CP, Wu HT, Lleó A, Osorio RS, Blessing EM, Fortea J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056071&quot;&gt;42056071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterizing-circadian-rest-activity-rhythm-patterns-across-alzheimers-disease-continuum#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterizing-circadian-rest-activity-rhythm-patterns-across-alzheimers-disease-continuum#comments</comments>
</item>
<item>
 <title>RETRACTION: The 12-15-Lipoxygenase is a Modulator of Alzheimer&#039;s-Related Tau Pathology In Vivo.</title>
 <link>https://www.alzforum.org/papers/retraction-12-15-lipoxygenase-modulator-alzheimers-related-tau-pathology-vivo</link>
 <description>Aging Cell. 2026 May;25(5):e70524. &lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053514&quot;&gt;42053514&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-12-15-lipoxygenase-modulator-alzheimers-related-tau-pathology-vivo#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-12-15-lipoxygenase-modulator-alzheimers-related-tau-pathology-vivo#comments</comments>
</item>
<item>
 <title>Clinically Deployable Handwriting Biomarkers of Parkinson&#039;s Disease via Multiscale Attention and Bayesian-Genetic Optimization.</title>
 <link>https://www.alzforum.org/papers/clinically-deployable-handwriting-biomarkers-parkinsons-disease-multiscale-attention-and</link>
 <description>Brain Behav. 2026 May;16(5):e71457. &lt;br&gt;Authors: Rezaee K, Fakhrabadi AK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050861&quot;&gt;42050861&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinically-deployable-handwriting-biomarkers-parkinsons-disease-multiscale-attention-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinically-deployable-handwriting-biomarkers-parkinsons-disease-multiscale-attention-and#comments</comments>
</item>
<item>
 <title>Development and validation of MethylCog, a blood DNA methylation proxy for cognition.</title>
 <link>https://www.alzforum.org/papers/development-and-validation-methylcog-blood-dna-methylation-proxy-cognition</link>
 <description>Alzheimers Dement. 2026 May;22(5):e71421. &lt;br&gt;Authors: O&amp;#039;Shea DM, Wang L, Lukacsovich D, Dhanekula D, Zhang W, Galvin C, Joshi M, Besser L, Rundek T, Galvin JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062774&quot;&gt;42062774&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-and-validation-methylcog-blood-dna-methylation-proxy-cognition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-and-validation-methylcog-blood-dna-methylation-proxy-cognition#comments</comments>
</item>
<item>
 <title>Sex differences in Alzheimer&#039;s.</title>
 <link>https://www.alzforum.org/papers/sex-differences-alzheimers</link>
 <description>Nat Immunol. 2026 May;27(5):885. &lt;br&gt;Authors: Houston S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062506&quot;&gt;42062506&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sex-differences-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sex-differences-alzheimers#comments</comments>
</item>
<item>
 <title>When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/when-viruses-talk-through-extracellular-vesicles-new-perspective-sars-cov-2-induced</link>
 <description>J Extracell Vesicles. 2026 May;15(5):e70272. &lt;br&gt;Authors: Bawne G, Coenen L, Nutma E, Middeldorp J, Lorenowicz MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060826&quot;&gt;42060826&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/when-viruses-talk-through-extracellular-vesicles-new-perspective-sars-cov-2-induced#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/when-viruses-talk-through-extracellular-vesicles-new-perspective-sars-cov-2-induced#comments</comments>
</item>
<item>
 <title>RETRACTION: Antileukotriene Therapy by Reducing Tau Phosphorylation Improves Synaptic Integrity and Cognition of P301S Transgenic Mice.</title>
 <link>https://www.alzforum.org/papers/retraction-antileukotriene-therapy-reducing-tau-phosphorylation-improves-synaptic-integrity</link>
 <description>Aging Cell. 2026 May;25(5):e70523. &lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060510&quot;&gt;42060510&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-antileukotriene-therapy-reducing-tau-phosphorylation-improves-synaptic-integrity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-antileukotriene-therapy-reducing-tau-phosphorylation-improves-synaptic-integrity#comments</comments>
</item>
<item>
 <title>Stress Accelerates Depressive-Like Behaviors through Increase of Notch2 Expression in N141I Mutation Presenilin-2 Transgenic Mice.</title>
 <link>https://www.alzforum.org/papers/stress-accelerates-depressive-behaviors-through-increase-notch2-expression-n141i-mutation</link>
 <description>Biomol Ther (Seoul). 2026 May 1;34(3):544-555.  Epub 2026 Apr 30&lt;br&gt;Authors: Yoo SS, Gu SM, Nam KT, Choi JS, Lee YS, Yeo IJ, Yu JE, Kim S, Lee DW, Ham HJ, Chang JY, Yun J, Son DJ, Han SB, Hong JT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42059026&quot;&gt;42059026&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stress-accelerates-depressive-behaviors-through-increase-notch2-expression-n141i-mutation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stress-accelerates-depressive-behaviors-through-increase-notch2-expression-n141i-mutation#comments</comments>
</item>
<item>
 <title>Real-world comparison of brain [18F]FDG-PET imaging with CSF Alzheimer&#039;s disease biomarkers in a tertiary memory clinic setting.</title>
 <link>https://www.alzforum.org/papers/real-world-comparison-brain-18ffdg-pet-imaging-csf-alzheimers-disease-biomarkers-tertiary</link>
 <description>EClinicalMedicine. 2026 May;95:103910.  Epub 2026 Apr 20&lt;br&gt;Authors: Rabaneda-Lombarte N, Ferrari-Souza JP, Celedon J, Zimmer ER, Dickerson BC, Arnold SE, Kivisäkk P, Serrano-Pozo A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42058506&quot;&gt;42058506&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/real-world-comparison-brain-18ffdg-pet-imaging-csf-alzheimers-disease-biomarkers-tertiary#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/real-world-comparison-brain-18ffdg-pet-imaging-csf-alzheimers-disease-biomarkers-tertiary#comments</comments>
</item>
<item>
 <title>Prebiotic intervention changes host and microbe proteomes in plasma extracellular vesicles of Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/prebiotic-intervention-changes-host-and-microbe-proteomes-plasma-extracellular-vesicles</link>
 <description>Sci Rep. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Sharma D, Voigt RM, Hall DA, Cantu-Jungles TM, Shaikh M, Engen PA, Jones J, Li S, Hamaker BR, Forsyth CB, Bishehsari F, de Menezes EG, Norris PJ, Goetz CG, Keshavarzian A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062487&quot;&gt;42062487&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prebiotic-intervention-changes-host-and-microbe-proteomes-plasma-extracellular-vesicles#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prebiotic-intervention-changes-host-and-microbe-proteomes-plasma-extracellular-vesicles#comments</comments>
</item>
<item>
 <title>Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer&#039;s brains.</title>
 <link>https://www.alzforum.org/papers/characterizing-metabolomes-microglia-astrocytes-and-neurons-ageing-and-alzheimers-brains</link>
 <description>Nat Cell Biol. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Yu J, Li F, Chen XJ, Mou C, Yao D, Bi Z, Chen X, Du L, Feng Z, Zhang X, Yu X, Zacharias LG, DeBerardinis RJ, Zhang L, Li Z, Luo B, Hu XL, Ge WP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062482&quot;&gt;42062482&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterizing-metabolomes-microglia-astrocytes-and-neurons-ageing-and-alzheimers-brains#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterizing-metabolomes-microglia-astrocytes-and-neurons-ageing-and-alzheimers-brains#comments</comments>
</item>
<item>
 <title>Correction: Post-mortem human Alzheimer&#039;s brain metallome depends on Braak stages and brain regions.</title>
 <link>https://www.alzforum.org/papers/correction-post-mortem-human-alzheimers-brain-metallome-depends-braak-stages-and-brain</link>
 <description>Sci Rep. 2026 Apr 30;16(1)&lt;br&gt;Authors: Parra-Martínez C, Callejón-Leblic B, Rodrigo-Lara H, Fernández-Vega I, Guerrero-Márquez MC, Rábano A, García-Barrera T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062336&quot;&gt;42062336&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-post-mortem-human-alzheimers-brain-metallome-depends-braak-stages-and-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-post-mortem-human-alzheimers-brain-metallome-depends-braak-stages-and-brain#comments</comments>
</item>
<item>
 <title>Innovation in Alzheimer&#039;s disease needs more than pharmaceutical solutions.</title>
 <link>https://www.alzforum.org/papers/innovation-alzheimers-disease-needs-more-pharmaceutical-solutions</link>
 <description>BMJ. 2026 Apr 30;393:s788. &lt;br&gt;Authors: Brayne C, Richard E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061951&quot;&gt;42061951&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/innovation-alzheimers-disease-needs-more-pharmaceutical-solutions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/innovation-alzheimers-disease-needs-more-pharmaceutical-solutions#comments</comments>
</item>
<item>
 <title>The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers.</title>
 <link>https://www.alzforum.org/papers/world-federation-neurology-specialty-group-alsmnd-toward-strategic-partnership-and-new</link>
 <description>Amyotroph Lateral Scler Frontotemporal Degener. 2026 Apr 30;:1-3.  Epub 2026 Apr 30&lt;br&gt;Authors: Kiernan MC, Genge A, Grosskreutz J, Kuwabara S, Lillo P, Rosenfeld J, Cummings C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060866&quot;&gt;42060866&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/world-federation-neurology-specialty-group-alsmnd-toward-strategic-partnership-and-new#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/world-federation-neurology-specialty-group-alsmnd-toward-strategic-partnership-and-new#comments</comments>
</item>
<item>
 <title>The Development of the Digital Cognitive Screen, Parkinson&#039;s Cognition (Par-Cog).</title>
 <link>https://www.alzforum.org/papers/development-digital-cognitive-screen-parkinsons-cognition-par-cog</link>
 <description>Appl Neuropsychol Adult. 2026 Apr 30;:1-12.  Epub 2026 Apr 30&lt;br&gt;Authors: Craig SN, Dempster M, Curran D, Lyttle N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060784&quot;&gt;42060784&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-digital-cognitive-screen-parkinsons-cognition-par-cog#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-digital-cognitive-screen-parkinsons-cognition-par-cog#comments</comments>
</item>
<item>
 <title>Tracking the turning point in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/tracking-turning-point-alzheimers-disease</link>
 <description>Science. 2026 Apr 30;392(6797):468-469.  Epub 2026 Apr 30&lt;br&gt;Authors: De Strooper B, Zetterberg H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060745&quot;&gt;42060745&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tracking-turning-point-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tracking-turning-point-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Multi-view Hilbert Curve-based Hierarchical Information Aggregation for Incomplete Multimodal Alzheimer&#039;s Disease Diagnosis.</title>
 <link>https://www.alzforum.org/papers/multi-view-hilbert-curve-based-hierarchical-information-aggregation-incomplete-multimodal</link>
 <description>IEEE Trans Med Imaging. 2026 Apr 30;PP Epub 2026 Apr 30&lt;br&gt;Authors: Liu C, Que Y, Wong WK, Liu Y, Luo X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060436&quot;&gt;42060436&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-view-hilbert-curve-based-hierarchical-information-aggregation-incomplete-multimodal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-view-hilbert-curve-based-hierarchical-information-aggregation-incomplete-multimodal#comments</comments>
</item>
<item>
 <title>Factors influencing accelerated progression in behavioral variant frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/factors-influencing-accelerated-progression-behavioral-variant-frontotemporal-dementia</link>
 <description>J Neurol. 2026 Apr 30;273(5)&lt;br&gt;Authors: Split M, Kunicki ZJ, Ross D, Keszycki R, Prieto S, Manoochehri M, De Vito AN, Appleby B, Hales CM, Onyike C, McMillan CT, Clark D, Irwin D, Knopman D, Galasko DR, Wint D, Roberson ED, Léger GC, Hsiung GR, Heuer HW, Rosen HJ, Grant IM, Mackenzie IR, Litvan I, Kornak J, Kwan J, Rascovsky K, Domoto-Reilly K, Massimo L, Honig LS, Forsberg LK, Tartaglia MC, Mendez MF, Graff-Radford N, Ghoshal N, Ljubenkov P, Darby RR, Barmada S, Weintraub S, Lee S, Sullivan AC, Boxer A, Staffaroni AM, Snyder A, Bozoki A, Pascual B, Dickerson BC, Boeve BF, Huey ED, Barker M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060164&quot;&gt;42060164&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/factors-influencing-accelerated-progression-behavioral-variant-frontotemporal-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/factors-influencing-accelerated-progression-behavioral-variant-frontotemporal-dementia#comments</comments>
</item>
<item>
 <title>Olfactory dysfunction as a marker of neurodegenerative disease in older adults.</title>
 <link>https://www.alzforum.org/papers/olfactory-dysfunction-marker-neurodegenerative-disease-older-adults</link>
 <description>Aging Clin Exp Res. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Klíčová K, Menšíková K, Šebelová D, Polčáková P, Kaleta M, Cook SE, Ildžová Z, Satke L, Zimek D, Kaňovský P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060155&quot;&gt;42060155&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/olfactory-dysfunction-marker-neurodegenerative-disease-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/olfactory-dysfunction-marker-neurodegenerative-disease-older-adults#comments</comments>
</item>
<item>
 <title>Outcome associations of CSF total tau in suspected non-Alzheimer pathophysiology.</title>
 <link>https://www.alzforum.org/papers/outcome-associations-csf-total-tau-suspected-non-alzheimer-pathophysiology</link>
 <description>J Neurol. 2026 Apr 30;273(5)&lt;br&gt;Authors: Briel N, Borsi M, Schreiner SJ, Schneider T, Loosli SV, Togni C, Carta MC, Loosli J, Köpp A, Ziegler M, Nicoletti T, Weller M, Felbecker A, Weiss T, Jung HH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060129&quot;&gt;42060129&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/outcome-associations-csf-total-tau-suspected-non-alzheimer-pathophysiology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/outcome-associations-csf-total-tau-suspected-non-alzheimer-pathophysiology#comments</comments>
</item>
<item>
 <title>Neural Stem Cell-Derived Extracellular Vesicles: The Next Frontier in Neurological and Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-next-frontier-neurological-and</link>
 <description>Stem Cell Rev Rep. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Marei HE, Cenciarelli C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060081&quot;&gt;42060081&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-next-frontier-neurological-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neural-stem-cell-derived-extracellular-vesicles-next-frontier-neurological-and#comments</comments>
</item>
<item>
 <title>A Multimodal Latent Severity Axis for Alzheimer&#039;s Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing Effects.</title>
 <link>https://www.alzforum.org/papers/multimodal-latent-severity-axis-alzheimers-disease-probabilistic-pca-bayesian-trajectories</link>
 <description>Neurol Ther. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Haji B, Tahami Monfared AA, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060036&quot;&gt;42060036&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multimodal-latent-severity-axis-alzheimers-disease-probabilistic-pca-bayesian-trajectories#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multimodal-latent-severity-axis-alzheimers-disease-probabilistic-pca-bayesian-trajectories#comments</comments>
</item>
<item>
 <title>Uncovering Spatiotemporal and Functional Dynamics of Long Non-coding RNAs During Alzheimer&#039;s Progression in the Human Brain at Single-Cell Resolution.</title>
 <link>https://www.alzforum.org/papers/uncovering-spatiotemporal-and-functional-dynamics-long-non-coding-rnas-during-alzheimers</link>
 <description>Mol Neurobiol. 2026 Apr 30;63(1)&lt;br&gt;Authors: de Carvalho A, Mamede I, Sanches L, Juvenal G, Viero FT, Franco GR, Tang Y, Reis EM, Ulrich H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060014&quot;&gt;42060014&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/uncovering-spatiotemporal-and-functional-dynamics-long-non-coding-rnas-during-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/uncovering-spatiotemporal-and-functional-dynamics-long-non-coding-rnas-during-alzheimers#comments</comments>
</item>
<item>
 <title>Subjective Sleep Traits and Cognition Across Mid- to Late-Adulthood: A Cross-Sectional Study of Gene-Environment Interplay.</title>
 <link>https://www.alzforum.org/papers/subjective-sleep-traits-and-cognition-across-mid-late-adulthood-cross-sectional-study-gene</link>
 <description>Sleep. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Vo-Eckerle TT, Gillespie NA, Christensen K, Finkel D, Kremen WS, Nygaard M, Sachdev PS, Thalamuthu A, Reynolds CA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42059651&quot;&gt;42059651&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subjective-sleep-traits-and-cognition-across-mid-late-adulthood-cross-sectional-study-gene#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subjective-sleep-traits-and-cognition-across-mid-late-adulthood-cross-sectional-study-gene#comments</comments>
</item>
<item>
 <title>Integrated multi-omics analysis reveals gut dysbiosis and altered energy metabolism in Chinese ALS patients.</title>
 <link>https://www.alzforum.org/papers/integrated-multi-omics-analysis-reveals-gut-dysbiosis-and-altered-energy-metabolism-chinese</link>
 <description>Microbiol Spectr. 2026 Apr 30;:e0060926.  Epub 2026 Apr 30&lt;br&gt;Authors: Ma X, Jiang Z, Yang T, Zhang H, Lu W, Liu K, Fan X, Yang G, Wu S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42059647&quot;&gt;42059647&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-multi-omics-analysis-reveals-gut-dysbiosis-and-altered-energy-metabolism-chinese#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-multi-omics-analysis-reveals-gut-dysbiosis-and-altered-energy-metabolism-chinese#comments</comments>
</item>
<item>
 <title>Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer&#039;s Disease Models.</title>
 <link>https://www.alzforum.org/papers/optimization-and-characterization-ship1-ligands-cellular-target-engagement-and-activity-0</link>
 <description>J Med Chem. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Jesudason CD, Rangel-Barajas C, Beach CJ, Beck DE, Caballero-Floran IH, Clayton WB, Da Silva L, David JC, Doolen S, Faulkner AN, Hamdani AK, Huhe H, Huynh K, Imhoff RD, Javens-Wolfe J, Mason ER, Moussaif M, Singhal K, Soni DM, van Buuren-Milne M, Williams SP, Angus SP, Chu S, Dage JL, Hipskind PA, Johnson TS, Kaddurah-Daouk R, Lamb BT, Meikle PJ, Mesecar AD, Palkowitz AD, Quinney SK, Sukoff Rizzo SJ, Oblak AL, Richardson TI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42059452&quot;&gt;42059452&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/optimization-and-characterization-ship1-ligands-cellular-target-engagement-and-activity-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/optimization-and-characterization-ship1-ligands-cellular-target-engagement-and-activity-0#comments</comments>
</item>
<item>
 <title>Neuro-reparative potential of hyperbaric oxygen therapy in animal models of Alzheimer&#039;s and Parkinson&#039;s diseases: systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/neuro-reparative-potential-hyperbaric-oxygen-therapy-animal-models-alzheimers-and-parkinsons</link>
 <description>Neurodegener Dis Manag. 2026 Apr 30;:1-9.  Epub 2026 Apr 30&lt;br&gt;Authors: Radhakrishnan A, Dutta D, Saha M, Venkatakrishnan S, Kulkarni A, Chandrachari KP, Salins PC, Suresh A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057743&quot;&gt;42057743&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuro-reparative-potential-hyperbaric-oxygen-therapy-animal-models-alzheimers-and-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuro-reparative-potential-hyperbaric-oxygen-therapy-animal-models-alzheimers-and-parkinsons#comments</comments>
</item>
<item>
 <title>The amplification of α-synuclein amyloid fibrils.</title>
 <link>https://www.alzforum.org/papers/amplification-synuclein-amyloid-fibrils</link>
 <description>Biochem Soc Trans. 2026 Apr 30;54(4):427-435. &lt;br&gt;Authors: Buell AK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057656&quot;&gt;42057656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amplification-synuclein-amyloid-fibrils#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amplification-synuclein-amyloid-fibrils#comments</comments>
</item>
<item>
 <title>Brain aging and neurodegenerative diseases: physiological insights from anti-aging protein Klotho.</title>
 <link>https://www.alzforum.org/papers/brain-aging-and-neurodegenerative-diseases-physiological-insights-anti-aging-protein-klotho</link>
 <description>Korean J Physiol Pharmacol. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Do PA, Nguyen HS, Cha SK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057473&quot;&gt;42057473&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-aging-and-neurodegenerative-diseases-physiological-insights-anti-aging-protein-klotho#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-aging-and-neurodegenerative-diseases-physiological-insights-anti-aging-protein-klotho#comments</comments>
</item>
<item>
 <title>Natural Products for Alzheimer&#039;s Disease: A New Twist Impacting Ferroptosis.</title>
 <link>https://www.alzforum.org/papers/natural-products-alzheimers-disease-new-twist-impacting-ferroptosis</link>
 <description>Am J Chin Med. 2026 Apr 30;:1-25.  Epub 2026 Apr 30&lt;br&gt;Authors: Yi Y, Jia P, Xie P, Peng X, Zhu X, Yin S, Yan C, Yu G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057258&quot;&gt;42057258&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/natural-products-alzheimers-disease-new-twist-impacting-ferroptosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/natural-products-alzheimers-disease-new-twist-impacting-ferroptosis#comments</comments>
</item>
<item>
 <title>Variant-to-function dissection of the 17q21.31 locus resolves ANKRD1 as a convergent regulatory target.</title>
 <link>https://www.alzforum.org/papers/variant-function-dissection-17q2131-locus-resolves-ankrd1-convergent-regulatory-target</link>
 <description>BMC Med Genomics. 2026 Apr 30; Epub 2026 Apr 30&lt;br&gt;Authors: Olaoye OJ, Farrow SL, Cooper AA, Nyaga DM, O&amp;#039;Sullivan JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057133&quot;&gt;42057133&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/variant-function-dissection-17q2131-locus-resolves-ankrd1-convergent-regulatory-target#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/variant-function-dissection-17q2131-locus-resolves-ankrd1-convergent-regulatory-target#comments</comments>
</item>
<item>
 <title>The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.</title>
 <link>https://www.alzforum.org/papers/dementias-platform-uk-petmr-harmonisation-and-test-retest-study-assessment-pet-repeatability</link>
 <description>Eur J Nucl Med Mol Imaging. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Markiewicz PJ, Thompson G, Wardlaw JM, Wimberley C, Ritchie C, Taylor JP, Brooks D, Maxwell R, Firbank M, Hoggard N, Su L, Wild J, Hillel P, Rhodes-Bradford V, Parkes LM, O&amp;#039;Brien JT, Carter SF, Aigbirhio FI, Fryer T, Matthews PM, Malhotra P, Grey G, Hallett W, Ocal D, Dickson JC, De Vita E, Thomas DL, Fox NC, Krokos G, Mackewn JE, Marsden P, Hammers A, Herholz K, Barkhof F, Matthews JC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050257&quot;&gt;42050257&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dementias-platform-uk-petmr-harmonisation-and-test-retest-study-assessment-pet-repeatability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dementias-platform-uk-petmr-harmonisation-and-test-retest-study-assessment-pet-repeatability#comments</comments>
</item>
<item>
 <title>CD33 Isoform Splicing Dysregulation: A Molecular Determinant of Microglial Dysfunction in Alzheimer&#039;s Disease Pathology.</title>
 <link>https://www.alzforum.org/papers/cd33-isoform-splicing-dysregulation-molecular-determinant-microglial-dysfunction-alzheimers</link>
 <description>Mol Neurobiol. 2026 Apr 29;63(1)&lt;br&gt;Authors: Li XY, Zhang Y, Ran Z, Luo JX, Yu XQ, Lu MH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050212&quot;&gt;42050212&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cd33-isoform-splicing-dysregulation-molecular-determinant-microglial-dysfunction-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cd33-isoform-splicing-dysregulation-molecular-determinant-microglial-dysfunction-alzheimers#comments</comments>
</item>
<item>
 <title>Unveiling an ALS Blood Transcriptomic Signature: A Machine Learning Classifier Distinct from Neurodegenerative Controls.</title>
 <link>https://www.alzforum.org/papers/unveiling-als-blood-transcriptomic-signature-machine-learning-classifier-distinct</link>
 <description>Neuroinformatics. 2026 Apr 29;24(2)&lt;br&gt;Authors: Gascón E, Calvo AC, Zaragoza P, Osta R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050008&quot;&gt;42050008&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unveiling-als-blood-transcriptomic-signature-machine-learning-classifier-distinct#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unveiling-als-blood-transcriptomic-signature-machine-learning-classifier-distinct#comments</comments>
</item>
<item>
 <title>Electrochemical detection of miRNA-128 in Alzheimer&#039;s disease using (3-aminopropyl) triethoxysilane and citrate-capped green-synthesized silver nanoparticles.</title>
 <link>https://www.alzforum.org/papers/electrochemical-detection-mirna-128-alzheimers-disease-using-3-aminopropyl-triethoxysilane</link>
 <description>Mikrochim Acta. 2026 Apr 29;193(5)&lt;br&gt;Authors: Rani S, Khatri A, Devi S, Mahesh KV, Sandhir R, Prabhakar N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056645&quot;&gt;42056645&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/electrochemical-detection-mirna-128-alzheimers-disease-using-3-aminopropyl-triethoxysilane#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/electrochemical-detection-mirna-128-alzheimers-disease-using-3-aminopropyl-triethoxysilane#comments</comments>
</item>
<item>
 <title>Author Correction: UK Biobank at 20 - a growing, global resource for dementia research.</title>
 <link>https://www.alzforum.org/papers/author-correction-uk-biobank-20-growing-global-resource-dementia-research</link>
 <description>Nat Rev Neurol. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Matthews PM, Allen NE, Debette S, Doherty A, Douaud G, Duff EP, Elliott P, Fulda ES, Ilina A, Le Grand Q, Lewandowski AJ, Mahoney R, Miller K, Rodriguez C, Rutter MK, Sandor C, Sims R, Smith SM, Wang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42056554&quot;&gt;42056554&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/author-correction-uk-biobank-20-growing-global-resource-dementia-research#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/author-correction-uk-biobank-20-growing-global-resource-dementia-research#comments</comments>
</item>
<item>
 <title>PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy.</title>
 <link>https://www.alzforum.org/papers/pet-guided-assessment-amyloid-clearance-and-outcomes-real-world-cohort-patients-alzheimer</link>
 <description>AJNR Am J Neuroradiol. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Ivanidze J, Gardella J, Olson A, Sun SM, Thomas C, Wong OL, Intorcia B, Moirano J, Tanavde V, Gershon B, Pahlajani S, Roytman M, Nordvig A, Lin M, Hamed M, Alport A, Salgado M, Keil S, O&amp;#039;Dwyer E, Lantos J, Huicochea Castellanos S, Ebani EJ, Agee M, Fink ME, Osborne JR, Chiang GC, Blum S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055956&quot;&gt;42055956&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pet-guided-assessment-amyloid-clearance-and-outcomes-real-world-cohort-patients-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pet-guided-assessment-amyloid-clearance-and-outcomes-real-world-cohort-patients-alzheimer#comments</comments>
</item>
<item>
 <title>Drug repositioning in Alzheimer&#039;s disease: a vascular perspective targeting the NO-cGMP pathway.</title>
 <link>https://www.alzforum.org/papers/drug-repositioning-alzheimers-disease-vascular-perspective-targeting-no-cgmp-pathway</link>
 <description>Eur J Hosp Pharm. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Caíña López S, Portela Sotelo A, Vázquez-Gómez S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055793&quot;&gt;42055793&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/drug-repositioning-alzheimers-disease-vascular-perspective-targeting-no-cgmp-pathway#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/drug-repositioning-alzheimers-disease-vascular-perspective-targeting-no-cgmp-pathway#comments</comments>
</item>
<item>
 <title>Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.</title>
 <link>https://www.alzforum.org/papers/low-overlap-plasma-and-csf-protein-quantitative-trait-loci-affects-protein-discovery</link>
 <description>Sci Transl Med. 2026 Apr 29;18(847):eadz2016.  Epub 2026 Apr 29&lt;br&gt;Authors: Western D, Yang C, Timsina J, Liu M, Wang C, Campbell MC, Kotzbauer P, Perlmutter JS, Schindler SE, Morris JC, Holtzman DM, Alvarez I, Pastor P, Wyss-Coray T, Marquié M, Cano A, Sung YJ, de Rojas I, Ruiz A, Budde J, Fernandez MV, Tarawneh R, Ibanez L, Cruchaga C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054495&quot;&gt;42054495&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/low-overlap-plasma-and-csf-protein-quantitative-trait-loci-affects-protein-discovery#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/low-overlap-plasma-and-csf-protein-quantitative-trait-loci-affects-protein-discovery#comments</comments>
</item>
<item>
 <title>A Polypharmacology-Driven Approach to Alzheimer&#039;s Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors.</title>
 <link>https://www.alzforum.org/papers/polypharmacology-driven-approach-alzheimers-disease-and-tauopathies-rational-design-synthesis</link>
 <description>J Med Chem. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Demuro S, Russo D, Penna I, Grabska S, Grabski H, Dalle Vedove A, Valeri A, Sauvey C, Ottonello G, Summa M, Bertozzi SM, Ortega J, Bertorelli R, Storici P, Girotto S, Cruciani G, Di Martino RM, Abagyan R, Cavalli A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054438&quot;&gt;42054438&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polypharmacology-driven-approach-alzheimers-disease-and-tauopathies-rational-design-synthesis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polypharmacology-driven-approach-alzheimers-disease-and-tauopathies-rational-design-synthesis#comments</comments>
</item>
<item>
 <title>The association between neurofilament light chain and cognitive function: a UK Biobank cohort study.</title>
 <link>https://www.alzforum.org/papers/association-between-neurofilament-light-chain-and-cognitive-function-uk-biobank-cohort-study</link>
 <description>J Neurol. 2026 Apr 29;273(5)&lt;br&gt;Authors: Niu Y, Chen Y, Li Y, Du Y, Li S, Gao T, Xu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053837&quot;&gt;42053837&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-neurofilament-light-chain-and-cognitive-function-uk-biobank-cohort-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-neurofilament-light-chain-and-cognitive-function-uk-biobank-cohort-study#comments</comments>
</item>
<item>
 <title>Unravelling the spatiotemporal dynamics of amyloid-  -induced astrocyte-neuron network model in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/unravelling-spatiotemporal-dynamics-amyloid-induced-astrocyte-neuron-network-model-alzheimers</link>
 <description>J Math Biol. 2026 Apr 29;92(5)&lt;br&gt;Authors: Pradhan D, Upadhyay RK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053826&quot;&gt;42053826&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unravelling-spatiotemporal-dynamics-amyloid-induced-astrocyte-neuron-network-model-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unravelling-spatiotemporal-dynamics-amyloid-induced-astrocyte-neuron-network-model-alzheimers#comments</comments>
</item>
<item>
 <title>Evolving 10-year epidemiological landscape of amyotrophic lateral sclerosis (ALS) in Ceará, Brazil.</title>
 <link>https://www.alzforum.org/papers/evolving-10-year-epidemiological-landscape-amyotrophic-lateral-sclerosis-als-ceara-brazil</link>
 <description>Amyotroph Lateral Scler Frontotemporal Degener. 2026 Apr 29;:1-7.  Epub 2026 Apr 29&lt;br&gt;Authors: Fernandes JM, Dutra Junior AM, Thomas FP, Gondim FA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053785&quot;&gt;42053785&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evolving-10-year-epidemiological-landscape-amyotrophic-lateral-sclerosis-als-ceara-brazil#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evolving-10-year-epidemiological-landscape-amyotrophic-lateral-sclerosis-als-ceara-brazil#comments</comments>
</item>
<item>
 <title>Therapeutic Mechanisms of Stem Cell-Derived Exosomes for Neurological Disorders: An Overview.</title>
 <link>https://www.alzforum.org/papers/therapeutic-mechanisms-stem-cell-derived-exosomes-neurological-disorders-overview</link>
 <description>Mol Neurobiol. 2026 Apr 29;63(1)&lt;br&gt;Authors: Lin C, Qi L, Gao X, Hu L, Qian B, Deng Y, Zhou C, Wang C, Liu G, Ding Q, Lin Z, Zhu X, Zhang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053700&quot;&gt;42053700&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-mechanisms-stem-cell-derived-exosomes-neurological-disorders-overview#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-mechanisms-stem-cell-derived-exosomes-neurological-disorders-overview#comments</comments>
</item>
<item>
 <title>Diagnosis of Alzheimer&#039;s disease based on particle swarm optimization EEG signal channel selection and gated recurrent unit.</title>
 <link>https://www.alzforum.org/papers/diagnosis-alzheimers-disease-based-particle-swarm-optimization-eeg-signal-channel-selection</link>
 <description>Comput Methods Biomech Biomed Engin. 2026 Apr 29;:1-16.  Epub 2026 Apr 29&lt;br&gt;Authors: Shen X, Ding L, Li X, Gu L, Yang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053612&quot;&gt;42053612&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diagnosis-alzheimers-disease-based-particle-swarm-optimization-eeg-signal-channel-selection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diagnosis-alzheimers-disease-based-particle-swarm-optimization-eeg-signal-channel-selection#comments</comments>
</item>
<item>
 <title>Effect of repeated hot water immersion on cognitive performance, cerebrovascular function, sleep and biomarkers of neurodegeneration in older adults.</title>
 <link>https://www.alzforum.org/papers/effect-repeated-hot-water-immersion-cognitive-performance-cerebrovascular-function-sleep-and</link>
 <description>Exp Physiol. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Piccolo DD, Corbett J, Costello JT, Williams TB, James TJ, Shute JK, Alnajjar MG, Hudson LC, Marsh PA, Praskacova V, Mayes HS, Tipton M, Perissiou M, McNarry MA, Mackintosh KA, Saynor ZL, Shepherd AI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053510&quot;&gt;42053510&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-repeated-hot-water-immersion-cognitive-performance-cerebrovascular-function-sleep-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-repeated-hot-water-immersion-cognitive-performance-cerebrovascular-function-sleep-and#comments</comments>
</item>
<item>
 <title>Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory.</title>
 <link>https://www.alzforum.org/papers/real-world-performance-lumipulse-g-plasma-p-tau217-six-month-experience-specialized-clinical</link>
 <description>Clin Chem Lab Med. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Arslan B, Gobom J, Simrén J, Fahlén H, Andreasson U, Andrea Lessa Benedet, Kvartsberg H, Zetterberg H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053135&quot;&gt;42053135&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/real-world-performance-lumipulse-g-plasma-p-tau217-six-month-experience-specialized-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/real-world-performance-lumipulse-g-plasma-p-tau217-six-month-experience-specialized-clinical#comments</comments>
</item>
<item>
 <title>Multi-target approaches to prion disease Drug discovery: a status update.</title>
 <link>https://www.alzforum.org/papers/multi-target-approaches-prion-disease-drug-discovery-status-update</link>
 <description>Expert Opin Drug Discov. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Nikolić L, Legname G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42053126&quot;&gt;42053126&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-target-approaches-prion-disease-drug-discovery-status-update#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-target-approaches-prion-disease-drug-discovery-status-update#comments</comments>
</item>
<item>
 <title>Comparative transcriptomics reveal molecular convergence and divergence in parkinsonian disorders.</title>
 <link>https://www.alzforum.org/papers/comparative-transcriptomics-reveal-molecular-convergence-and-divergence-parkinsonian</link>
 <description>Brain. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Geithus S, Flønes IH, Alves G, Tysnes OB, van de Berg WD, Pihlstrøm L, Nido GS, Tzoulis C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052893&quot;&gt;42052893&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-transcriptomics-reveal-molecular-convergence-and-divergence-parkinsonian#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-transcriptomics-reveal-molecular-convergence-and-divergence-parkinsonian#comments</comments>
</item>
<item>
 <title>APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer&#039;s disease trials.</title>
 <link>https://www.alzforum.org/papers/apoe-shifts-tipping-point-addressing-pathological-heterogeneity-alzheimers-disease-trials</link>
 <description>Brain. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Tosun D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052872&quot;&gt;42052872&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe-shifts-tipping-point-addressing-pathological-heterogeneity-alzheimers-disease-trials#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe-shifts-tipping-point-addressing-pathological-heterogeneity-alzheimers-disease-trials#comments</comments>
</item>
<item>
 <title>The caregiver&#039;s inventory neuropsychological diagnosis dementia (CINDD) as useful tool in differential diagnosis of dementias.</title>
 <link>https://www.alzforum.org/papers/caregivers-inventory-neuropsychological-diagnosis-dementia-cindd-useful-tool-differential</link>
 <description>Clin Neuropsychol. 2026 Apr 29;:1-15.  Epub 2026 Apr 29&lt;br&gt;Authors: Blundo C, Ricci M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051176&quot;&gt;42051176&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/caregivers-inventory-neuropsychological-diagnosis-dementia-cindd-useful-tool-differential#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/caregivers-inventory-neuropsychological-diagnosis-dementia-cindd-useful-tool-differential#comments</comments>
</item>
<item>
 <title>Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer&#039;s Pathology-Attenuating Effects in In Vitro and In Vivo Models.</title>
 <link>https://www.alzforum.org/papers/multi-target-neuroprotective-compound-exhibits-eaat2-modulating-and-alzheimers-pathology</link>
 <description>ACS Chem Neurosci. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Hacımüftüoğlu A, Saraçoğlu N, Saffour S, Abad N, Kesgun Y, Zegheb N, Gundeger E, Yeşilyurt F, Ataş MN, Bati-Ayaz G, Altunlu Ö, Çınar B, Yörük MA, Okkay U, Özkaraca M, Ateş O, Taghizadehghalehjoughi A, Lafzi F, Türkez H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051019&quot;&gt;42051019&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-target-neuroprotective-compound-exhibits-eaat2-modulating-and-alzheimers-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-target-neuroprotective-compound-exhibits-eaat2-modulating-and-alzheimers-pathology#comments</comments>
</item>
<item>
 <title>Endogenous Ecotropic Murine Leukemia Virus Promotes Prion Pathogenesis in Senescence-accelerated Mice.</title>
 <link>https://www.alzforum.org/papers/endogenous-ecotropic-murine-leukemia-virus-promotes-prion-pathogenesis-senescence-accelerated</link>
 <description>Exp Neurobiol. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Choi MW, Mostafa MN, Kim MJ, Jang B, Choi MJ, Kim JI, Kim YS, Choi EK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050988&quot;&gt;42050988&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/endogenous-ecotropic-murine-leukemia-virus-promotes-prion-pathogenesis-senescence-accelerated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/endogenous-ecotropic-murine-leukemia-virus-promotes-prion-pathogenesis-senescence-accelerated#comments</comments>
</item>
<item>
 <title>Amyloid pathology and modifiable risk factors in cognitive decline among cognitively unimpaired older adults.</title>
 <link>https://www.alzforum.org/papers/amyloid-pathology-and-modifiable-risk-factors-cognitive-decline-among-cognitively-unimpaired</link>
 <description>J Prev Alzheimers Dis. 2026 Apr 29;13(6):100574.  Epub 2026 Apr 29&lt;br&gt;Authors: Hsu YH, Liang CK, Chou MY, Davidson J, Wang YC, Nalls MA, Ferrucci L, Cookson M, Iwaki H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060990&quot;&gt;42060990&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-pathology-and-modifiable-risk-factors-cognitive-decline-among-cognitively-unimpaired#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-pathology-and-modifiable-risk-factors-cognitive-decline-among-cognitively-unimpaired#comments</comments>
</item>
<item>
 <title>Donepezil increases angiogenic potential in patients with Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/donepezil-increases-angiogenic-potential-patients-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 Apr 29;:13872877261444020.  Epub 2026 Apr 29&lt;br&gt;Authors: Lee M, Kim M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057407&quot;&gt;42057407&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/donepezil-increases-angiogenic-potential-patients-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/donepezil-increases-angiogenic-potential-patients-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Return of Individual Research Information in the Parkinson&#039;s Progression Markers Initiative.</title>
 <link>https://www.alzforum.org/papers/return-individual-research-information-parkinsons-progression-markers-initiative</link>
 <description>Ann Neurol. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Tropea TF, Brodkin K, Brumm MC, Carley JK, Destro C, Flagg E, Heathers LE, Henry B, Lemon LP, Kuhl MM, McMahon BA, Miller M, Myers H, Stanley CE Jr, Talarico JM, Pico C, Chahine LM, Siderowf A, Marek K, Foroud T, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057343&quot;&gt;42057343&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/return-individual-research-information-parkinsons-progression-markers-initiative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/return-individual-research-information-parkinsons-progression-markers-initiative#comments</comments>
</item>
<item>
 <title>Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay.</title>
 <link>https://www.alzforum.org/papers/performance-plasma-ptau217-ptau181-and-their-ratios-av42-detecting-av-pathology-using-china</link>
 <description>Alzheimers Res Ther. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: Yang D, Ke Z, Chen N, Yue L, Chen S, Jiang M, Hu Z, Xie C, Zhu W, Xu J, Yu L, Tang L, Zhao H, Dong J, Li C, Chen G, Luo B, Zhang J, Xu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057058&quot;&gt;42057058&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/performance-plasma-ptau217-ptau181-and-their-ratios-av42-detecting-av-pathology-using-china#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/performance-plasma-ptau217-ptau181-and-their-ratios-av42-detecting-av-pathology-using-china#comments</comments>
</item>
<item>
 <title>PTP1B in astrocytes drives pathogen-induced neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/ptp1b-astrocytes-drives-pathogen-induced-neurodegeneration</link>
 <description>J Neuroinflammation. 2026 Apr 29; Epub 2026 Apr 29&lt;br&gt;Authors: He Z, Xing Y, Gu J, Xu D, He P, Lin X, Cui W, Lv H, Ding H, Sui K, Hao W, Zheng Y, Yang X, Huang X, Yin K, He C, Zheng K, Yu Y, Pan W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057007&quot;&gt;42057007&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ptp1b-astrocytes-drives-pathogen-induced-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ptp1b-astrocytes-drives-pathogen-induced-neurodegeneration#comments</comments>
</item>
<item>
 <title>Rational Design of a Multivalent RNA Combining Structural Motifs Tailored to Multiple Domains of Fused in Sarcoma for Potent Inhibition of Aggregation.</title>
 <link>https://www.alzforum.org/papers/rational-design-multivalent-rna-combining-structural-motifs-tailored-multiple-domains-fused</link>
 <description>Chembiochem. 2026 Apr 28;27(8):e202500568. &lt;br&gt;Authors: Kuroiwa N, Sakaue F, Miura M, Go A, Iwase R, Iwata Hara R, Sanjo N, Ui-Tei K, Yokota T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029573&quot;&gt;42029573&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rational-design-multivalent-rna-combining-structural-motifs-tailored-multiple-domains-fused#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rational-design-multivalent-rna-combining-structural-motifs-tailored-multiple-domains-fused#comments</comments>
</item>
<item>
 <title>Molecular Dynamics Study of the Binding of Cationic, Anionic, and Neutral Luminescent Conjugated Ligands to the Alzheimer Folds of Aβ(1-42) and Tau Fibrils.</title>
 <link>https://www.alzforum.org/papers/molecular-dynamics-study-binding-cationic-anionic-and-neutral-luminescent-conjugated-ligands</link>
 <description>Chembiochem. 2026 Apr 28;27(8):e202500902. &lt;br&gt;Authors: Todarwal Y, Linares M, Norman P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033067&quot;&gt;42033067&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-dynamics-study-binding-cationic-anionic-and-neutral-luminescent-conjugated-ligands#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-dynamics-study-binding-cationic-anionic-and-neutral-luminescent-conjugated-ligands#comments</comments>
</item>
<item>
 <title>Atomic structures of medin and Aβ fibrils reveal polymorphic remodeling in mixed amyloid systems.</title>
 <link>https://www.alzforum.org/papers/atomic-structures-medin-and-av-fibrils-reveal-polymorphic-remodeling-mixed-amyloid-systems</link>
 <description>Nat Commun. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Pradhan B, Kumar ST, Wagner J, Gallardo R, Orlando G, De Vleeschouwer M, Zorzini V, Madine J, Louros N, Neher JJ, Rousseau F, Schymkowitz J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045275&quot;&gt;42045275&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/atomic-structures-medin-and-av-fibrils-reveal-polymorphic-remodeling-mixed-amyloid-systems#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/atomic-structures-medin-and-av-fibrils-reveal-polymorphic-remodeling-mixed-amyloid-systems#comments</comments>
</item>
<item>
 <title>Identification of Secondary Nucleation Inhibitors of Amyloid-β Aggregation by Cellular Selection of a SICLOPPS Library.</title>
 <link>https://www.alzforum.org/papers/identification-secondary-nucleation-inhibitors-amyloid-v-aggregation-cellular-selection</link>
 <description>Chembiochem. 2026 Apr 28;27(8):e202500908. &lt;br&gt;Authors: Lee B, Flood B, Potter E, Wang T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041135&quot;&gt;42041135&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identification-secondary-nucleation-inhibitors-amyloid-v-aggregation-cellular-selection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identification-secondary-nucleation-inhibitors-amyloid-v-aggregation-cellular-selection#comments</comments>
</item>
<item>
 <title>Retraction Note: A novel approach integrating topological deep learning from EEG Data in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/retraction-note-novel-approach-integrating-topological-deep-learning-eeg-data-alzheimers</link>
 <description>Sci Rep. 2026 Apr 28;16(1)&lt;br&gt;Authors: Esteve M, Martinez-Gracia A, Rodríguez-Sala JJ, Brotons-Mas JR, Falcó A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050120&quot;&gt;42050120&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-note-novel-approach-integrating-topological-deep-learning-eeg-data-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-note-novel-approach-integrating-topological-deep-learning-eeg-data-alzheimers#comments</comments>
</item>
<item>
 <title>Diagnostic accuracy of digital clock drawing test for Alzheimer disease and mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/diagnostic-accuracy-digital-clock-drawing-test-alzheimer-disease-and-mild-cognitive</link>
 <description>NPJ Digit Med. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Chang SH, Lin HL, Qian H, Liu ZT, Lu J, Zhong BL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050061&quot;&gt;42050061&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diagnostic-accuracy-digital-clock-drawing-test-alzheimer-disease-and-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diagnostic-accuracy-digital-clock-drawing-test-alzheimer-disease-and-mild-cognitive#comments</comments>
</item>
<item>
 <title>Associations of social isolation and loneliness with neurological disorders, psychiatric disorders, brain structures and behavioural phenotypes among UK Biobank participants.</title>
 <link>https://www.alzforum.org/papers/associations-social-isolation-and-loneliness-neurological-disorders-psychiatric-disorders</link>
 <description>Nat Commun. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Zhao YL, Zhang DD, Gao PY, Fu Y, Ge YJ, Chi HC, Guo ZX, Yu HH, Feng JF, Tan L, Cheng W, Zhang YR, Yu JT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049746&quot;&gt;42049746&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-social-isolation-and-loneliness-neurological-disorders-psychiatric-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-social-isolation-and-loneliness-neurological-disorders-psychiatric-disorders#comments</comments>
</item>
<item>
 <title>Are Cannabis and/or Cannabinoids a Potential Therapy for ALS?</title>
 <link>https://www.alzforum.org/papers/are-cannabis-andor-cannabinoids-potential-therapy-als</link>
 <description>Muscle Nerve. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Vrana KE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049669&quot;&gt;42049669&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/are-cannabis-andor-cannabinoids-potential-therapy-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/are-cannabis-andor-cannabinoids-potential-therapy-als#comments</comments>
</item>
<item>
 <title>[Clinical practice guideline for integrated PET/MRI in Parkinson&#039;s disease (2026 edition)].</title>
 <link>https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-parkinsons-disease-2026-edition</link>
 <description>Zhonghua Yi Xue Za Zhi. 2026 Apr 28;106(16):1541-1554. &lt;br&gt;Authors: Chinese Society of Medical Imaging Technology, Chinese Society of Radiology, Chinese Society of Nuclear Medicine, Beijing Society of Nuclear Medicine, Beijing Society of Radiology&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049519&quot;&gt;42049519&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-parkinsons-disease-2026-edition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-parkinsons-disease-2026-edition#comments</comments>
</item>
<item>
 <title>[Clinical practice guideline for integrated PET/MRI in Alzheimer&#039;s disease (2026 edition)].</title>
 <link>https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-alzheimers-disease-2026-edition</link>
 <description>Zhonghua Yi Xue Za Zhi. 2026 Apr 28;106(16):1527-1540. &lt;br&gt;Authors: Chinese Society of Medical Imaging Technology, Chinese Society of Radiology, Chinese Society of Nuclear Medicine, Beijing Society of Nuclear Medicine, Beijing Society of Radiology&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049518&quot;&gt;42049518&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-alzheimers-disease-2026-edition#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-practice-guideline-integrated-petmri-alzheimers-disease-2026-edition#comments</comments>
</item>
<item>
 <title>Predicting Peptide Aggregation with Protein Language Model Embeddings.</title>
 <link>https://www.alzforum.org/papers/predicting-peptide-aggregation-protein-language-model-embeddings</link>
 <description>J Chem Inf Model. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Eschbach E, Deibler K, Korani D, Swanson S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049499&quot;&gt;42049499&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predicting-peptide-aggregation-protein-language-model-embeddings#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predicting-peptide-aggregation-protein-language-model-embeddings#comments</comments>
</item>
<item>
 <title>α,β-Dehydroamino-Acid-Containing Peptides Resist Proteolysis and Inhibit Aggregation of a Tau-Derived Model Peptide.</title>
 <link>https://www.alzforum.org/papers/av-dehydroamino-acid-containing-peptides-resist-proteolysis-and-inhibit-aggregation-tau</link>
 <description>J Org Chem. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Garcia SG, Almardini AA, Pereira AJ, Xing H, Knox LJ, Jimenez JV, Webster-Ford JC, Moyá DA, Payne JC, Dawes CK, Conda-Sheridan M, Castle SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42048649&quot;&gt;42048649&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/av-dehydroamino-acid-containing-peptides-resist-proteolysis-and-inhibit-aggregation-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/av-dehydroamino-acid-containing-peptides-resist-proteolysis-and-inhibit-aggregation-tau#comments</comments>
</item>
<item>
 <title>Disrupted emotion-memory interactions in behavioral variant frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/disrupted-emotion-memory-interactions-behavioral-variant-frontotemporal-dementia</link>
 <description>Neurol Sci. 2026 Apr 28;47(5)&lt;br&gt;Authors: El Haj M, Chapelet G, Hallit S, Boutoleau-Bretonnière C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047896&quot;&gt;42047896&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disrupted-emotion-memory-interactions-behavioral-variant-frontotemporal-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disrupted-emotion-memory-interactions-behavioral-variant-frontotemporal-dementia#comments</comments>
</item>
<item>
 <title>Association Between Blood-Brain Barrier Disruption and Gut Microbiota Dysbiosis in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/association-between-blood-brain-barrier-disruption-and-gut-microbiota-dysbiosis-parkinsons</link>
 <description>Cell Mol Neurobiol. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Yao W, Liu L, Wang J, Chen S, Zhang C, Liao R, Wang Y, Ou K, Jiang L, Yu Y, Dong W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047847&quot;&gt;42047847&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-blood-brain-barrier-disruption-and-gut-microbiota-dysbiosis-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-blood-brain-barrier-disruption-and-gut-microbiota-dysbiosis-parkinsons#comments</comments>
</item>
<item>
 <title>Parkinson&#039;s disease and the concept of resilience, cognitive, and motor reserve.</title>
 <link>https://www.alzforum.org/papers/parkinsons-disease-and-concept-resilience-cognitive-and-motor-reserve</link>
 <description>J Parkinsons Dis. 2026 Apr 28;:1877718X261444486.  Epub 2026 Apr 28&lt;br&gt;Authors: Hoenig MC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047602&quot;&gt;42047602&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parkinsons-disease-and-concept-resilience-cognitive-and-motor-reserve#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parkinsons-disease-and-concept-resilience-cognitive-and-motor-reserve#comments</comments>
</item>
<item>
 <title>Associations of circulating resistin with Alzheimer&#039;s disease biomarkers and cognitive function in the preclinical stage of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/associations-circulating-resistin-alzheimers-disease-biomarkers-and-cognitive-function</link>
 <description>J Alzheimers Dis. 2026 Apr 28;:13872877261442230.  Epub 2026 Apr 28&lt;br&gt;Authors: Eruysal E, Ravdin L, Iadecola C, Ishii M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047539&quot;&gt;42047539&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-circulating-resistin-alzheimers-disease-biomarkers-and-cognitive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-circulating-resistin-alzheimers-disease-biomarkers-and-cognitive-function#comments</comments>
</item>
<item>
 <title>Charge-Based Discrimination of Amyloids Using an Amyloid-Targeting Chemiluminescent Probe.</title>
 <link>https://www.alzforum.org/papers/charge-based-discrimination-amyloids-using-amyloid-targeting-chemiluminescent-probe</link>
 <description>Chembiochem. 2026 Apr 28;27(8):e202600008. &lt;br&gt;Authors: Chung J, Jessup RE, Yang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047469&quot;&gt;42047469&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/charge-based-discrimination-amyloids-using-amyloid-targeting-chemiluminescent-probe#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/charge-based-discrimination-amyloids-using-amyloid-targeting-chemiluminescent-probe#comments</comments>
</item>
<item>
 <title>Integrating Acridinium Ester with a Soluble Macromolecular Amplification Carrier for Ultrasensitive Detection of Aβ1-42 in Plasma.</title>
 <link>https://www.alzforum.org/papers/integrating-acridinium-ester-soluble-macromolecular-amplification-carrier-ultrasensitive</link>
 <description>Anal Chem. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Guo C, Liu M, An Z, Li S, Cui M, Nie J, Sun Y, Bai Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047375&quot;&gt;42047375&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-acridinium-ester-soluble-macromolecular-amplification-carrier-ultrasensitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-acridinium-ester-soluble-macromolecular-amplification-carrier-ultrasensitive#comments</comments>
</item>
<item>
 <title>Innovative therapies under clinical development for ALS treatment: Small molecules.</title>
 <link>https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-small-molecules</link>
 <description>Expert Opin Investig Drugs. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Martinez-Gonzalez L, Sanchez-Santos C, Huang CS, Gil C, Martinez A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046889&quot;&gt;42046889&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-small-molecules#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-small-molecules#comments</comments>
</item>
<item>
 <title>Medial temporal lobe Tau-Neurodegeneration mismatch from structural imaging and plasma biomarkers.</title>
 <link>https://www.alzforum.org/papers/medial-temporal-lobe-tau-neurodegeneration-mismatch-structural-imaging-and-plasma-biomarkers</link>
 <description>Brain. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Lyu X, Mundada NS, Brown CA, Sadeghpour N, McGrew E, Xie L, Li Y, Wuestefeld A, Duong MT, Cook P, Gee J, Nasrallah IM, Chen-Plotkin AS, Shaw LM, Mechanic-Hamilton D, Wisse LE, Yushkevich PA, Das SR, Wolk DA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046390&quot;&gt;42046390&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/medial-temporal-lobe-tau-neurodegeneration-mismatch-structural-imaging-and-plasma-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/medial-temporal-lobe-tau-neurodegeneration-mismatch-structural-imaging-and-plasma-biomarkers#comments</comments>
</item>
<item>
 <title>A digital twin methodology using retrospective patient data for sample size reduction in Alzheimer&#039;s disease clinical trials.</title>
 <link>https://www.alzforum.org/papers/digital-twin-methodology-using-retrospective-patient-data-sample-size-reduction-alzheimers</link>
 <description>Alzheimers Res Ther. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Andrews D, Golchi S, Collins DL, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046101&quot;&gt;42046101&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/digital-twin-methodology-using-retrospective-patient-data-sample-size-reduction-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/digital-twin-methodology-using-retrospective-patient-data-sample-size-reduction-alzheimers#comments</comments>
</item>
<item>
 <title>From necroptosis to neuroinflammation: Unraveling mechanisms and therapeutic targets in age-related cognitive decline.</title>
 <link>https://www.alzforum.org/papers/necroptosis-neuroinflammation-unraveling-mechanisms-and-therapeutic-targets-age-related</link>
 <description>Biomed Pharmacother. 2026 Apr 28;199:119326.  Epub 2026 Apr 28&lt;br&gt;Authors: Biscetti L, Gambuzza ME, Princiotto M, Sabbatinelli J, Olivieri F, Fiorillo M, Chinigò C, Muglia L, Cozza A, Beccacece A, Gembillo G, Bruschetta G, Villalta Savedra E, Lattanzio F, Corsonello A, Soraci L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054746&quot;&gt;42054746&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/necroptosis-neuroinflammation-unraveling-mechanisms-and-therapeutic-targets-age-related#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/necroptosis-neuroinflammation-unraveling-mechanisms-and-therapeutic-targets-age-related#comments</comments>
</item>
<item>
 <title>Rational design of η6-arene Ru(II) complexes for amyloid-β targeting: influence of coordination lability and aromaticity.</title>
 <link>https://www.alzforum.org/papers/rational-design-i6-arene-ruii-complexes-amyloid-v-targeting-influence-coordination-lability</link>
 <description>Dalton Trans. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Florio D, De Simone C, Annunziata A, Ruffo F, Marasco D, La Manna S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052711&quot;&gt;42052711&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rational-design-i6-arene-ruii-complexes-amyloid-v-targeting-influence-coordination-lability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rational-design-i6-arene-ruii-complexes-amyloid-v-targeting-influence-coordination-lability#comments</comments>
</item>
<item>
 <title>A microglia membrane biomimetic platinum-based MOF-loaded quercetin nanodrug delivery system for the treatment of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/microglia-membrane-biomimetic-platinum-based-mof-loaded-quercetin-nanodrug-delivery-system</link>
 <description>J Mater Chem B. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Zhao R, Guo M, Yang F, Yan Y, Tian D, Deng L, Wang Q, Xie M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052655&quot;&gt;42052655&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-membrane-biomimetic-platinum-based-mof-loaded-quercetin-nanodrug-delivery-system#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-membrane-biomimetic-platinum-based-mof-loaded-quercetin-nanodrug-delivery-system#comments</comments>
</item>
<item>
 <title>Women&#039;s reproductive life patterns, intrinsic capacity, and the risk of all-cause and cause-specific dementia: a prospective cohort study.</title>
 <link>https://www.alzforum.org/papers/womens-reproductive-life-patterns-intrinsic-capacity-and-risk-all-cause-and-cause-specific</link>
 <description>Alzheimers Res Ther. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Zhang Y, Tan Q, Wu S, Xu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050742&quot;&gt;42050742&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/womens-reproductive-life-patterns-intrinsic-capacity-and-risk-all-cause-and-cause-specific#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/womens-reproductive-life-patterns-intrinsic-capacity-and-risk-all-cause-and-cause-specific#comments</comments>
</item>
<item>
 <title>Impact of appendicular skeletal muscle mass on Alzheimer&#039;s disease in relation to age and comorbidities: an 8-year longitudinal follow-up study of a nationwide cohort.</title>
 <link>https://www.alzforum.org/papers/impact-appendicular-skeletal-muscle-mass-alzheimers-disease-relation-age-and-comorbidities-8</link>
 <description>Alzheimers Res Ther. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Chung SJ, Kang M, Park YJ, Oh K, Koh SB, Kang SH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050739&quot;&gt;42050739&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impact-appendicular-skeletal-muscle-mass-alzheimers-disease-relation-age-and-comorbidities-8#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impact-appendicular-skeletal-muscle-mass-alzheimers-disease-relation-age-and-comorbidities-8#comments</comments>
</item>
<item>
 <title>Shared genetic architecture between Alzheimer&#039;s disease and psychiatric disorders revealed by multi-trait genome-wide analyses.</title>
 <link>https://www.alzforum.org/papers/shared-genetic-architecture-between-alzheimers-disease-and-psychiatric-disorders-revealed</link>
 <description>BMC Med Genomics. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Zhang H, Xie L, Meng F, Cui J, Ma B, Wang Y, Zhang K, Miao X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050540&quot;&gt;42050540&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/shared-genetic-architecture-between-alzheimers-disease-and-psychiatric-disorders-revealed#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/shared-genetic-architecture-between-alzheimers-disease-and-psychiatric-disorders-revealed#comments</comments>
</item>
<item>
 <title>The Davos Alzheimer&#039;s Collaborative Healthcare System Preparedness US Early Detection of Cognitive Impairment Program in primary care: Methodology.</title>
 <link>https://www.alzforum.org/papers/davos-alzheimers-collaborative-healthcare-system-preparedness-us-early-detection-cognitive</link>
 <description>BMC Prim Care. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Hornbecker M, Suchsland MZ, MacLeod T, Koppenhofer MJ, Selzler KJ, Ferrell P, Deckert A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42050423&quot;&gt;42050423&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/davos-alzheimers-collaborative-healthcare-system-preparedness-us-early-detection-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/davos-alzheimers-collaborative-healthcare-system-preparedness-us-early-detection-cognitive#comments</comments>
</item>
<item>
 <title>Lipoprotein lipase facilitates Aβ transport across the blood-brain barrier via LRP1: Validation of the obesity paradox in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/lipoprotein-lipase-facilitates-av-transport-across-blood-brain-barrier-lrp1-validation</link>
 <description>J Adv Res. 2026 Apr 28; Epub 2026 Apr 28&lt;br&gt;Authors: Meng N, Li C, Bai F, Zhang J, Li X, Zhang J, Zhang C, Fu J, Fu J, An L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061814&quot;&gt;42061814&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipoprotein-lipase-facilitates-av-transport-across-blood-brain-barrier-lrp1-validation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipoprotein-lipase-facilitates-av-transport-across-blood-brain-barrier-lrp1-validation#comments</comments>
</item>
<item>
 <title>UNEXPECTED MECHANISMS OF REPURPOSED DRUGS IN THE PATHOGENIC PATHWAYS OF NEURODEGENERATIVE DISEASES. DISCOVERING NEW NEUROPROTECTIVE THERAPIES IN CELLULAR MODELS.</title>
 <link>https://www.alzforum.org/papers/unexpected-mechanisms-repurposed-drugs-pathogenic-pathways-neurodegenerative-diseases</link>
 <description>Neuropharmacology. 2026 Apr 28;:110994.  Epub 2026 Apr 28&lt;br&gt;Authors: Arasmou-Idrovo MS, Marín-Rodríguez B, Gironda-Martínez A, García AG, León R, Pascual-Guerra J, Torres-Rico M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061810&quot;&gt;42061810&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unexpected-mechanisms-repurposed-drugs-pathogenic-pathways-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unexpected-mechanisms-repurposed-drugs-pathogenic-pathways-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Apolipoprotein E4 and Synaptic Dysfunction in Alzheimer&#039;s Disease: Mechanisms and Therapeutic Implications.</title>
 <link>https://www.alzforum.org/papers/apolipoprotein-e4-and-synaptic-dysfunction-alzheimers-disease-mechanisms-and-therapeutic</link>
 <description>Ageing Res Rev. 2026 Apr 28;:103153.  Epub 2026 Apr 28&lt;br&gt;Authors: Yao Z, Godje IS, Jiao B, Shen L, Luo SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061654&quot;&gt;42061654&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apolipoprotein-e4-and-synaptic-dysfunction-alzheimers-disease-mechanisms-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apolipoprotein-e4-and-synaptic-dysfunction-alzheimers-disease-mechanisms-and-therapeutic#comments</comments>
</item>
<item>
 <title>Quantitative imaging of iron dysregulation in multiple system atrophy.</title>
 <link>https://www.alzforum.org/papers/quantitative-imaging-iron-dysregulation-multiple-system-atrophy</link>
 <description>Neuroimage. 2026 Apr 28;334:121965.  Epub 2026 Apr 28&lt;br&gt;Authors: Trujillo P, Hett K, Cooper A, Brown AE, Donahue MJ, McKnight CD, Bradbury M, Wong C, Stamler D, Claassen DO&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061593&quot;&gt;42061593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quantitative-imaging-iron-dysregulation-multiple-system-atrophy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quantitative-imaging-iron-dysregulation-multiple-system-atrophy#comments</comments>
</item>
<item>
 <title>Energy metabolic failure drives the selective degeneration of dopaminergic neurons in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/energy-metabolic-failure-drives-selective-degeneration-dopaminergic-neurons-parkinsons</link>
 <description>Prog Neuropsychopharmacol Biol Psychiatry. 2026 Apr 28;:111722.  Epub 2026 Apr 28&lt;br&gt;Authors: Zhou Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061580&quot;&gt;42061580&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/energy-metabolic-failure-drives-selective-degeneration-dopaminergic-neurons-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/energy-metabolic-failure-drives-selective-degeneration-dopaminergic-neurons-parkinsons#comments</comments>
</item>
<item>
 <title>Impaired sleep microarchitecture is associated with locus coeruleus degeneration in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/impaired-sleep-microarchitecture-associated-locus-coeruleus-degeneration-parkinsons-disease</link>
 <description>Parkinsonism Relat Disord. 2026 Apr 28;147:108339.  Epub 2026 Apr 28&lt;br&gt;Authors: Doppler CE, Sembowski N, Plottka D, Hommelsen M, Röttgen S, Schwabedal JT, Schreiner SJ, Fink GR, Borghammer P, Bialonski S, Sommerauer M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061026&quot;&gt;42061026&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impaired-sleep-microarchitecture-associated-locus-coeruleus-degeneration-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impaired-sleep-microarchitecture-associated-locus-coeruleus-degeneration-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Correction to: Dementia risk across distinct metabolic profiles in the UK Biobank.</title>
 <link>https://www.alzforum.org/papers/correction-dementia-risk-across-distinct-metabolic-profiles-uk-biobank</link>
 <description>Geroscience. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Lumsden AL, Mulugeta A, Hyppönen E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036541&quot;&gt;42036541&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-dementia-risk-across-distinct-metabolic-profiles-uk-biobank#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-dementia-risk-across-distinct-metabolic-profiles-uk-biobank#comments</comments>
</item>
<item>
 <title>LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?</title>
 <link>https://www.alzforum.org/papers/lrrk2-and-gba1-lewy-body-diseases-neuropathological-subtypes-opposite-ends-spectrum</link>
 <description>Mol Neurodegener. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Jha V, Kalia LV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045964&quot;&gt;42045964&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lrrk2-and-gba1-lewy-body-diseases-neuropathological-subtypes-opposite-ends-spectrum#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lrrk2-and-gba1-lewy-body-diseases-neuropathological-subtypes-opposite-ends-spectrum#comments</comments>
</item>
<item>
 <title>An interpretable deep learning diagnostic framework for early Alzheimer&#039;s disease based on EEG microstate spectra and multi-branch CNN.</title>
 <link>https://www.alzforum.org/papers/interpretable-deep-learning-diagnostic-framework-early-alzheimers-disease-based-eeg</link>
 <description>J Neuroeng Rehabil. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Li Z, Li X, Qu Z, Su R, Yin B, Yin L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045954&quot;&gt;42045954&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-deep-learning-diagnostic-framework-early-alzheimers-disease-based-eeg#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-deep-learning-diagnostic-framework-early-alzheimers-disease-based-eeg#comments</comments>
</item>
<item>
 <title>Peripheral blood biomarkers RCAN1, Clusterin, RAGE, and malondialdehyde for early diagnosis and progression of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/peripheral-blood-biomarkers-rcan1-clusterin-rage-and-malondialdehyde-early-diagnosis-and</link>
 <description>BMC Med. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Román-Domínguez A, Mas-Bargues C, Pérez V, Medina M, Ávila J, Borrás C, Viña J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045900&quot;&gt;42045900&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/peripheral-blood-biomarkers-rcan1-clusterin-rage-and-malondialdehyde-early-diagnosis-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/peripheral-blood-biomarkers-rcan1-clusterin-rage-and-malondialdehyde-early-diagnosis-and#comments</comments>
</item>
<item>
 <title>Modulation of biomolecular condensation of alpha-synuclein variants by eprodisate.</title>
 <link>https://www.alzforum.org/papers/modulation-biomolecular-condensation-alpha-synuclein-variants-eprodisate</link>
 <description>Commun Chem. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Biswas S, Mavlankar NA, Panuganti V, Pal A, Roy I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045548&quot;&gt;42045548&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modulation-biomolecular-condensation-alpha-synuclein-variants-eprodisate#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modulation-biomolecular-condensation-alpha-synuclein-variants-eprodisate#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease-like brain pattern biomarker: capturing risks and predicting disease onset.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-brain-pattern-biomarker-capturing-risks-and-predicting-disease-onset-0</link>
 <description>Mol Psychiatry. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Kochunov P, Gao S, Salminen LE, Jahanshad N, Nir TM, Thompson PM, Du X, Adhikari BM, Kochunov A, Cassidy R, Ma Y, Chiappelli J, Ament S, Pan Y, Chen S, Shuldiner AR, Mitchell BD, Soares LJ, Hong LE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045435&quot;&gt;42045435&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-brain-pattern-biomarker-capturing-risks-and-predicting-disease-onset-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-brain-pattern-biomarker-capturing-risks-and-predicting-disease-onset-0#comments</comments>
</item>
<item>
 <title>Estren prevents beta-amyloid-induced basal forebrain cholinergic loss and long-term spatial memory deficits in aged female mice.</title>
 <link>https://www.alzforum.org/papers/estren-prevents-beta-amyloid-induced-basal-forebrain-cholinergic-loss-and-long-term-spatial</link>
 <description>Sci Rep. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: McLoughlin J, Sayfullaeva J, Kiliç E, Carmody C, Grochowska N, Potapov K, Potapov D, Clarkson A, Peppercorn K, Tate W, Kwakowsky A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045407&quot;&gt;42045407&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/estren-prevents-beta-amyloid-induced-basal-forebrain-cholinergic-loss-and-long-term-spatial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/estren-prevents-beta-amyloid-induced-basal-forebrain-cholinergic-loss-and-long-term-spatial#comments</comments>
</item>
<item>
 <title>Effects of exercise modalities on cognitive and muscle function in older adults with cognitive impairment: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/effects-exercise-modalities-cognitive-and-muscle-function-older-adults-cognitive-impairment</link>
 <description>Sci Rep. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Choe YH, Cho EJ, Choi Y, Park DH, Kang JH, Kwak HB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045298&quot;&gt;42045298&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-exercise-modalities-cognitive-and-muscle-function-older-adults-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-exercise-modalities-cognitive-and-muscle-function-older-adults-cognitive-impairment#comments</comments>
</item>
<item>
 <title>The PM20D1-OLE pathway induces microglia rewiring to ameliorate Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/pm20d1-ole-pathway-induces-microglia-rewiring-ameliorate-alzheimer-disease</link>
 <description>Cell Death Dis. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Pozzi-Ruiz V, Giner de Gracia A, Glauser L, Romani M, Gunter-Rahman F, González-Ramón A, Haj-Yahya M, Kolla R, Burns AM, Lashuel HA, Auwerx J, Gräff J, Sanchez-Mut JV&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045164&quot;&gt;42045164&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pm20d1-ole-pathway-induces-microglia-rewiring-ameliorate-alzheimer-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pm20d1-ole-pathway-induces-microglia-rewiring-ameliorate-alzheimer-disease#comments</comments>
</item>
<item>
 <title>Correction to &quot;Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson&#039;s Disease&quot;.</title>
 <link>https://www.alzforum.org/papers/correction-discovery-potent-selective-cns-penetrant-macrocyclic-lrrk2-inhibitors-treatment</link>
 <description>J Med Chem. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Yu EC, Zhou H, Yan X, Logan KM, Li D, Gulati A, Poremba KE, Ardolino MJ, Su J, Xiao D, Palte RL, McMinn SE, Nogle LM, Adpressa DA, Burgess SA, Xiong T, Otte KM, Chobanian HR, Bass A, Lee S, Pearson K, Messina E, Parisi M, Barnum J, Sobol Z, Ciaccio PJ, DiMauro EF, Fell MJ, Fuller PH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045162&quot;&gt;42045162&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-discovery-potent-selective-cns-penetrant-macrocyclic-lrrk2-inhibitors-treatment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-discovery-potent-selective-cns-penetrant-macrocyclic-lrrk2-inhibitors-treatment#comments</comments>
</item>
<item>
 <title>Cerebrospinal Fluid Amyloid-β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy.</title>
 <link>https://www.alzforum.org/papers/cerebrospinal-fluid-amyloid-v-biomarkers-predict-future-hemorrhage-patients-cerebral-amyloid</link>
 <description>Ann Neurol. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Arndt P, Pfister M, Perosa V, Mattern H, Tas M, Holzheimer L, Engel J, Dörner M, Al-Dubai M, Garz C, Khadhraoui E, Müller SJ, Müller P, Meuth SG, Neumann K, Schreiber S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42045103&quot;&gt;42045103&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebrospinal-fluid-amyloid-v-biomarkers-predict-future-hemorrhage-patients-cerebral-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebrospinal-fluid-amyloid-v-biomarkers-predict-future-hemorrhage-patients-cerebral-amyloid#comments</comments>
</item>
<item>
 <title>Stimuli-Chromic Oxazolidine Derivatives as Highly Efficient Molecular Probes for Monitoring Fibrillation Kinetics and Intracellular Detection of Amyloid Fibrils.</title>
 <link>https://www.alzforum.org/papers/stimuli-chromic-oxazolidine-derivatives-highly-efficient-molecular-probes-monitoring</link>
 <description>Biochemistry. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Tondkar F, Rezaeifar F, Ghorbani M, Abdollahi A, Meratan AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044386&quot;&gt;42044386&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stimuli-chromic-oxazolidine-derivatives-highly-efficient-molecular-probes-monitoring#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stimuli-chromic-oxazolidine-derivatives-highly-efficient-molecular-probes-monitoring#comments</comments>
</item>
<item>
 <title>Chronic traumatic encephalopathy neuropathologic change is associated with highest stage limbic-predominant age-related TDP-43 encephalopathy.</title>
 <link>https://www.alzforum.org/papers/chronic-traumatic-encephalopathy-neuropathologic-change-associated-highest-stage-limbic</link>
 <description>J Neuropathol Exp Neurol. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Song H, Ameen-Ali KE, Kennedy-Dietrich C, Dolle JP, Lee EB, Smith DH, Stewart W, CONNECT-TBI Investigators&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044052&quot;&gt;42044052&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chronic-traumatic-encephalopathy-neuropathologic-change-associated-highest-stage-limbic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chronic-traumatic-encephalopathy-neuropathologic-change-associated-highest-stage-limbic#comments</comments>
</item>
<item>
 <title>The central role of mitochondrial dysfunction in neurodegeneration: implications for therapy.</title>
 <link>https://www.alzforum.org/papers/central-role-mitochondrial-dysfunction-neurodegeneration-implications-therapy</link>
 <description>Mol Cell Biochem. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Raafat MA, Al-Hasnaawei S, Mousa HM, Hanumanthayya M, Sahoo S, Prathiba S, Singh G, Sinha A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043769&quot;&gt;42043769&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/central-role-mitochondrial-dysfunction-neurodegeneration-implications-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/central-role-mitochondrial-dysfunction-neurodegeneration-implications-therapy#comments</comments>
</item>
<item>
 <title>Chitosan-curcumin nanoparticles: a potential nano-therapeutic for cognitive restoration in a streptozotocin-induced rat model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/chitosan-curcumin-nanoparticles-potential-nano-therapeutic-cognitive-restoration</link>
 <description>Inflammopharmacology. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Khozani MS, Palizvan M, Mosayebi G, Ganji A, Ghazavi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043712&quot;&gt;42043712&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chitosan-curcumin-nanoparticles-potential-nano-therapeutic-cognitive-restoration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chitosan-curcumin-nanoparticles-potential-nano-therapeutic-cognitive-restoration#comments</comments>
</item>
<item>
 <title>Twenty-four-hour blood pressure and CSF biomarkers of Alzheimer&#039;s disease and related dementias in a community cohort.</title>
 <link>https://www.alzforum.org/papers/twenty-four-hour-blood-pressure-and-csf-biomarkers-alzheimers-disease-and-related-dementias</link>
 <description>Geroscience. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Gibson M, O&amp;#039;Brien WT, Rowsthorn E, Franks KH, Cribb L, Cavuoto M, Campbell-Brown B, Harding I, Law M, Chong TT, McDonald SJ, O&amp;#039;Brien TJ, Vivash L, Yiallourou S, Pase MP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043710&quot;&gt;42043710&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/twenty-four-hour-blood-pressure-and-csf-biomarkers-alzheimers-disease-and-related-dementias#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/twenty-four-hour-blood-pressure-and-csf-biomarkers-alzheimers-disease-and-related-dementias#comments</comments>
</item>
<item>
 <title>Role of Folate Metabolism in Neurodegenerative Diseases: Insight from Experimental and Clinical Studies.</title>
 <link>https://www.alzforum.org/papers/role-folate-metabolism-neurodegenerative-diseases-insight-experimental-and-clinical-studies</link>
 <description>Curr Nutr Rep. 2026 Apr 27;15(1)&lt;br&gt;Authors: Umar M, Franjieh K, White AL, Ward-Dones E, Ismael S, Roskey RC, Courseault J, Bix GJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043709&quot;&gt;42043709&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-folate-metabolism-neurodegenerative-diseases-insight-experimental-and-clinical-studies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-folate-metabolism-neurodegenerative-diseases-insight-experimental-and-clinical-studies#comments</comments>
</item>
<item>
 <title>Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer&#039;s Disease: A Recent Review.</title>
 <link>https://www.alzforum.org/papers/signaling-pathways-triggering-therapeutical-potential-marine-derived-polysaccharides</link>
 <description>Mol Neurobiol. 2026 Apr 27;63(1)&lt;br&gt;Authors: Kumar D, Kondaveeti SB, Agrawal M, Kumar A, Awasthi A, Mahmood S, Singh TG, Kumar M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043700&quot;&gt;42043700&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/signaling-pathways-triggering-therapeutical-potential-marine-derived-polysaccharides#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/signaling-pathways-triggering-therapeutical-potential-marine-derived-polysaccharides#comments</comments>
</item>
<item>
 <title>FTDP-17T Mutations Promote Formation of Phosphorylated FTDP-17T TAU Oligomers That Cause Degeneration of Dopaminergic and Hippocampal Neurons via Activating ER Stress and Mitochondrial Pro-apoptotic Cascades.</title>
 <link>https://www.alzforum.org/papers/ftdp-17t-mutations-promote-formation-phosphorylated-ftdp-17t-tau-oligomers-cause-degeneration</link>
 <description>Neurochem Res. 2026 Apr 27;51(3)&lt;br&gt;Authors: Wang HL, Weng YH, Chiu CC, Chen WS, Liu SY, Yeh TH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043652&quot;&gt;42043652&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ftdp-17t-mutations-promote-formation-phosphorylated-ftdp-17t-tau-oligomers-cause-degeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ftdp-17t-mutations-promote-formation-phosphorylated-ftdp-17t-tau-oligomers-cause-degeneration#comments</comments>
</item>
<item>
 <title>Correction: Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups.</title>
 <link>https://www.alzforum.org/papers/correction-cutaneous-synuclein-pathology-differential-marker-histological-and-statistical</link>
 <description>J Mol Neurosci. 2026 Apr 27;76(2)&lt;br&gt;Authors: Šebelová D, Menšíková K, Kaiserová M, Satke L, Grambalová Z, Čížková K, Tauber Z, Klíčová K, Hraboš D, Cook SE, Zapletalová J, Kaňovský P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043620&quot;&gt;42043620&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-cutaneous-synuclein-pathology-differential-marker-histological-and-statistical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-cutaneous-synuclein-pathology-differential-marker-histological-and-statistical#comments</comments>
</item>
<item>
 <title>Targeting the BDNF/TrkB/CREB pathway: emerging strategies for neuroprotection in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/targeting-bdnftrkbcreb-pathway-emerging-strategies-neuroprotection-parkinsons-disease</link>
 <description>Mol Biol Rep. 2026 Apr 27;53(1)&lt;br&gt;Authors: Ahire C, Kaur G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043595&quot;&gt;42043595&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-bdnftrkbcreb-pathway-emerging-strategies-neuroprotection-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-bdnftrkbcreb-pathway-emerging-strategies-neuroprotection-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Plasma biomarkers of neurodegeneration and intraindividual cognitive variability: Comparing variability across test at one time point and using repeated ecological momentary assessment.</title>
 <link>https://www.alzforum.org/papers/plasma-biomarkers-neurodegeneration-and-intraindividual-cognitive-variability-comparing</link>
 <description>Neuropsychology. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Fonseca LM, Weeks DL, Cleveland M, Hawks ZW, Jung L, Kudva YC, Rizvi S, Bulger J, Grinspoon E, Janess K, Sliwinski M, Pratley RE, Rickels MR, Weinstock RS, Chhatwal JP, Kivisäkk PW, Beeri MS, Germine LT, Chaytor NS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043433&quot;&gt;42043433&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-biomarkers-neurodegeneration-and-intraindividual-cognitive-variability-comparing#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-biomarkers-neurodegeneration-and-intraindividual-cognitive-variability-comparing#comments</comments>
</item>
<item>
 <title>Barriers and enablers to cognitive assessment in Parkinson&#039;s disease: A qualitative contextual inquiry.</title>
 <link>https://www.alzforum.org/papers/barriers-and-enablers-cognitive-assessment-parkinsons-disease-qualitative-contextual-inquiry</link>
 <description>J Parkinsons Dis. 2026 Apr 27;:1877718X261440707.  Epub 2026 Apr 27&lt;br&gt;Authors: Brooks D, Shrubsole K, Sriram D, Yang J, Mitchell LK, Worthy P, Lobo E, Pourzinal D, Dissanayaka NN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041287&quot;&gt;42041287&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/barriers-and-enablers-cognitive-assessment-parkinsons-disease-qualitative-contextual-inquiry#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/barriers-and-enablers-cognitive-assessment-parkinsons-disease-qualitative-contextual-inquiry#comments</comments>
</item>
<item>
 <title>Probing Allosteric Kinase Modulators as Next Game-Changers in Fighting Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/probing-allosteric-kinase-modulators-next-game-changers-fighting-neurodegeneration</link>
 <description>J Med Chem. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Roggiolani E, Rosini M, Minarini A, Basagni F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041106&quot;&gt;42041106&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/probing-allosteric-kinase-modulators-next-game-changers-fighting-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/probing-allosteric-kinase-modulators-next-game-changers-fighting-neurodegeneration#comments</comments>
</item>
<item>
 <title>EXPRESS: Association Between PTEN-Induced Kinase 1 (PINK1) rs3738136 Polymorphism and Parkinson&#039;s Disease: A Meta-Analytic Study.</title>
 <link>https://www.alzforum.org/papers/express-association-between-pten-induced-kinase-1-pink1-rs3738136-polymorphism-and-parkinsons</link>
 <description>J Investig Med. 2026 Apr 27;:10815589261448841.  Epub 2026 Apr 27&lt;br&gt;Authors: Shibi Anilkumar A, Thomas SM, Veerabathiran R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037593&quot;&gt;42037593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/express-association-between-pten-induced-kinase-1-pink1-rs3738136-polymorphism-and-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/express-association-between-pten-induced-kinase-1-pink1-rs3738136-polymorphism-and-parkinsons#comments</comments>
</item>
<item>
 <title>Protective Effects of a Propolis-Petasites japonicus Mixture on Scopolamine-Induced Memory Impairment in Mice.</title>
 <link>https://www.alzforum.org/papers/protective-effects-propolis-petasites-japonicus-mixture-scopolamine-induced-memory-impairment</link>
 <description>J Microbiol Biotechnol. 2026 Apr 27;36:e2602019. &lt;br&gt;Authors: Kim MY, Shin JY, Lim JH, Park JH, Hur YK, Yun SI, Cho BO, Jang SI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049692&quot;&gt;42049692&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protective-effects-propolis-petasites-japonicus-mixture-scopolamine-induced-memory-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protective-effects-propolis-petasites-japonicus-mixture-scopolamine-induced-memory-impairment#comments</comments>
</item>
<item>
 <title>Retraction notice to &quot;Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance&quot; [Biomedicine &amp; Pharmacotherapy 153 (2022) 113305].</title>
 <link>https://www.alzforum.org/papers/retraction-notice-recent-advancements-nanoparticles-application-cancer-and-neurodegenerative</link>
 <description>Biomed Pharmacother. 2026 Apr 27;:119424.  Epub 2026 Apr 27&lt;br&gt;Authors: Rahman MM, Islam MR, Akash S, Harun-Or-Rashid M, Ray TK, Rahaman MS, Islam M, Anika F, Hosain MK, Aovi FI, Hemeg HA, Rauf A, Wilairatana P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049627&quot;&gt;42049627&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-notice-recent-advancements-nanoparticles-application-cancer-and-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-notice-recent-advancements-nanoparticles-application-cancer-and-neurodegenerative#comments</comments>
</item>
<item>
 <title>Lipid-lowering regimens in Alzheimer&#039;s disease dementia: small effects with potential long-term benefit.</title>
 <link>https://www.alzforum.org/papers/lipid-lowering-regimens-alzheimers-disease-dementia-small-effects-potential-long-term-benefit</link>
 <description>J Prev Alzheimers Dis. 2026 Apr 27;13(6):100576.  Epub 2026 Apr 27&lt;br&gt;Authors: Hartmann T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42048844&quot;&gt;42048844&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipid-lowering-regimens-alzheimers-disease-dementia-small-effects-potential-long-term-benefit#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipid-lowering-regimens-alzheimers-disease-dementia-small-effects-potential-long-term-benefit#comments</comments>
</item>
<item>
 <title>The Unusual Suspects: Macrophages in Parkinson&#039;s Disease?</title>
 <link>https://www.alzforum.org/papers/unusual-suspects-macrophages-parkinsons-disease</link>
 <description>Mov Disord. 2026 Apr 27; Epub 2026 Apr 27&lt;br&gt;Authors: Bhardwaj S, Stezin A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046394&quot;&gt;42046394&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unusual-suspects-macrophages-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unusual-suspects-macrophages-parkinsons-disease#comments</comments>
</item>
<item>
 <title>N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/n-terminally-acetylated-met11-tau-new-pathological-truncated-tau-species-functional-relevance</link>
 <description>Transl Neurodegener. 2026 Apr 27;15(1)&lt;br&gt;Authors: Guedjdal S, Leghay C, Derisbourg M, Eddarkaoui S, Lecerf S, Vermon F, Caillierez R, Begard S, Regost C, Laloux C, da Costa PJ, Carvalho K, Chiappetta G, Verdier Y, Buée-Scherrer V, Deramecourt V, Schraen S, Blum D, Martin F, Buée L, Hamdane M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046086&quot;&gt;42046086&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/n-terminally-acetylated-met11-tau-new-pathological-truncated-tau-species-functional-relevance#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/n-terminally-acetylated-met11-tau-new-pathological-truncated-tau-species-functional-relevance#comments</comments>
</item>
<item>
 <title>Amyloid-beta statuses prediction with free water MR imaging features in Alzheimer&#039;s disease using machine learning models.</title>
 <link>https://www.alzforum.org/papers/amyloid-beta-statuses-prediction-free-water-mr-imaging-features-alzheimers-disease-using</link>
 <description>BMC Med Imaging. 2026 Apr 27;26(1)&lt;br&gt;Authors: Zhou R, Sun X, Chen S, Zhao S, Zhao C, Qu J, Zeng W, Li C, Zhang X, Li Z, Wang Y, Zhang T, Xu X, Jia J, Liang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046023&quot;&gt;42046023&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-beta-statuses-prediction-free-water-mr-imaging-features-alzheimers-disease-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-beta-statuses-prediction-free-water-mr-imaging-features-alzheimers-disease-using#comments</comments>
</item>
<item>
 <title>Essence: A benchmarking-validated transformer framework for early diagnosis of Parkinson&#039;s disease using cerebrospinal fluid protein biomarkers.</title>
 <link>https://www.alzforum.org/papers/essence-benchmarking-validated-transformer-framework-early-diagnosis-parkinsons-disease-using</link>
 <description>Int J Biol Macromol. 2026 Apr 27;:152244.  Epub 2026 Apr 27&lt;br&gt;Authors: Zhou Z, Xie X, Hao Y, Han K, Wang T, Hong F, Wei Y, Xie S, Luo X, Li X, Liu L, Dao F, Lin H, Lai H, Lyu H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055361&quot;&gt;42055361&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/essence-benchmarking-validated-transformer-framework-early-diagnosis-parkinsons-disease-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/essence-benchmarking-validated-transformer-framework-early-diagnosis-parkinsons-disease-using#comments</comments>
</item>
<item>
 <title>A coherent structural picture of the interaction of Tau with tubulin provides a link to its aggregation.</title>
 <link>https://www.alzforum.org/papers/coherent-structural-picture-interaction-tau-tubulin-provides-link-its-aggregation</link>
 <description>J Biol Chem. 2026 Apr 27;:113086.  Epub 2026 Apr 27&lt;br&gt;Authors: Gigant B, Khodja LA, Campanacci V, Lippens G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055333&quot;&gt;42055333&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/coherent-structural-picture-interaction-tau-tubulin-provides-link-its-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/coherent-structural-picture-interaction-tau-tubulin-provides-link-its-aggregation#comments</comments>
</item>
<item>
 <title>Bridging the gaps in Alzheimer&#039;s disease biomarker research: From multi-omics integration to point-of-care diagnostics, a comprehensive review.</title>
 <link>https://www.alzforum.org/papers/bridging-gaps-alzheimers-disease-biomarker-research-multi-omics-integration-point-care</link>
 <description>Clin Chim Acta. 2026 Apr 27;589:121046.  Epub 2026 Apr 27&lt;br&gt;Authors: Khasanov S, Tolibov M, Daminova N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055309&quot;&gt;42055309&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bridging-gaps-alzheimers-disease-biomarker-research-multi-omics-integration-point-care#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bridging-gaps-alzheimers-disease-biomarker-research-multi-omics-integration-point-care#comments</comments>
</item>
<item>
 <title>Selective vulnerability of monoaminergic neurons and network spread of alpha-synuclein jointly explain pathology progression in Parkinson&#039;s disease models.</title>
 <link>https://www.alzforum.org/papers/selective-vulnerability-monoaminergic-neurons-and-network-spread-alpha-synuclein-jointly</link>
 <description>Neurobiol Dis. 2026 Apr 27;:107403.  Epub 2026 Apr 27&lt;br&gt;Authors: Teshome S, Torok J, Mezias C, Gupta A, Raj A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055257&quot;&gt;42055257&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/selective-vulnerability-monoaminergic-neurons-and-network-spread-alpha-synuclein-jointly#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/selective-vulnerability-monoaminergic-neurons-and-network-spread-alpha-synuclein-jointly#comments</comments>
</item>
<item>
 <title>Cognitive trajectories in early Parkinson&#039;s disease: A multimodal MRI study of brain structure and cognitive decline.</title>
 <link>https://www.alzforum.org/papers/cognitive-trajectories-early-parkinsons-disease-multimodal-mri-study-brain-structure-and</link>
 <description>Neurobiol Dis. 2026 Apr 27;:107407.  Epub 2026 Apr 27&lt;br&gt;Authors: Wen C, Xing Y, Zhou H, Li J, Feng Y, Xu Y, Shi H, Hu X, Zheng J, Liu W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055256&quot;&gt;42055256&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-trajectories-early-parkinsons-disease-multimodal-mri-study-brain-structure-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-trajectories-early-parkinsons-disease-multimodal-mri-study-brain-structure-and#comments</comments>
</item>
<item>
 <title>Compensatory and impaired trust updating in mild cognitive impairment: Evidence from computational modeling and fMRI.</title>
 <link>https://www.alzforum.org/papers/compensatory-and-impaired-trust-updating-mild-cognitive-impairment-evidence-computational</link>
 <description>Neuroimage. 2026 Apr 27;:121956.  Epub 2026 Apr 27&lt;br&gt;Authors: Chen Y, He H, Ding Y, Tao W, Guan Q, Krueger F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055236&quot;&gt;42055236&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/compensatory-and-impaired-trust-updating-mild-cognitive-impairment-evidence-computational#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/compensatory-and-impaired-trust-updating-mild-cognitive-impairment-evidence-computational#comments</comments>
</item>
<item>
 <title>Longitudinal Surface-Based Morphometry Changes in the Hippocampus in Dementia.</title>
 <link>https://www.alzforum.org/papers/longitudinal-surface-based-morphometry-changes-hippocampus-dementia</link>
 <description>Neuropsychologia. 2026 Apr 27;:109470.  Epub 2026 Apr 27&lt;br&gt;Authors: Aziz S, Penheiro R, Morrison C, Zhukovsky P, Anderson JA, Alzheimer&amp;#039;s Disease Neuroimaging Initiative (ADNI)&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055188&quot;&gt;42055188&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longitudinal-surface-based-morphometry-changes-hippocampus-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longitudinal-surface-based-morphometry-changes-hippocampus-dementia#comments</comments>
</item>
<item>
 <title>Icariin promotes lysosomal degradation of amyloid-β precursor protein via enhanced endosome-lysosome trafficking to reduce amyloid-β accumulation and improve cognitive function in Alzheimer&#039;s disease models.</title>
 <link>https://www.alzforum.org/papers/icariin-promotes-lysosomal-degradation-amyloid-v-precursor-protein-enhanced-endosome-lysosome</link>
 <description>Brain Res Bull. 2026 Apr 27;240:111906.  Epub 2026 Apr 27&lt;br&gt;Authors: Lin C, Xu Z, Yan J, Liu B, Li F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055146&quot;&gt;42055146&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/icariin-promotes-lysosomal-degradation-amyloid-v-precursor-protein-enhanced-endosome-lysosome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/icariin-promotes-lysosomal-degradation-amyloid-v-precursor-protein-enhanced-endosome-lysosome#comments</comments>
</item>
<item>
 <title>The role of ultrasound in addressing neurodegenerative diseases: A review of mechanisms, applications, and challenges.</title>
 <link>https://www.alzforum.org/papers/role-ultrasound-addressing-neurodegenerative-diseases-review-mechanisms-applications-and</link>
 <description>Neuroscience. 2026 Apr 27;606:126-137.  Epub 2026 Apr 27&lt;br&gt;Authors: Zhu Y, Zhang H, Zhang Z, Song G, Fu J, Wang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055109&quot;&gt;42055109&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-ultrasound-addressing-neurodegenerative-diseases-review-mechanisms-applications-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-ultrasound-addressing-neurodegenerative-diseases-review-mechanisms-applications-and#comments</comments>
</item>
<item>
 <title>Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/tiny-titans-big-promise-nanotechnology-and-microrna-fight-against-alzheimers-disease</link>
 <description>Ageing Res Rev. 2026 Apr 27;119:103149.  Epub 2026 Apr 27&lt;br&gt;Authors: Nakum B, Vejpara D, Faldu K, Soni R, Shah J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055093&quot;&gt;42055093&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tiny-titans-big-promise-nanotechnology-and-microrna-fight-against-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tiny-titans-big-promise-nanotechnology-and-microrna-fight-against-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Serious side effects of Alzheimer&#039;s immunotherapy demand scrutiny.</title>
 <link>https://www.alzforum.org/papers/serious-side-effects-alzheimers-immunotherapy-demand-scrutiny</link>
 <description>Ageing Res Rev. 2026 Apr 27;119:103151.  Epub 2026 Apr 27&lt;br&gt;Authors: Høilund-Carlsen PF, Alavi A, Andalib S, Castellani RJ, Costa T, de Girolamo G, Espay AJ, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B, Barrio JR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055092&quot;&gt;42055092&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/serious-side-effects-alzheimers-immunotherapy-demand-scrutiny#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/serious-side-effects-alzheimers-immunotherapy-demand-scrutiny#comments</comments>
</item>
<item>
 <title>Poly-GR promotes ferroptosis-associated vulnerability in C9orf72-ALS.</title>
 <link>https://www.alzforum.org/papers/poly-gr-promotes-ferroptosis-associated-vulnerability-c9orf72-als</link>
 <description>Cell Biosci. 2026 Apr 26; Epub 2026 Apr 26&lt;br&gt;Authors: Lin CY, Hsieh WC, Wang SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036719&quot;&gt;42036719&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/poly-gr-promotes-ferroptosis-associated-vulnerability-c9orf72-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/poly-gr-promotes-ferroptosis-associated-vulnerability-c9orf72-als#comments</comments>
</item>
<item>
 <title>Seeing Invisible Oligomers: Rethinking α-Synuclein Pathology Through Proximity Ligation Assay.</title>
 <link>https://www.alzforum.org/papers/seeing-invisible-oligomers-rethinking-synuclein-pathology-through-proximity-ligation-assay</link>
 <description>Mov Disord. 2026 Apr 26; Epub 2026 Apr 26&lt;br&gt;Authors: Sekiya H, Jensen NM, Dickson DW, Jensen PH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036389&quot;&gt;42036389&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/seeing-invisible-oligomers-rethinking-synuclein-pathology-through-proximity-ligation-assay#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/seeing-invisible-oligomers-rethinking-synuclein-pathology-through-proximity-ligation-assay#comments</comments>
</item>
<item>
 <title>Data-driven thresholds for standardized classification of severe Alzheimer&#039;s disease neuropathology using digital neuropathology.</title>
 <link>https://www.alzforum.org/papers/data-driven-thresholds-standardized-classification-severe-alzheimers-disease-neuropathology</link>
 <description>Brain Pathol. 2026 Apr 26;:e70102.  Epub 2026 Apr 26&lt;br&gt;Authors: Shahidehpour RK, Neltner AM, Klusty MA, Corbett C, Gonzalez AD, Gutman DA, Fardo DW, Bachstetter AD, Bumgardner C, Flanagan ME, Nelson PT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035704&quot;&gt;42035704&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/data-driven-thresholds-standardized-classification-severe-alzheimers-disease-neuropathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/data-driven-thresholds-standardized-classification-severe-alzheimers-disease-neuropathology#comments</comments>
</item>
<item>
 <title>Social dysfunction and default mode network functional integrity in neuropsychiatric disorders: A cross-disorder replication and generalization study.</title>
 <link>https://www.alzforum.org/papers/social-dysfunction-and-default-mode-network-functional-integrity-neuropsychiatric-disorders</link>
 <description>Eur Neuropsychopharmacol. 2026 Apr 26;110:112847.  Epub 2026 Apr 26&lt;br&gt;Authors: Braak S, Mennes M, Su T, Pijnenburg Y, Bakker G, Arango C, van der Wee N, Bauduin S, Ortiz-Tallo Moya A, Lopez-Morinigo JD, Dawson GR, Abrahams AB, Beckenstrom AC, Beckmann CF, Marston HM, Penninx BW, Kas MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044556&quot;&gt;42044556&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/social-dysfunction-and-default-mode-network-functional-integrity-neuropsychiatric-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/social-dysfunction-and-default-mode-network-functional-integrity-neuropsychiatric-disorders#comments</comments>
</item>
<item>
 <title>Insights Gained From the PPMI Brain Donation Program.</title>
 <link>https://www.alzforum.org/papers/insights-gained-ppmi-brain-donation-program</link>
 <description>Ann Neurol. 2026 Apr 26; Epub 2026 Apr 26&lt;br&gt;Authors: Foroud T, Heathers LE, Bukhari S, Poston KL, Antonopoulos G, Mantravadi K, Rumbaugh M, Mac Donald CL, Latimer CS, Tropea TF, Marek K, Keene CD, Montine TJ, Parkinson&amp;#039;s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036930&quot;&gt;42036930&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/insights-gained-ppmi-brain-donation-program#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/insights-gained-ppmi-brain-donation-program#comments</comments>
</item>
<item>
 <title>Guiding Approaches to Studying Alzheimer&#039;s Disease: A Scoping Review of Community Engagement, Health Communication, and Implementation Science Research.</title>
 <link>https://www.alzforum.org/papers/guiding-approaches-studying-alzheimers-disease-scoping-review-community-engagement-health</link>
 <description>Gerontologist. 2026 Apr 26; Epub 2026 Apr 26&lt;br&gt;Authors: Yelton B, Workman L, Schaurer L, Riccardi N, McCollum Q, Belza B, Ory MG, Thorpe RJ, Wheeler SB, Trinh-Shevrin C, Kreps GL, Langa KM, Friedman DB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036812&quot;&gt;42036812&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/guiding-approaches-studying-alzheimers-disease-scoping-review-community-engagement-health#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/guiding-approaches-studying-alzheimers-disease-scoping-review-community-engagement-health#comments</comments>
</item>
<item>
 <title>Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/plasma-nfl-gfap-and-ptau181-define-distinct-biological-axes-amyotrophic-lateral-sclerosis</link>
 <description>Neurobiol Dis. 2026 Apr 26;224:107415.  Epub 2026 Apr 26&lt;br&gt;Authors: Senerchia G, Iuzzolino VV, Spisto M, Panico F, Polito C, Aruta L, Fiorenza M, Sirica R, Terracciano D, Dubbioso R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049146&quot;&gt;42049146&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-nfl-gfap-and-ptau181-define-distinct-biological-axes-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-nfl-gfap-and-ptau181-define-distinct-biological-axes-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/humanized-mice-carrying-pathogenic-grn-deletion-pre-clinical-platform-targeted-gene-therapies</link>
 <description>Neurobiol Dis. 2026 Apr 26;:107419.  Epub 2026 Apr 26&lt;br&gt;Authors: Life BE, Kazemian P, Petkau TL, de Moura Gomes A, Thomson SB, Shen N, Myung J, Jayousi F, Lengyell TC, Lange PF, Simpson EM, Korthauer K, Leavitt BR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049145&quot;&gt;42049145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/humanized-mice-carrying-pathogenic-grn-deletion-pre-clinical-platform-targeted-gene-therapies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/humanized-mice-carrying-pathogenic-grn-deletion-pre-clinical-platform-targeted-gene-therapies#comments</comments>
</item>
<item>
 <title>Physiological and pathological functions of TAF15 in neurodegenerative diseases and cancers.</title>
 <link>https://www.alzforum.org/papers/physiological-and-pathological-functions-taf15-neurodegenerative-diseases-and-cancers</link>
 <description>J Adv Res. 2026 Apr 26; Epub 2026 Apr 26&lt;br&gt;Authors: Liu C, Meng L, Zhang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42049092&quot;&gt;42049092&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/physiological-and-pathological-functions-taf15-neurodegenerative-diseases-and-cancers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/physiological-and-pathological-functions-taf15-neurodegenerative-diseases-and-cancers#comments</comments>
</item>
<item>
 <title>Does insomnia severity increase the risk of dementia? A 7-year longitudinal study.</title>
 <link>https://www.alzforum.org/papers/does-insomnia-severity-increase-risk-dementia-7-year-longitudinal-study</link>
 <description>Arch Gerontol Geriatr. 2026 Apr 26;148:106274.  Epub 2026 Apr 26&lt;br&gt;Authors: Oo AT, Yamada T, Sato S, Takeda N, Nakamura M, Ueda T, Kitabatake Y, Maruo K, Arao T, Nemoto Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060953&quot;&gt;42060953&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/does-insomnia-severity-increase-risk-dementia-7-year-longitudinal-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/does-insomnia-severity-increase-risk-dementia-7-year-longitudinal-study#comments</comments>
</item>
<item>
 <title>Association between amyloid-β deposition and cognitive function in cognitively normal adults: a multilevel meta-analysis.</title>
 <link>https://www.alzforum.org/papers/association-between-amyloid-v-deposition-and-cognitive-function-cognitively-normal-adults</link>
 <description>Alzheimers Res Ther. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Huang Y, Gong Q, Zhong Z, Guo Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032771&quot;&gt;42032771&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-amyloid-v-deposition-and-cognitive-function-cognitively-normal-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-amyloid-v-deposition-and-cognitive-function-cognitively-normal-adults#comments</comments>
</item>
<item>
 <title>In silico design, chemistry and biological activity of thiazole-based azetidinone Schiff bases as potential anti-Alzheimer agents.</title>
 <link>https://www.alzforum.org/papers/silico-design-chemistry-and-biological-activity-thiazole-based-azetidinone-schiff-bases</link>
 <description>J Comput Aided Mol Des. 2026 Apr 25;40(1)&lt;br&gt;Authors: Johny ST, James JP, Cherangai ZF, Vasudevan R, Vidya VS, Dixit S, Parameswaran S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032417&quot;&gt;42032417&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/silico-design-chemistry-and-biological-activity-thiazole-based-azetidinone-schiff-bases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/silico-design-chemistry-and-biological-activity-thiazole-based-azetidinone-schiff-bases#comments</comments>
</item>
<item>
 <title>Opportunities and challenges related to participant stratification and cohort enrichment in ALS clinical trials.</title>
 <link>https://www.alzforum.org/papers/opportunities-and-challenges-related-participant-stratification-and-cohort-enrichment-als</link>
 <description>Amyotroph Lateral Scler Frontotemporal Degener. 2026 Apr 25;:1-10.  Epub 2026 Apr 25&lt;br&gt;Authors: Yusuf S, Allen MD, Kang H, Phillips DE, Genge A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033202&quot;&gt;42033202&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/opportunities-and-challenges-related-participant-stratification-and-cohort-enrichment-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/opportunities-and-challenges-related-participant-stratification-and-cohort-enrichment-als#comments</comments>
</item>
<item>
 <title>Schedule-dependent neuroprotection by pioglitazone in a novel model of α-synucleinopathy in rats: Integrated behavioural and histological outcomes.</title>
 <link>https://www.alzforum.org/papers/schedule-dependent-neuroprotection-pioglitazone-novel-model-synucleinopathy-rats-integrated</link>
 <description>Br J Pharmacol. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Santiago-Balmaseda A, Villegas-Rojas MM, Pérez-Segura I, Espino-Cambrón M, Martinez-Fong D, Soto-Rojas LO&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033189&quot;&gt;42033189&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/schedule-dependent-neuroprotection-pioglitazone-novel-model-synucleinopathy-rats-integrated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/schedule-dependent-neuroprotection-pioglitazone-novel-model-synucleinopathy-rats-integrated#comments</comments>
</item>
<item>
 <title>Presenilin 1 is located in the mitochondrial inner inner membrane and regulates mitochondrial cristae junction protein arrangement and cristae formation in HEK293 cells.</title>
 <link>https://www.alzforum.org/papers/presenilin-1-located-mitochondrial-inner-inner-membrane-and-regulates-mitochondrial-cristae</link>
 <description>Acta Biochim Biophys Sin (Shanghai). 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: You P, Zhu P, Yu H, Wang L, Su B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033138&quot;&gt;42033138&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/presenilin-1-located-mitochondrial-inner-inner-membrane-and-regulates-mitochondrial-cristae#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/presenilin-1-located-mitochondrial-inner-inner-membrane-and-regulates-mitochondrial-cristae#comments</comments>
</item>
<item>
 <title>In vivo tau in epilepsy reflects clinical severity and immune- and ageing-related proteomic changes.</title>
 <link>https://www.alzforum.org/papers/vivo-tau-epilepsy-reflects-clinical-severity-and-immune-and-ageing-related-proteomic-changes</link>
 <description>Brain. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Hong SB, Shin YW, Moon J, Park KI, Jung KY, Cho K, Choi H, Chu K, Lee SK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032827&quot;&gt;42032827&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/vivo-tau-epilepsy-reflects-clinical-severity-and-immune-and-ageing-related-proteomic-changes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/vivo-tau-epilepsy-reflects-clinical-severity-and-immune-and-ageing-related-proteomic-changes#comments</comments>
</item>
<item>
 <title>Genetic drivers of progression in Alzheimer&#039;s disease are distinct from disease risk.</title>
 <link>https://www.alzforum.org/papers/genetic-drivers-progression-alzheimers-disease-are-distinct-disease-risk-0</link>
 <description>Alzheimers Res Ther. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Cohen CE, Fernandez S, Yaman U, Ehyaei AR, Kodosaki E, Askarova A, Porter T, O&amp;#039;Brien E, Australian Imaging Biomarkers and Lifestyle Study, Alzheimer’s Disease Neuroimaging Initiative, Maruff P, Nott A, Hardy JA, Laws SM, A Salih D, Shoai M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035106&quot;&gt;42035106&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-drivers-progression-alzheimers-disease-are-distinct-disease-risk-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-drivers-progression-alzheimers-disease-are-distinct-disease-risk-0#comments</comments>
</item>
<item>
 <title>Lactate metabolism links reactive microglia, amyloid pathology, and Aβ dynamics.</title>
 <link>https://www.alzforum.org/papers/lactate-metabolism-links-reactive-microglia-amyloid-pathology-and-av-dynamics</link>
 <description>J Neuroinflammation. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Ashley CC, Constantino NJ, Pettit-Mee RJ, Snipes JA, Saito K, Irmen RE, Zhang R, Neary EM, Lanning MJ, Karch CM, Johnson LA, Morganti JM, Macauley SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035056&quot;&gt;42035056&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lactate-metabolism-links-reactive-microglia-amyloid-pathology-and-av-dynamics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lactate-metabolism-links-reactive-microglia-amyloid-pathology-and-av-dynamics#comments</comments>
</item>
<item>
 <title>Targeting central immune signaling enhances the effects of methylphenidate in alleviating apathy-like behavior in 5xFAD mice.</title>
 <link>https://www.alzforum.org/papers/targeting-central-immune-signaling-enhances-effects-methylphenidate-alleviating-apathy-0</link>
 <description>Sci Rep. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Monteiro R, Dunn JT, Rodriguez G, Fisher DW, Dong H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034805&quot;&gt;42034805&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-central-immune-signaling-enhances-effects-methylphenidate-alleviating-apathy-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-central-immune-signaling-enhances-effects-methylphenidate-alleviating-apathy-0#comments</comments>
</item>
<item>
 <title>Passive digital health technologies for Alzheimer&#039;s disease screening and diagnosis: a systematic review.</title>
 <link>https://www.alzforum.org/papers/passive-digital-health-technologies-alzheimers-disease-screening-and-diagnosis-systematic</link>
 <description>NPJ Digit Med. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Matias I, Prociów P, Daza EJ, Kliegel M, Wac K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034769&quot;&gt;42034769&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/passive-digital-health-technologies-alzheimers-disease-screening-and-diagnosis-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/passive-digital-health-technologies-alzheimers-disease-screening-and-diagnosis-systematic#comments</comments>
</item>
<item>
 <title>Adaptive neighborhood aggregation graph neural network for early diagnosis of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/adaptive-neighborhood-aggregation-graph-neural-network-early-diagnosis-alzheimers-disease</link>
 <description>Sci Rep. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Sheng J, Zhong H, Zhang Q, Zhang R, Gong Z, Lin J, Chen Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034728&quot;&gt;42034728&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adaptive-neighborhood-aggregation-graph-neural-network-early-diagnosis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adaptive-neighborhood-aggregation-graph-neural-network-early-diagnosis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>von Willebrand Factor fibers formed at pathological high shear provide a scaffold for α-synuclein binding and aggregation.</title>
 <link>https://www.alzforum.org/papers/von-willebrand-factor-fibers-formed-pathological-high-shear-provide-scaffold-synuclein</link>
 <description>Sci Rep. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Rossi JM, Diamond SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034708&quot;&gt;42034708&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/von-willebrand-factor-fibers-formed-pathological-high-shear-provide-scaffold-synuclein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/von-willebrand-factor-fibers-formed-pathological-high-shear-provide-scaffold-synuclein#comments</comments>
</item>
<item>
 <title>Plasma proteomics for Parkinson&#039;s disease classification: cross-cohort benchmarking of proteomic, transcriptomic, and multimodal models.</title>
 <link>https://www.alzforum.org/papers/plasma-proteomics-parkinsons-disease-classification-cross-cohort-benchmarking-proteomic</link>
 <description>NPJ Parkinsons Dis. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Minster N, Jafri S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034648&quot;&gt;42034648&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-proteomics-parkinsons-disease-classification-cross-cohort-benchmarking-proteomic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-proteomics-parkinsons-disease-classification-cross-cohort-benchmarking-proteomic#comments</comments>
</item>
<item>
 <title>Mapping Neurodegenerative Changes in Clinically Uncertain Parkinsonian Syndrome Patients Using Fast MR Spin TomogrAphy in Time-Domain (MR-STAT) Relaxometry at 3T.</title>
 <link>https://www.alzforum.org/papers/mapping-neurodegenerative-changes-clinically-uncertain-parkinsonian-syndrome-patients-using</link>
 <description>J Magn Reson Imaging. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Schilder MB, Wallert ED, Mandija S, van der Heide O, Liu H, Fuderer M, Versteeg E, Booij J, de Bie RM, Beudel M, Berendse HW, van Mierlo T, Blankevoort J, van den Berg CA, van de Giessen E, Sbrizzi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033789&quot;&gt;42033789&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-neurodegenerative-changes-clinically-uncertain-parkinsonian-syndrome-patients-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-neurodegenerative-changes-clinically-uncertain-parkinsonian-syndrome-patients-using#comments</comments>
</item>
<item>
 <title>Reduced expression of SOCS1-5 and STAT5a genes in Parkinson&#039;s disease patients: evidence for dysregulated immune signaling.</title>
 <link>https://www.alzforum.org/papers/reduced-expression-socs1-5-and-stat5a-genes-parkinsons-disease-patients-evidence-dysregulated</link>
 <description>Mol Biol Rep. 2026 Apr 25;53(1)&lt;br&gt;Authors: Salmani M, Rastegari-Pouyani M, Afshar S, Talebi-Ghane E, Eftekharian MM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033629&quot;&gt;42033629&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reduced-expression-socs1-5-and-stat5a-genes-parkinsons-disease-patients-evidence-dysregulated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reduced-expression-socs1-5-and-stat5a-genes-parkinsons-disease-patients-evidence-dysregulated#comments</comments>
</item>
<item>
 <title>Unveiling the Gut-Brain Axis: Fusobacteriaceae Promotes Parkinson&#039;s Disease Development via CA9 Suppression-Induced Ferroptosis.</title>
 <link>https://www.alzforum.org/papers/unveiling-gut-brain-axis-fusobacteriaceae-promotes-parkinsons-disease-development-ca9</link>
 <description>J Mol Neurosci. 2026 Apr 25;76(2)&lt;br&gt;Authors: Zihan R, Pengfei L, Jingsi C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033567&quot;&gt;42033567&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unveiling-gut-brain-axis-fusobacteriaceae-promotes-parkinsons-disease-development-ca9#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unveiling-gut-brain-axis-fusobacteriaceae-promotes-parkinsons-disease-development-ca9#comments</comments>
</item>
<item>
 <title>Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/brain-pet-era-anti-amyloid-v-antibody-therapy-alzheimer-disease</link>
 <description>Jpn J Radiol. 2026 Apr 25; Epub 2026 Apr 25&lt;br&gt;Authors: Ishii K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033565&quot;&gt;42033565&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-pet-era-anti-amyloid-v-antibody-therapy-alzheimer-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-pet-era-anti-amyloid-v-antibody-therapy-alzheimer-disease#comments</comments>
</item>
<item>
 <title>Age-related macular degeneration and dementia: Association through pathogenesis or visual impairment?</title>
 <link>https://www.alzforum.org/papers/age-related-macular-degeneration-and-dementia-association-through-pathogenesis-or-visual</link>
 <description>J Alzheimers Dis. 2026 Apr 25;:13872877261438849.  Epub 2026 Apr 25&lt;br&gt;Authors: Gu X, Terebuh P, Xu R, Kaelber DC, Davis PB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033410&quot;&gt;42033410&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-related-macular-degeneration-and-dementia-association-through-pathogenesis-or-visual#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-related-macular-degeneration-and-dementia-association-through-pathogenesis-or-visual#comments</comments>
</item>
<item>
 <title>Plasma phosphorylated tau 181, vascular risk factors, and cognition in elderly Hispanics.</title>
 <link>https://www.alzforum.org/papers/plasma-phosphorylated-tau-181-vascular-risk-factors-and-cognition-elderly-hispanics</link>
 <description>J Alzheimers Dis. 2026 Apr 25;:13872877261443653.  Epub 2026 Apr 25&lt;br&gt;Authors: Bahl A, Honig LS, Kang MS, Sanchez D, Reyes-Dumeyer D, Manly JJ, Lantigua RA, Brickman AM, Vardarajan BN, Mayeux R, Gu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033409&quot;&gt;42033409&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-phosphorylated-tau-181-vascular-risk-factors-and-cognition-elderly-hispanics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-phosphorylated-tau-181-vascular-risk-factors-and-cognition-elderly-hispanics#comments</comments>
</item>
<item>
 <title>Dietary intervention and cognition across Alzheimer&#039;s disease biomarker levels: The MIND clinical trial.</title>
 <link>https://www.alzforum.org/papers/dietary-intervention-and-cognition-across-alzheimers-disease-biomarker-levels-mind-clinical</link>
 <description>J Alzheimers Dis. 2026 Apr 25;:13872877261442856.  Epub 2026 Apr 25&lt;br&gt;Authors: Dhana K, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033408&quot;&gt;42033408&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dietary-intervention-and-cognition-across-alzheimers-disease-biomarker-levels-mind-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dietary-intervention-and-cognition-across-alzheimers-disease-biomarker-levels-mind-clinical#comments</comments>
</item>
<item>
 <title>Dementia screening with the Rivermead Behavioural Memory Test: A machine learning analysis.</title>
 <link>https://www.alzforum.org/papers/dementia-screening-rivermead-behavioural-memory-test-machine-learning-analysis</link>
 <description>J Alzheimers Dis. 2026 Apr 25;:13872877261443699.  Epub 2026 Apr 25&lt;br&gt;Authors: Fujiwara Y, Toyoda K, Maruyama S, Kitano M, Toda H, Kanazawa T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033406&quot;&gt;42033406&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dementia-screening-rivermead-behavioural-memory-test-machine-learning-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dementia-screening-rivermead-behavioural-memory-test-machine-learning-analysis#comments</comments>
</item>
<item>
 <title>Lysosome-Acidifying Nanoparticles Rescue A30P α-Synuclein Induced Neuronal Death in Cellular and Drosophila Models of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/lysosome-acidifying-nanoparticles-rescue-a30p-synuclein-induced-neuronal-death-cellular-and</link>
 <description>Adv Healthc Mater. 2026 Apr 25;:e02906.  Epub 2026 Apr 25&lt;br&gt;Authors: Lo CH, Ren M, Loi GW, Saipuljumri EN, Indajang J, Lim KL, Zeng J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033266&quot;&gt;42033266&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lysosome-acidifying-nanoparticles-rescue-a30p-synuclein-induced-neuronal-death-cellular-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lysosome-acidifying-nanoparticles-rescue-a30p-synuclein-induced-neuronal-death-cellular-and#comments</comments>
</item>
<item>
 <title>Large-Screen Group Digital Reminiscence Therapy Reduces BPSD in Dementia: Findings from a Crossover Comparative Study.</title>
 <link>https://www.alzforum.org/papers/large-screen-group-digital-reminiscence-therapy-reduces-bpsd-dementia-findings-crossover</link>
 <description>Clin Gerontol. 2026 Apr 25;:1-12.  Epub 2026 Apr 25&lt;br&gt;Authors: Asano T, Izumi K, Ishikawa T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033242&quot;&gt;42033242&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/large-screen-group-digital-reminiscence-therapy-reduces-bpsd-dementia-findings-crossover#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/large-screen-group-digital-reminiscence-therapy-reduces-bpsd-dementia-findings-crossover#comments</comments>
</item>
<item>
 <title>Mitochondrial-nuclear crosstalk: A central axis in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mitochondrial-nuclear-crosstalk-central-axis-alzheimers-disease</link>
 <description>Ageing Res Rev. 2026 Apr 25;119:103150.  Epub 2026 Apr 25&lt;br&gt;Authors: Samantaray K, Sinha A, Tomar D, Jadiya P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044748&quot;&gt;42044748&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondrial-nuclear-crosstalk-central-axis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondrial-nuclear-crosstalk-central-axis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Reductions in regional cerebral blood flow and dopamine transporter uptake in a patient with Gerstmann-Sträussler-Scheinker disease harboring the prion protein gene P105L mutation.</title>
 <link>https://www.alzforum.org/papers/reductions-regional-cerebral-blood-flow-and-dopamine-transporter-uptake-patient-gerstmann</link>
 <description>J Neurol Sci. 2026 Apr 25;486:125941.  Epub 2026 Apr 25&lt;br&gt;Authors: Ikeda M, Kuwabara T, Amari M, Ishiguro T, Inohana Y, Kasuga K, Hara N, Miyashita A, Higuchi T, Tsushima Y, Ikeuchi T, Okamoto K, Takatama M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42061151&quot;&gt;42061151&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reductions-regional-cerebral-blood-flow-and-dopamine-transporter-uptake-patient-gerstmann#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reductions-regional-cerebral-blood-flow-and-dopamine-transporter-uptake-patient-gerstmann#comments</comments>
</item>
<item>
 <title>Olfactory radiomics signatures link pTau217 to cognitive impairment in probable Alzheimer&#039;s disease: a multi-cohort machine learning study.</title>
 <link>https://www.alzforum.org/papers/olfactory-radiomics-signatures-link-ptau217-cognitive-impairment-probable-alzheimers-disease</link>
 <description>Alzheimers Res Ther. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Chen B, Gao P, Liu H, Xu D, Wang Q, Yang M, Tan H, Xiao Z, Tian S, Wang Z, Zheng Y, Zheng X, Liang S, Liu Q, Li J, Zhong X, Ning Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032766&quot;&gt;42032766&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/olfactory-radiomics-signatures-link-ptau217-cognitive-impairment-probable-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/olfactory-radiomics-signatures-link-ptau217-cognitive-impairment-probable-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Plasma proteomic signatures of preclinical Alzheimer&#039;s disease in clinically unimpaired older adults.</title>
 <link>https://www.alzforum.org/papers/plasma-proteomic-signatures-preclinical-alzheimers-disease-clinically-unimpaired-older-adults</link>
 <description>Mol Neurodegener. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Trelle AN, Cody KA, Nguyen TT, Winer JR, Weiss S, Sai I, Ward T, Cheng G, Channappa D, Mendiola J, Al-Rajhi A, Raghuraman K, Sha SJ, Wilson EN, Wyss-Coray T, Maecker HT, Wagner AD, Mormino EC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032756&quot;&gt;42032756&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-proteomic-signatures-preclinical-alzheimers-disease-clinically-unimpaired-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-proteomic-signatures-preclinical-alzheimers-disease-clinically-unimpaired-older-adults#comments</comments>
</item>
<item>
 <title>Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer&#039;s disease biomarkers.</title>
 <link>https://www.alzforum.org/papers/pathways-resilience-relationships-between-cognitive-reserve-psychological-debt-and-alzheimers</link>
 <description>Alzheimers Res Ther. 2026 Apr 24;18(1)&lt;br&gt;Authors: Boscheck H, Luft M, Mauer R, Senguel S, D&amp;#039;elia Y, Dechent P, Fliessbach K, Glanz W, Hetzer S, Janowitz D, Kilimann I, Kleineidam L, Kronmüller M, Lüsebrink F, Preis L, Rauchmann B, Rostamzadeh A, Schott BH, Sodenkamp S, Spruth E, Stoecklein S, Yakupov R, Ziegler G, Brosseron F, Buerger K, Hellmann-Regen J, Laske C, Perneczky R, Peters O, Priller J, Ramirez A, Schneider A, Spottke A, Teipel S, Wiltfang J, Jessen F, Düzel E, Röske S, Wagner M, Glöckner F, Marchant NL, Klimecki O, Wirth M, DELCODE study group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032739&quot;&gt;42032739&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pathways-resilience-relationships-between-cognitive-reserve-psychological-debt-and-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pathways-resilience-relationships-between-cognitive-reserve-psychological-debt-and-alzheimers#comments</comments>
</item>
<item>
 <title>Author Correction: Astrocytic Sox9 overexpression in Alzheimer&#039;s disease mouse models promotes Aβ plaque phagocytosis and preserves cognitive function.</title>
 <link>https://www.alzforum.org/papers/author-correction-astrocytic-sox9-overexpression-alzheimers-disease-mouse-models-promotes-av</link>
 <description>Nat Neurosci. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Choi DJ, Murali S, Kwon W, Woo J, Song EC, Ko Y, Sardar D, Lozzi B, Cheng YT, Williamson MR, Huang TW, Sanchez K, Jankowsky J, Deneen B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032434&quot;&gt;42032434&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/author-correction-astrocytic-sox9-overexpression-alzheimers-disease-mouse-models-promotes-av#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/author-correction-astrocytic-sox9-overexpression-alzheimers-disease-mouse-models-promotes-av#comments</comments>
</item>
<item>
 <title>Application of a Three-Cell Blood-Brain Barrier Model to Assess Neurovascular Unit Cell Damage in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/application-three-cell-blood-brain-barrier-model-assess-neurovascular-unit-cell-damage</link>
 <description>Bull Exp Biol Med. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Rozanova NA, Averchuk AS, Kapkaeva MR, Zhdankina VI, Makarov VI, Skobeltsin AS, Romanishkin ID, Baranich TI, Salmina AB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032403&quot;&gt;42032403&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/application-three-cell-blood-brain-barrier-model-assess-neurovascular-unit-cell-damage#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/application-three-cell-blood-brain-barrier-model-assess-neurovascular-unit-cell-damage#comments</comments>
</item>
<item>
 <title>DeepDrugDiscovery identifies blood-brain barrier permeable autophagy enhancers for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/deepdrugdiscovery-identifies-blood-brain-barrier-permeable-autophagy-enhancers-alzheimers</link>
 <description>Nat Biomed Eng. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Dong Y, Xiao X, Zhuang XX, Wu W, Wang ZY, Zhang S, Li JT, Zhang K, Fu WY, Chen JM, Xiong SH, Deng S, Li K, Ma C, Jin W, Jin X, Cai Q, Shen HM, Li M, Su H, Wan JB, Yu H, Ouyang D, Ye K, Fang EF, Tan CS, Yang G, Niu Z, Lu JH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032039&quot;&gt;42032039&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deepdrugdiscovery-identifies-blood-brain-barrier-permeable-autophagy-enhancers-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deepdrugdiscovery-identifies-blood-brain-barrier-permeable-autophagy-enhancers-alzheimers#comments</comments>
</item>
<item>
 <title>LASSO-HHO two-stage hybrid gene selection framework for accurate Alzheimer&#039;s disease diagnosis.</title>
 <link>https://www.alzforum.org/papers/lasso-hho-two-stage-hybrid-gene-selection-framework-accurate-alzheimers-disease-diagnosis</link>
 <description>Sci Rep. 2026 Apr 24;16(1)&lt;br&gt;Authors: Asiry O, El-Gawady A, Eltoukhy MM, Mohamed MF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031881&quot;&gt;42031881&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lasso-hho-two-stage-hybrid-gene-selection-framework-accurate-alzheimers-disease-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lasso-hho-two-stage-hybrid-gene-selection-framework-accurate-alzheimers-disease-diagnosis#comments</comments>
</item>
<item>
 <title>Disruption of the LRRK2 substrate RAB12 facilitates neurotransmission and causes hyperactivity in mice.</title>
 <link>https://www.alzforum.org/papers/disruption-lrrk2-substrate-rab12-facilitates-neurotransmission-and-causes-hyperactivity-mice</link>
 <description>NPJ Parkinsons Dis. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Li X, Chen Y, Wang H, Zhang X, Guiberson NG, Li X, Burré J, Peng J, Zhang H, Yue Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031745&quot;&gt;42031745&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disruption-lrrk2-substrate-rab12-facilitates-neurotransmission-and-causes-hyperactivity-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disruption-lrrk2-substrate-rab12-facilitates-neurotransmission-and-causes-hyperactivity-mice#comments</comments>
</item>
<item>
 <title>An Immuno-Infrared Sensor Detects Preclinical Alzheimer&#039;s and Parkinson&#039;s Disease by Protein Misfolding.</title>
 <link>https://www.alzforum.org/papers/immuno-infrared-sensor-detects-preclinical-alzheimers-and-parkinsons-disease-protein</link>
 <description>J Phys Chem B. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Gerwert G, Mann M, Langenhoff L, Woitzik N, Hubert D, Duman D, Höveler A, Budde S, Simon J, Beyer L, Schuler M, Weber S, Mollenhauer B, Kötting C, Güldenhaupt J, Gerwert K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031363&quot;&gt;42031363&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/immuno-infrared-sensor-detects-preclinical-alzheimers-and-parkinsons-disease-protein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/immuno-infrared-sensor-detects-preclinical-alzheimers-and-parkinsons-disease-protein#comments</comments>
</item>
<item>
 <title>Modulation of Mitochondrial Dynamics by Loganic Acid Ameliorates Alzheimer&#039;s Disease Pathology: Evidence from In Vitro and In Vivo Studies.</title>
 <link>https://www.alzforum.org/papers/modulation-mitochondrial-dynamics-loganic-acid-ameliorates-alzheimers-disease-pathology</link>
 <description>ACS Chem Neurosci. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Panda SR, Soni U, Panja P, Rajdev B, Singh M, Kundu S, Ranade A, Pawar SD, Acharya R, Naidu VG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030370&quot;&gt;42030370&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/modulation-mitochondrial-dynamics-loganic-acid-ameliorates-alzheimers-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/modulation-mitochondrial-dynamics-loganic-acid-ameliorates-alzheimers-disease-pathology#comments</comments>
</item>
<item>
 <title>Parental obesity exacerbates cognitive dysfunction and cardiac vulnerability in offspring of an Alzheimer disease model.</title>
 <link>https://www.alzforum.org/papers/parental-obesity-exacerbates-cognitive-dysfunction-and-cardiac-vulnerability-offspring</link>
 <description>Am J Physiol Heart Circ Physiol. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: do Carmo JM, Hall JE, Ladnier E, Dai X, Wang Z, Mouton AJ, Omoto AC, Jorge L, da Silva AA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030244&quot;&gt;42030244&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parental-obesity-exacerbates-cognitive-dysfunction-and-cardiac-vulnerability-offspring#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parental-obesity-exacerbates-cognitive-dysfunction-and-cardiac-vulnerability-offspring#comments</comments>
</item>
<item>
 <title>Toxic Alpha-Synuclein and the Opening of the Gate: Blood-Brain Barrier Damage and Stepwise Leukocyte Infiltration.</title>
 <link>https://www.alzforum.org/papers/toxic-alpha-synuclein-and-opening-gate-blood-brain-barrier-damage-and-stepwise-leukocyte</link>
 <description>Cell Mol Neurobiol. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Wójcik P, Culmsee C, Adamczyk A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029809&quot;&gt;42029809&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/toxic-alpha-synuclein-and-opening-gate-blood-brain-barrier-damage-and-stepwise-leukocyte#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/toxic-alpha-synuclein-and-opening-gate-blood-brain-barrier-damage-and-stepwise-leukocyte#comments</comments>
</item>
<item>
 <title>TDP-43 Dysfunction Causes Hyper-Lactate State, Increased AARS1 Expression and Enhanced Protein Lactylation.</title>
 <link>https://www.alzforum.org/papers/tdp-43-dysfunction-causes-hyper-lactate-state-increased-aars1-expression-and-enhanced-protein</link>
 <description>Neurotox Res. 2026 Apr 24;44(3)&lt;br&gt;Authors: Zhang T, Yan K, Liao Q, Liu R, Liu R, Zhou J, Liu Y, Bi F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029805&quot;&gt;42029805&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tdp-43-dysfunction-causes-hyper-lactate-state-increased-aars1-expression-and-enhanced-protein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tdp-43-dysfunction-causes-hyper-lactate-state-increased-aars1-expression-and-enhanced-protein#comments</comments>
</item>
<item>
 <title>A perspective for alzheimer disease from gut microbiota-associated NMR-based fecal metabolomics: a study with 5XFAD mice.</title>
 <link>https://www.alzforum.org/papers/perspective-alzheimer-disease-gut-microbiota-associated-nmr-based-fecal-metabolomics-study</link>
 <description>Metab Brain Dis. 2026 Apr 24;41(1)&lt;br&gt;Authors: Tekin N, Şahin F, Şahin B, Kaya ZZ, Yılmaz A, Graham SF, Serteser M, Baykal AT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029761&quot;&gt;42029761&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/perspective-alzheimer-disease-gut-microbiota-associated-nmr-based-fecal-metabolomics-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/perspective-alzheimer-disease-gut-microbiota-associated-nmr-based-fecal-metabolomics-study#comments</comments>
</item>
<item>
 <title>Altered astrocyte-neuron crosstalk in progressive supranuclear palsy: integrated evidence from proteomics and magnetic resonance spectroscopy.</title>
 <link>https://www.alzforum.org/papers/altered-astrocyte-neuron-crosstalk-progressive-supranuclear-palsy-integrated-evidence</link>
 <description>Acta Neuropathol. 2026 Apr 24;151(1)&lt;br&gt;Authors: Ono M, Kumagai Y, Hirata K, Maeda Y, Abe Y, Endo H, Shimizu H, Kakita A, Uchida Y, Takado Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029746&quot;&gt;42029746&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/altered-astrocyte-neuron-crosstalk-progressive-supranuclear-palsy-integrated-evidence#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/altered-astrocyte-neuron-crosstalk-progressive-supranuclear-palsy-integrated-evidence#comments</comments>
</item>
<item>
 <title>The Development of the Novel Positron Emission Tomography Radiotracer for Selective HDAC8 Imaging.</title>
 <link>https://www.alzforum.org/papers/development-novel-positron-emission-tomography-radiotracer-selective-hdac8-imaging</link>
 <description>ACS Chem Neurosci. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Huang Y, Wang Y, Wang Y, Cheng H, Yang H, Wang C, Xu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029694&quot;&gt;42029694&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-novel-positron-emission-tomography-radiotracer-selective-hdac8-imaging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-novel-positron-emission-tomography-radiotracer-selective-hdac8-imaging#comments</comments>
</item>
<item>
 <title>Cause, consequence, or synergy: the role of T-cell infiltration across neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/cause-consequence-or-synergy-role-t-cell-infiltration-across-neurodegenerative-diseases</link>
 <description>Brain. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Cullinane PW, Nelvagal H, Wong C, Curless T, Baranauskiene G, Jurkeviciene J, Farin Z, Pimparkar S, Bechtawi M, Chiraki N, de Pablo Fernandez E, Brandner S, Warner TT, Lim YM, Jaunmuktane Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028849&quot;&gt;42028849&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cause-consequence-or-synergy-role-t-cell-infiltration-across-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cause-consequence-or-synergy-role-t-cell-infiltration-across-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Cross-sectional assessment of telephone- and computer-administered instruments in detection of cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/cross-sectional-assessment-telephone-and-computer-administered-instruments-detection</link>
 <description>J Clin Exp Neuropsychol. 2026 Apr 24;:1-12.  Epub 2026 Apr 24&lt;br&gt;Authors: Aaltonen A, Saari TT, Urjansson M, Palviainen T, Paajanen TI, FinnGen, Palotie A, Runz H, Kaprio J, Julkunen V, Vuoksimaa E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027189&quot;&gt;42027189&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cross-sectional-assessment-telephone-and-computer-administered-instruments-detection#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cross-sectional-assessment-telephone-and-computer-administered-instruments-detection#comments</comments>
</item>
<item>
 <title>Moiety-specific mechanism of ATP&#039;s hydrotropic action on α-synuclein.</title>
 <link>https://www.alzforum.org/papers/moiety-specific-mechanism-atps-hydrotropic-action-synuclein</link>
 <description>Phys Chem Chem Phys. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Shuto Y, Mori T, Kohn B, Walinda E, Morimoto D, Scheler U, So M, Furukawa A, Yoshida N, Sugase K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027070&quot;&gt;42027070&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/moiety-specific-mechanism-atps-hydrotropic-action-synuclein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/moiety-specific-mechanism-atps-hydrotropic-action-synuclein#comments</comments>
</item>
<item>
 <title>Synthesis and Evaluation of a PET Radiotracer [18F]LY3000328 Selectively Targeting the Cysteine Protease Cathepsin S.</title>
 <link>https://www.alzforum.org/papers/synthesis-and-evaluation-pet-radiotracer-18fly3000328-selectively-targeting-cysteine-protease</link>
 <description>ACS Chem Neurosci. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Yang H, Wang Y, Wang Y, Cheng H, Huang Y, Xu Y, Zhang C, Wang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42032832&quot;&gt;42032832&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synthesis-and-evaluation-pet-radiotracer-18fly3000328-selectively-targeting-cysteine-protease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synthesis-and-evaluation-pet-radiotracer-18fly3000328-selectively-targeting-cysteine-protease#comments</comments>
</item>
<item>
 <title>Analysis of mitochondrial DNA heteroplasmy in sporadic ALS suggests technical limitations rather than disease association.</title>
 <link>https://www.alzforum.org/papers/analysis-mitochondrial-dna-heteroplasmy-sporadic-als-suggests-technical-limitations-rather</link>
 <description>Neurobiol Dis. 2026 Apr 24;224:107412.  Epub 2026 Apr 24&lt;br&gt;Authors: Codron P, Desquiret V, Prunier D, Amati-Bonneau P, Nguefackngoune V, Rapenne C, Legoff L, Cassereau J, Procaccio V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035928&quot;&gt;42035928&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/analysis-mitochondrial-dna-heteroplasmy-sporadic-als-suggests-technical-limitations-rather#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/analysis-mitochondrial-dna-heteroplasmy-sporadic-als-suggests-technical-limitations-rather#comments</comments>
</item>
<item>
 <title>Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system.</title>
 <link>https://www.alzforum.org/papers/galectins-stress-integrating-regulators-neuroimmune-signaling-and-proteinopathy-central</link>
 <description>Neurobiol Dis. 2026 Apr 24;224:107410.  Epub 2026 Apr 24&lt;br&gt;Authors: Siew JJ, Chern Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035925&quot;&gt;42035925&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/galectins-stress-integrating-regulators-neuroimmune-signaling-and-proteinopathy-central#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/galectins-stress-integrating-regulators-neuroimmune-signaling-and-proteinopathy-central#comments</comments>
</item>
<item>
 <title>Blood-based biomarkers of ferroptosis in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/blood-based-biomarkers-ferroptosis-parkinsons-disease</link>
 <description>Neurobiol Dis. 2026 Apr 24;:107414.  Epub 2026 Apr 24&lt;br&gt;Authors: Huin V, Cailliau E, Poupelin C, Garcon G, Dutheil M, Simonin O, Beauval N, Labreuche J, Blum D, Moreau C, Hainque E, Marques A, Eusebio A, Benatru I, Brefel-Courbon C, Maltete D, Giordana C, Tir M, Thobois S, Brandel JP, Jarraya B, Hopes L, Rascol O, Corvol JC, Devos D, Rolland AS, PREDISTIM study group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035924&quot;&gt;42035924&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-based-biomarkers-ferroptosis-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-based-biomarkers-ferroptosis-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Challenging memory tests in early Alzheimer&#039;s disease: From research to clinical practice.</title>
 <link>https://www.alzforum.org/papers/challenging-memory-tests-early-alzheimers-disease-research-clinical-practice</link>
 <description>Neurosci Biobehav Rev. 2026 Apr 24;186:106701.  Epub 2026 Apr 24&lt;br&gt;Authors: Horakova H, Fendrych Mazancova A, Vyhnalek M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035900&quot;&gt;42035900&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/challenging-memory-tests-early-alzheimers-disease-research-clinical-practice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/challenging-memory-tests-early-alzheimers-disease-research-clinical-practice#comments</comments>
</item>
<item>
 <title>Vitamin E and melatonin synergistically attenuate sleep deprivation-induced Nrf2 dysregulation and hippocampal ferroptosis in Alzheimer&#039;s disease mouse models.</title>
 <link>https://www.alzforum.org/papers/vitamin-e-and-melatonin-synergistically-attenuate-sleep-deprivation-induced-nrf2</link>
 <description>Exp Neurol. 2026 Apr 24;402:115781.  Epub 2026 Apr 24&lt;br&gt;Authors: Gao Q, Sun J, Hei B, Zhou J, Wang B, Wang D, Hu S, Liu J, Wang D, Fan J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035843&quot;&gt;42035843&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/vitamin-e-and-melatonin-synergistically-attenuate-sleep-deprivation-induced-nrf2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/vitamin-e-and-melatonin-synergistically-attenuate-sleep-deprivation-induced-nrf2#comments</comments>
</item>
<item>
 <title>Health-economic challenges for new Alzheimer&#039;s disease treatments.</title>
 <link>https://www.alzforum.org/papers/health-economic-challenges-new-alzheimers-disease-treatments</link>
 <description>J Prev Alzheimers Dis. 2026 Apr 24;13(6):100575.  Epub 2026 Apr 24&lt;br&gt;Authors: Fu J, Sköldunger A, Bradshaw A, Broulíková HM, Brück CC, Chapel JM, Grimm S, Hansson A, Herring WL, Hlávka J, Hoang MT, Jönsson L, Landeiro F, Mar J, McKean A, Misik M, Neumann P, Rapp T, Ritchie C, Schiel A, Sun Y, Trépel D, Trueman D, van der Veere PJ, van Rosmalen L, Vonsy JL, Walker L, Wimo A, Winblad B, Xia X, Handels R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034066&quot;&gt;42034066&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/health-economic-challenges-new-alzheimers-disease-treatments#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/health-economic-challenges-new-alzheimers-disease-treatments#comments</comments>
</item>
<item>
 <title>Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer&#039;s pathology and cognitive resilience.</title>
 <link>https://www.alzforum.org/papers/transcriptional-profiles-immature-neurons-aged-human-hippocampus-track-alzheimers-pathology</link>
 <description>Cell Stem Cell. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Tosoni G, Ayyildiz D, Snoeck S, Moreno-Jiménez EP, Penning A, Santiago-Mujika E, Ruiz Ormaechea O, Lee H, Poovathingal S, Davie K, Bryois J, Macnair W, Anink J, De Vries LE, Farmand S, Nutma E, Swaab DF, Aronica E, Middeldorp J, Thuret S, Roybon L, Basak O, Fitzsimons CP, Lucassen PJ, Salta E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034060&quot;&gt;42034060&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/transcriptional-profiles-immature-neurons-aged-human-hippocampus-track-alzheimers-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/transcriptional-profiles-immature-neurons-aged-human-hippocampus-track-alzheimers-pathology#comments</comments>
</item>
<item>
 <title>Translating brain anatomy and disease from mouse to human in latent gene expression space.</title>
 <link>https://www.alzforum.org/papers/translating-brain-anatomy-and-disease-mouse-human-latent-gene-expression-space</link>
 <description>EBioMedicine. 2026 Apr 24;127:106259.  Epub 2026 Apr 24&lt;br&gt;Authors: Jaroszynski C, Amer M, Beauchamp A, Lerch JP, Sotiropoulos SN, Mars RB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034047&quot;&gt;42034047&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/translating-brain-anatomy-and-disease-mouse-human-latent-gene-expression-space#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/translating-brain-anatomy-and-disease-mouse-human-latent-gene-expression-space#comments</comments>
</item>
<item>
 <title>Multi-ancestry studies in multi-omics of Alzheimer&#039;s disease: Recent insights and future directions.</title>
 <link>https://www.alzforum.org/papers/multi-ancestry-studies-multi-omics-alzheimers-disease-recent-insights-and-future-directions</link>
 <description>Curr Opin Neurobiol. 2026 Apr 24;99:103205.  Epub 2026 Apr 24&lt;br&gt;Authors: Shir D, Seifar F, Ertekin-Taner N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033978&quot;&gt;42033978&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-ancestry-studies-multi-omics-alzheimers-disease-recent-insights-and-future-directions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-ancestry-studies-multi-omics-alzheimers-disease-recent-insights-and-future-directions#comments</comments>
</item>
<item>
 <title>Complement C3aR deletion does not attenuate degeneration in a tauopathy model or alter acute inflammation-induced gene expression changes.</title>
 <link>https://www.alzforum.org/papers/complement-c3ar-deletion-does-not-attenuate-degeneration-tauopathy-model-or-alter-acute</link>
 <description>Cell Rep. 2026 Apr 24;45(5):117313.  Epub 2026 Apr 24&lt;br&gt;Authors: Wang Y, Pandey S, Weber M, Choy MK, Wu T, Chernov-Rogan T, Adrian M, Tsai MC, Ngu H, Foreman O, Xie L, Hanson JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033726&quot;&gt;42033726&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/complement-c3ar-deletion-does-not-attenuate-degeneration-tauopathy-model-or-alter-acute#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/complement-c3ar-deletion-does-not-attenuate-degeneration-tauopathy-model-or-alter-acute#comments</comments>
</item>
<item>
 <title>Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial.</title>
 <link>https://www.alzforum.org/papers/safety-and-efficacy-anti-synuclein-monoclonal-antibody-amlenetug-treatment-patients-multiple</link>
 <description>Lancet Neurol. 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Kjærsgaard L, Wiedemann J, Singer W, Takeda A, Berger AK, Flensburg MF, Hansen L, Kallunki P, Kompus K, Nighah K, Schmidt SN, Jørgensen MN, Svanholm Fogh B, Zanigni S, Luthman J, AMULET Trial Group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044642&quot;&gt;42044642&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/safety-and-efficacy-anti-synuclein-monoclonal-antibody-amlenetug-treatment-patients-multiple#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/safety-and-efficacy-anti-synuclein-monoclonal-antibody-amlenetug-treatment-patients-multiple#comments</comments>
</item>
<item>
 <title>Comparative proteomic analysis of cerebrospinal fluid and brain tissue using Orbitrap Astral and timsTOF Pro 2 platforms with data-independent acquisition.</title>
 <link>https://www.alzforum.org/papers/comparative-proteomic-analysis-cerebrospinal-fluid-and-brain-tissue-using-orbitrap-astral-and</link>
 <description>Diagnosis (Berl). 2026 Apr 24; Epub 2026 Apr 24&lt;br&gt;Authors: Chatanaka MK, Lorén MP, Wong CJ, Soosaipillai A, Boada M, Molina-Porcel L, Morató X, Prassas I, Diamandis EP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42044326&quot;&gt;42044326&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-proteomic-analysis-cerebrospinal-fluid-and-brain-tissue-using-orbitrap-astral-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-proteomic-analysis-cerebrospinal-fluid-and-brain-tissue-using-orbitrap-astral-and#comments</comments>
</item>
<item>
 <title>The influence of beta-amyloid and tau proteins on cognitive changes in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/influence-beta-amyloid-and-tau-proteins-cognitive-changes-parkinsons-disease</link>
 <description>Parkinsonism Relat Disord. 2026 Apr 24;:108332.  Epub 2026 Apr 24&lt;br&gt;Authors: Abraham B, Carl S, Ye L, Wegner F, Höllerhage M, Schulze Westhoff M, Konen F, Schneidereit IV, Skripuletz T, Klietz M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062191&quot;&gt;42062191&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/influence-beta-amyloid-and-tau-proteins-cognitive-changes-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/influence-beta-amyloid-and-tau-proteins-cognitive-changes-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Recent advances in the development of selective hMAO-B inhibitors for neurodegenerative diseases: An update from 2020 to present.</title>
 <link>https://www.alzforum.org/papers/recent-advances-development-selective-hmao-b-inhibitors-neurodegenerative-diseases-update</link>
 <description>Eur J Med Chem. 2026 Apr 24;313:118893.  Epub 2026 Apr 24&lt;br&gt;Authors: Salerno S, Fabbri G, Di Paolo ML, Piazzola F, Piccarducci R, Costa B, Castellano S, Dalla Via L, Taliani S, Da Settimo F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060966&quot;&gt;42060966&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/recent-advances-development-selective-hmao-b-inhibitors-neurodegenerative-diseases-update#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/recent-advances-development-selective-hmao-b-inhibitors-neurodegenerative-diseases-update#comments</comments>
</item>
<item>
 <title>LOESS-based normalization workflow for targeted HDL glycoproteomics in an Alzheimer&#039;s disease cohort.</title>
 <link>https://www.alzforum.org/papers/loess-based-normalization-workflow-targeted-hdl-glycoproteomics-alzheimers-disease-cohort</link>
 <description>RSC Adv. 2026 Apr 24;16(24):22252-22260.  Epub 2026 Apr 28&lt;br&gt;Authors: Hong BV, Liu Y, Oloumi A, K Agus J, Bouchibti Y, Jin LW, Maezawa I, Harvey DJ, Lebrilla CB, Zivkovic AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42058034&quot;&gt;42058034&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/loess-based-normalization-workflow-targeted-hdl-glycoproteomics-alzheimers-disease-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/loess-based-normalization-workflow-targeted-hdl-glycoproteomics-alzheimers-disease-cohort#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in an insulin-resistance-induced Alzheimer&#039;s disease rat model: Synthesis, in-silico and in-vivo insights&quot; [Experimental Neurology, 398 (2026) 115634].</title>
 <link>https://www.alzforum.org/papers/corrigendum-demethyleneberberine-attenuates-combined-cognitive-and-metabolic-dysfunctions</link>
 <description>Exp Neurol. 2026 Apr 23;:115774.  Epub 2026 Apr 23&lt;br&gt;Authors: Kaur A, Singh S, Singh M, Silakari P, Mannan A, Vishwas S, Kumar P, Subramaniyan V, Singh TG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031657&quot;&gt;42031657&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-demethyleneberberine-attenuates-combined-cognitive-and-metabolic-dysfunctions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-demethyleneberberine-attenuates-combined-cognitive-and-metabolic-dysfunctions#comments</comments>
</item>
<item>
 <title>Mild cognitive impairment: New directions in predictors, diagnosis and biomarkers.</title>
 <link>https://www.alzforum.org/papers/mild-cognitive-impairment-new-directions-predictors-diagnosis-and-biomarkers</link>
 <description>Int Psychogeriatr. 2026 Apr 23;:100211.  Epub 2026 Apr 23&lt;br&gt;Authors: Fischer CE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031631&quot;&gt;42031631&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mild-cognitive-impairment-new-directions-predictors-diagnosis-and-biomarkers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mild-cognitive-impairment-new-directions-predictors-diagnosis-and-biomarkers#comments</comments>
</item>
<item>
 <title>Single-molecule detection methods to study alpha-synuclein aggregation in postmortem Parkinson&#039;s disease brains.</title>
 <link>https://www.alzforum.org/papers/single-molecule-detection-methods-study-alpha-synuclein-aggregation-postmortem-parkinsons</link>
 <description>Cell Rep Methods. 2026 Apr 23;:101418.  Epub 2026 Apr 23&lt;br&gt;Authors: Fertan E, Danial JS, Neame S, Lam JY, Cotton MW, Burke M, Xia Z, Wu Y, Powney B, Imaizumi Y, Quaegebeur A, Meisl G, Staddon J, Klenerman D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030949&quot;&gt;42030949&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-molecule-detection-methods-study-alpha-synuclein-aggregation-postmortem-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-molecule-detection-methods-study-alpha-synuclein-aggregation-postmortem-parkinsons#comments</comments>
</item>
<item>
 <title>Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer&#039;s disease brain.</title>
 <link>https://www.alzforum.org/papers/redox-regulation-neuroinflammatory-pathways-contributes-damage-alzheimers-disease-brain-0</link>
 <description>Cell Chem Biol. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Carnevale LN, Banerjee P, Zhang X, Navarro J, Raspur CK, Patel P, Nakamura T, Schahrer E, Scott H, Lang N, Diedrich JK, Roberts AJ, Yates JR 3rd, Lipton SA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42030932&quot;&gt;42030932&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/redox-regulation-neuroinflammatory-pathways-contributes-damage-alzheimers-disease-brain-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/redox-regulation-neuroinflammatory-pathways-contributes-damage-alzheimers-disease-brain-0#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease immunotherapy and the amyloid hypothesis: when aggregation obscures interpretation.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-immunotherapy-and-amyloid-hypothesis-when-aggregation-obscures</link>
 <description>Lancet. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Fox NC, Kohlhaas S, Schott JM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035783&quot;&gt;42035783&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-immunotherapy-and-amyloid-hypothesis-when-aggregation-obscures#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-immunotherapy-and-amyloid-hypothesis-when-aggregation-obscures#comments</comments>
</item>
<item>
 <title>Functional Adaptive Longitudinal Reorganization of Superior Parietal Lobule Networks in Amyotrophic Lateral Sclerosis: Evidence Suggesting Compensatory Mechanisms.</title>
 <link>https://www.alzforum.org/papers/functional-adaptive-longitudinal-reorganization-superior-parietal-lobule-networks-amyotrophic</link>
 <description>Brain Res Bull. 2026 Apr 23;:111900.  Epub 2026 Apr 23&lt;br&gt;Authors: Ghaderi S, Mohammadi S, Kalra S, Batouli SA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42034127&quot;&gt;42034127&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-adaptive-longitudinal-reorganization-superior-parietal-lobule-networks-amyotrophic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-adaptive-longitudinal-reorganization-superior-parietal-lobule-networks-amyotrophic#comments</comments>
</item>
<item>
 <title>Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides.</title>
 <link>https://www.alzforum.org/papers/direct-targeting-c9orf72-repeat-rna-fluorinated-antisense-oligonucleotides</link>
 <description>Nucleic Acids Res. 2026 Apr 23;54(8)&lt;br&gt;Authors: Barber HM, Parasrampuria MA, Jurado-Arjona J, Gamir-Morralla A, Berninger B, González C, Gagnon KT, Damha MJ, Garavís M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033225&quot;&gt;42033225&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/direct-targeting-c9orf72-repeat-rna-fluorinated-antisense-oligonucleotides#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/direct-targeting-c9orf72-repeat-rna-fluorinated-antisense-oligonucleotides#comments</comments>
</item>
<item>
 <title>Divalent siRNA for prion disease.</title>
 <link>https://www.alzforum.org/papers/divalent-sirna-prion-disease-0</link>
 <description>Nucleic Acids Res. 2026 Apr 23;54(8)&lt;br&gt;Authors: Gentile JE, Corridon TL, Serack FE, Echeverria D, Kennedy ZC, Gallant-Behm CL, Hassler MR, Kinberger GA, Kelemen MN, Kamath NG, Lian Y, Gross KY, Miller R, DeSouza-Lenz K, Howard M, Guzman K, Chan N, Laversenne V, Curtis D, Fettes K, Lemaitre M, Jackson AL, Yamada K, Alterman JF, Coffey AA, Minikel EV, Khvorova A, Vallabh SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033217&quot;&gt;42033217&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/divalent-sirna-prion-disease-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/divalent-sirna-prion-disease-0#comments</comments>
</item>
<item>
 <title>Glycolysis as a central pathological axis in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/glycolysis-central-pathological-axis-neurodegenerative-diseases</link>
 <description>Rev Neurosci. 2026 Apr 23; Epub 2026 Apr 23&lt;br&gt;Authors: Cheng T, Li M, Yang Y, Rao Z, Yang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043421&quot;&gt;42043421&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycolysis-central-pathological-axis-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycolysis-central-pathological-axis-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Co-aggregation of amyloidogenic proteins in age-related neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/co-aggregation-amyloidogenic-proteins-age-related-neurodegenerative-diseases</link>
 <description>Ageing Res Rev. 2026 Apr 22;118:103148.  Epub 2026 Apr 22&lt;br&gt;Authors: Basha S, Nadkarni PP, Pai AR, Mahato KK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031321&quot;&gt;42031321&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/co-aggregation-amyloidogenic-proteins-age-related-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/co-aggregation-amyloidogenic-proteins-age-related-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Metabolic reprogramming and signalling networks in microglial activation: Implications for neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/metabolic-reprogramming-and-signalling-networks-microglial-activation-implications</link>
 <description>Ageing Res Rev. 2026 Apr 22;118:103138.  Epub 2026 Apr 22&lt;br&gt;Authors: El-Hamri MA, Abboussi O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031319&quot;&gt;42031319&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metabolic-reprogramming-and-signalling-networks-microglial-activation-implications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metabolic-reprogramming-and-signalling-networks-microglial-activation-implications#comments</comments>
</item>
<item>
 <title>Robust validation of neuroimaging and clinical models via the SAR method: A case study based on the ADNI dataset.</title>
 <link>https://www.alzforum.org/papers/robust-validation-neuroimaging-and-clinical-models-sar-method-case-study-based-adni-dataset</link>
 <description>Neuroimage. 2026 Apr 22;333:121917.  Epub 2026 Apr 22&lt;br&gt;Authors: Hernández A, Illán IA, Ramírez J, Segovia F, Martínez-Murcia FJ, Levin J, Górriz JM, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031084&quot;&gt;42031084&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/robust-validation-neuroimaging-and-clinical-models-sar-method-case-study-based-adni-dataset#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/robust-validation-neuroimaging-and-clinical-models-sar-method-case-study-based-adni-dataset#comments</comments>
</item>
<item>
 <title>In vivo classification of neuropathological disease stages in Parkinson&#039;s disease by diffusion tensor imaging.</title>
 <link>https://www.alzforum.org/papers/vivo-classification-neuropathological-disease-stages-parkinsons-disease-diffusion-tensor</link>
 <description>Neuroimage. 2026 Apr 22;333:121947.  Epub 2026 Apr 22&lt;br&gt;Authors: Müller HP, Bârlescu LA, Sollmann N, Tredici KD, Braak H, Kassubek J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031082&quot;&gt;42031082&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/vivo-classification-neuropathological-disease-stages-parkinsons-disease-diffusion-tensor#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/vivo-classification-neuropathological-disease-stages-parkinsons-disease-diffusion-tensor#comments</comments>
</item>
<item>
 <title>Disulfidptosis in neurodegenerative diseases: From redox imbalance to neuronal dysfunction.</title>
 <link>https://www.alzforum.org/papers/disulfidptosis-neurodegenerative-diseases-redox-imbalance-neuronal-dysfunction</link>
 <description>Behav Brain Res. 2026 Apr 22;509:116242.  Epub 2026 Apr 22&lt;br&gt;Authors: Shi C, Jia K, Guo Y, Qian S, Wang B, Qiu Y, Dan L, Dang Z, Xue K, Gao F, Zhao L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031063&quot;&gt;42031063&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disulfidptosis-neurodegenerative-diseases-redox-imbalance-neuronal-dysfunction#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disulfidptosis-neurodegenerative-diseases-redox-imbalance-neuronal-dysfunction#comments</comments>
</item>
<item>
 <title>SEC62-mediated ER-Phagy activation alleviates Alzheimer&#039;s disease pathology and restores cognitive function in 5×FAD mice.</title>
 <link>https://www.alzforum.org/papers/sec62-mediated-er-phagy-activation-alleviates-alzheimers-disease-pathology-and-restores</link>
 <description>Mol Ther. 2026 Apr 22; Epub 2026 Apr 22&lt;br&gt;Authors: Huang J, Wang YB, Wu J, Qian PJ, Shao J, Cao DD, Liu Y, Luo ZG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42026868&quot;&gt;42026868&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sec62-mediated-er-phagy-activation-alleviates-alzheimers-disease-pathology-and-restores#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sec62-mediated-er-phagy-activation-alleviates-alzheimers-disease-pathology-and-restores#comments</comments>
</item>
<item>
 <title>Disease duration-dependent alteration of regulatory natural killer cells in patients with Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/disease-duration-dependent-alteration-regulatory-natural-killer-cells-patients-parkinsons</link>
 <description>Parkinsonism Relat Disord. 2026 Apr 22;147:108322.  Epub 2026 Apr 22&lt;br&gt;Authors: Yamanishi Y, Miyaue N, Choudhury ME, Nagai M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035741&quot;&gt;42035741&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disease-duration-dependent-alteration-regulatory-natural-killer-cells-patients-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disease-duration-dependent-alteration-regulatory-natural-killer-cells-patients-parkinsons#comments</comments>
</item>
<item>
 <title>Astrocytes and Their Role in the Development and Progression of Alzheimer&#039;s Disease: Gatekeepers of Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/astrocytes-and-their-role-development-and-progression-alzheimers-disease-gatekeepers</link>
 <description>J Integr Neurosci. 2026 Apr 22;25(4):49765. &lt;br&gt;Authors: Svobodova I, Bendova Z, Novotny J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052757&quot;&gt;42052757&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astrocytes-and-their-role-development-and-progression-alzheimers-disease-gatekeepers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astrocytes-and-their-role-development-and-progression-alzheimers-disease-gatekeepers#comments</comments>
</item>
<item>
 <title>An exploratory analysis of plasma biomarkers associated with cerebral amyloid angiopathy.</title>
 <link>https://www.alzforum.org/papers/exploratory-analysis-plasma-biomarkers-associated-cerebral-amyloid-angiopathy</link>
 <description>Neurobiol Aging. 2026 Apr 21;165:1-7.  Epub 2026 Apr 21&lt;br&gt;Authors: Ersözlü E, Meyer F, Preis L, Arslan O, Gref D, Droste L, Hellmann-Regen J, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033997&quot;&gt;42033997&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploratory-analysis-plasma-biomarkers-associated-cerebral-amyloid-angiopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploratory-analysis-plasma-biomarkers-associated-cerebral-amyloid-angiopathy#comments</comments>
</item>
<item>
 <title>Microglial Innate Immune Memory: Implications and Research Advances in Central Nervous System Disorders.</title>
 <link>https://www.alzforum.org/papers/microglial-innate-immune-memory-implications-and-research-advances-central-nervous-system</link>
 <description>Curr Issues Mol Biol. 2026 Apr 21;48(4)&lt;br&gt;Authors: Song Y, Shu S, Zeng X, Xia M, Liu J, Li L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042086&quot;&gt;42042086&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglial-innate-immune-memory-implications-and-research-advances-central-nervous-system#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglial-innate-immune-memory-implications-and-research-advances-central-nervous-system#comments</comments>
</item>
<item>
 <title>Plant-Derived Peptides with Neuroprotective Activity: Advances and Perspectives in the Prevention of Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/plant-derived-peptides-neuroprotective-activity-advances-and-perspectives-prevention</link>
 <description>ACS Omega. 2026 Apr 21;11(15):22458-22478.  Epub 2026 Apr 8&lt;br&gt;Authors: Maia ME, Carvalho M, Sousa Gomes C, Arruda M, Antunes de Magalhães AJ, Farias D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040397&quot;&gt;42040397&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plant-derived-peptides-neuroprotective-activity-advances-and-perspectives-prevention#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plant-derived-peptides-neuroprotective-activity-advances-and-perspectives-prevention#comments</comments>
</item>
<item>
 <title>Targeting Lipid Metabolism in Alzheimer&#039;s Disease: Emerging Insights and Future Directions.</title>
 <link>https://www.alzforum.org/papers/targeting-lipid-metabolism-alzheimers-disease-emerging-insights-and-future-directions</link>
 <description>J Integr Neurosci. 2026 Apr 21;25(4):48436. &lt;br&gt;Authors: Balakrishnan J, Kannan S, Shanmugam K, Sugasini D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052762&quot;&gt;42052762&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-lipid-metabolism-alzheimers-disease-emerging-insights-and-future-directions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-lipid-metabolism-alzheimers-disease-emerging-insights-and-future-directions#comments</comments>
</item>
<item>
 <title>Functional Connectivity Alterations in the Cholinergic Neural Circuits of Patients With Alzheimer&#039;s Disease: A Donepezil Intervention Study Using Resting-State Functional Magnetic Resonance Imaging.</title>
 <link>https://www.alzforum.org/papers/functional-connectivity-alterations-cholinergic-neural-circuits-patients-alzheimers-disease</link>
 <description>J Integr Neurosci. 2026 Apr 21;25(4):50039. &lt;br&gt;Authors: Guo Y, Zhang Z, Chen B, Liu H, Wei F, Liu X, Guo Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052761&quot;&gt;42052761&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-connectivity-alterations-cholinergic-neural-circuits-patients-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-connectivity-alterations-cholinergic-neural-circuits-patients-alzheimers-disease#comments</comments>
</item>
<item>
 <title>A Perspective on Alzheimer&#039;s Therapeutics: A Multitarget Approach with Rho-associated Kinase and Histone Deacetylase Inhibitors.</title>
 <link>https://www.alzforum.org/papers/perspective-alzheimers-therapeutics-multitarget-approach-rho-associated-kinase-and-histone</link>
 <description>Med Chem. 2026 Apr 21; Epub 2026 Apr 21&lt;br&gt;Authors: Lopes LF, Tolomeu HV, Vieira RP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42059217&quot;&gt;42059217&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/perspective-alzheimers-therapeutics-multitarget-approach-rho-associated-kinase-and-histone#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/perspective-alzheimers-therapeutics-multitarget-approach-rho-associated-kinase-and-histone#comments</comments>
</item>
<item>
 <title>Polyphenols and physical activity stimulate gut microbiota mediated Nrf2 signaling to combat neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/polyphenols-and-physical-activity-stimulate-gut-microbiota-mediated-nrf2-signaling-combat</link>
 <description>Pathol Res Pract. 2026 Apr 20;283:156478.  Epub 2026 Apr 20&lt;br&gt;Authors: Wang F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033865&quot;&gt;42033865&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/polyphenols-and-physical-activity-stimulate-gut-microbiota-mediated-nrf2-signaling-combat#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/polyphenols-and-physical-activity-stimulate-gut-microbiota-mediated-nrf2-signaling-combat#comments</comments>
</item>
<item>
 <title>Ginkgo Biloba for Alzheimer&#039;s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment-What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?</title>
 <link>https://www.alzforum.org/papers/ginkgo-biloba-alzheimers-disease-mixed-dementia-trials-biomarker-confirmed-mild-cognitive</link>
 <description>Brain Sci. 2026 Apr 20;16(4)&lt;br&gt;Authors: Yang Y, Kwak YT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041838&quot;&gt;42041838&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ginkgo-biloba-alzheimers-disease-mixed-dementia-trials-biomarker-confirmed-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ginkgo-biloba-alzheimers-disease-mixed-dementia-trials-biomarker-confirmed-mild-cognitive#comments</comments>
</item>
<item>
 <title>Predicting future cognitive impairment in preclinical Alzheimer&#039;s disease using amyloid PET and MRI: A multisite machine learning study.</title>
 <link>https://www.alzforum.org/papers/predicting-future-cognitive-impairment-preclinical-alzheimers-disease-using-amyloid-pet-and</link>
 <description>Neurobiol Aging. 2026 Apr 19;165:8-23.  Epub 2026 Apr 19&lt;br&gt;Authors: Yang B, Earnest T, Bilgel M, Albert MS, Johnson SC, Davatzikos C, Erus G, Masters CL, Resnick SM, Miller MI, Bakker A, Morris JC, Benzinger TL, Gordon BA, Sotiras A, Alzheimer’s Disease Neuroimaging Initiative, Preclinical Alzheimer’s Disease Consortium&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033998&quot;&gt;42033998&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/predicting-future-cognitive-impairment-preclinical-alzheimers-disease-using-amyloid-pet-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/predicting-future-cognitive-impairment-preclinical-alzheimers-disease-using-amyloid-pet-and#comments</comments>
</item>
<item>
 <title>Associations of obstructive sleep apnea with A/T/N biomarkers, neuroimaging abnormalities, neurodegenerative progression, and CPAP-related changes in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/associations-obstructive-sleep-apnea-atn-biomarkers-neuroimaging-abnormalities</link>
 <description>Sleep Med. 2026 Apr 18;144:108975.  Epub 2026 Apr 18&lt;br&gt;Authors: Zheng W, Zhou Y, Lu M, Wang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055498&quot;&gt;42055498&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-obstructive-sleep-apnea-atn-biomarkers-neuroimaging-abnormalities#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-obstructive-sleep-apnea-atn-biomarkers-neuroimaging-abnormalities#comments</comments>
</item>
<item>
 <title>Design, synthesis and anti-Alzheimer&#039;s disease activity evaluation of dual 17β-HSD10 and CDK5/p25 inhibitors based on the naphtho[2,3-b]furan-4,9-dione scaffold.</title>
 <link>https://www.alzforum.org/papers/design-synthesis-and-anti-alzheimers-disease-activity-evaluation-dual-17v-hsd10-and-cdk5p25</link>
 <description>Eur J Med Chem. 2026 Apr 17;313:118874.  Epub 2026 Apr 17&lt;br&gt;Authors: Dao S, Cui C, He W, Liu E, Zhang L, Tang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035670&quot;&gt;42035670&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/design-synthesis-and-anti-alzheimers-disease-activity-evaluation-dual-17v-hsd10-and-cdk5p25#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/design-synthesis-and-anti-alzheimers-disease-activity-evaluation-dual-17v-hsd10-and-cdk5p25#comments</comments>
</item>
<item>
 <title>MambaKAN: An Interpretable Framework for Alzheimer&#039;s Disease Diagnosis via Selective State Space Modeling of Dynamic Functional Connectivity.</title>
 <link>https://www.alzforum.org/papers/mambakan-interpretable-framework-alzheimers-disease-diagnosis-selective-state-space-modeling</link>
 <description>Brain Sci. 2026 Apr 17;16(4)&lt;br&gt;Authors: Gao L, Hu Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041829&quot;&gt;42041829&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mambakan-interpretable-framework-alzheimers-disease-diagnosis-selective-state-space-modeling#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mambakan-interpretable-framework-alzheimers-disease-diagnosis-selective-state-space-modeling#comments</comments>
</item>
<item>
 <title>Writing Abilities in Primary Progressive Aphasia: A Scoping Literature Review.</title>
 <link>https://www.alzforum.org/papers/writing-abilities-primary-progressive-aphasia-scoping-literature-review</link>
 <description>Brain Sci. 2026 Apr 17;16(4)&lt;br&gt;Authors: Esposito V, Conca F, Santi GC, Cappa SF, Catricalà E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041828&quot;&gt;42041828&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/writing-abilities-primary-progressive-aphasia-scoping-literature-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/writing-abilities-primary-progressive-aphasia-scoping-literature-review#comments</comments>
</item>
<item>
 <title>Brain Delivery of Antibody-Derived Biologicals for Alzheimer&#039;s Disease: An Updated Narrative Review.</title>
 <link>https://www.alzforum.org/papers/brain-delivery-antibody-derived-biologicals-alzheimers-disease-updated-narrative-review</link>
 <description>Antibodies (Basel). 2026 Apr 17;15(2)&lt;br&gt;Authors: Sumbria RK, Boado RJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041396&quot;&gt;42041396&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-delivery-antibody-derived-biologicals-alzheimers-disease-updated-narrative-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-delivery-antibody-derived-biologicals-alzheimers-disease-updated-narrative-review#comments</comments>
</item>
<item>
 <title>Keap1-Nrf2 Signaling Pathway-Mediated Antioxidant Defense in Neurodegenerative Diseases: Mechanisms and Traditional Chinese Medicine Therapeutic Strategies.</title>
 <link>https://www.alzforum.org/papers/keap1-nrf2-signaling-pathway-mediated-antioxidant-defense-neurodegenerative-diseases</link>
 <description>Front Biosci (Landmark Ed). 2026 Apr 17;31(4):45233. &lt;br&gt;Authors: Chen W, Wang J, Li Q, Zhang L, Wu X, Luo S, Xie Y, Guo P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052844&quot;&gt;42052844&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/keap1-nrf2-signaling-pathway-mediated-antioxidant-defense-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/keap1-nrf2-signaling-pathway-mediated-antioxidant-defense-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Explainable Patient-Level Cognitive Impairment Screening via Temporal, Semantic, and Psycholinguistic Multimodal AI.</title>
 <link>https://www.alzforum.org/papers/explainable-patient-level-cognitive-impairment-screening-temporal-semantic-and</link>
 <description>J Intell. 2026 Apr 15;14(4)&lt;br&gt;Authors: Abdullah, Fatima Z, Ruiz MJ, Espinosa-Sosa O, Sánchez-Mejorada CG, Téllez RQ, Rodríguez JL, Sidorov G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042246&quot;&gt;42042246&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/explainable-patient-level-cognitive-impairment-screening-temporal-semantic-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/explainable-patient-level-cognitive-impairment-screening-temporal-semantic-and#comments</comments>
</item>
<item>
 <title>Sporadic Alzheimer&#039;s disease with bipolar-like features: a case report and a brief review of the current research status.</title>
 <link>https://www.alzforum.org/papers/sporadic-alzheimers-disease-bipolar-features-case-report-and-brief-review-current-research</link>
 <description>J Zhejiang Univ Sci B. 2026 Apr 15;27(4):416-425. &lt;br&gt;Authors: Kong L, Yang Y, Zhou W, Hu S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046874&quot;&gt;42046874&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sporadic-alzheimers-disease-bipolar-features-case-report-and-brief-review-current-research#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sporadic-alzheimers-disease-bipolar-features-case-report-and-brief-review-current-research#comments</comments>
</item>
<item>
 <title>Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio - a new therapeutic strategy for APPSwe/PS1ΔE9 transgenic mice?</title>
 <link>https://www.alzforum.org/papers/combining-cannabidiol-and-delta-9-tetrahydrocannabinol-503-ratio-new-therapeutic-strategy</link>
 <description>Neurobiol Aging. 2026 Apr 15;164:79-90.  Epub 2026 Apr 15&lt;br&gt;Authors: Coles M, Rosa Porto R, Chesworth R, Steiner-Lim GZ, Karl T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054867&quot;&gt;42054867&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/combining-cannabidiol-and-delta-9-tetrahydrocannabinol-503-ratio-new-therapeutic-strategy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/combining-cannabidiol-and-delta-9-tetrahydrocannabinol-503-ratio-new-therapeutic-strategy#comments</comments>
</item>
<item>
 <title>Platelet-Derived Granules and Extracellular Vesicles in Neurodegenerative Diseases: Neurovascular Mechanisms and Clinical Implications.</title>
 <link>https://www.alzforum.org/papers/platelet-derived-granules-and-extracellular-vesicles-neurodegenerative-diseases-neurovascular</link>
 <description>Cells. 2026 Apr 14;15(8)&lt;br&gt;Authors: Lee BK, Yoo JR, Jung YS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041560&quot;&gt;42041560&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/platelet-derived-granules-and-extracellular-vesicles-neurodegenerative-diseases-neurovascular#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/platelet-derived-granules-and-extracellular-vesicles-neurodegenerative-diseases-neurovascular#comments</comments>
</item>
<item>
 <title>Outer Membrane Vesicles as Systems-Level Drivers of Neuroinflammation, Metabolic Dysfunction, and Proteinopathy in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/outer-membrane-vesicles-systems-level-drivers-neuroinflammation-metabolic-dysfunction-and</link>
 <description>Cells. 2026 Apr 14;15(8)&lt;br&gt;Authors: Delbaz A, St John JA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041558&quot;&gt;42041558&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/outer-membrane-vesicles-systems-level-drivers-neuroinflammation-metabolic-dysfunction-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/outer-membrane-vesicles-systems-level-drivers-neuroinflammation-metabolic-dysfunction-and#comments</comments>
</item>
<item>
 <title>Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma.</title>
 <link>https://www.alzforum.org/papers/effect-synuclein-overexpression-napp-129-and-tlqp-62-rat-brain-and-plasma</link>
 <description>Med Sci (Basel). 2026 Apr 13;14(2)&lt;br&gt;Authors: Manai AL, Noli B, Anjum A, Manca E, Casu MA, Pardon MC, Cocco C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029619&quot;&gt;42029619&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-synuclein-overexpression-napp-129-and-tlqp-62-rat-brain-and-plasma#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-synuclein-overexpression-napp-129-and-tlqp-62-rat-brain-and-plasma#comments</comments>
</item>
<item>
 <title>Zebrafish (Danio rerio) as a Model for Neurodegenerative Disease Research: Mechanisms, Biomarkers, and Translational Promise.</title>
 <link>https://www.alzforum.org/papers/zebrafish-danio-rerio-model-neurodegenerative-disease-research-mechanisms-biomarkers-and</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Apr 13; Epub 2026 Apr 13&lt;br&gt;Authors: Khan N, Doshi G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051098&quot;&gt;42051098&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/zebrafish-danio-rerio-model-neurodegenerative-disease-research-mechanisms-biomarkers-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/zebrafish-danio-rerio-model-neurodegenerative-disease-research-mechanisms-biomarkers-and#comments</comments>
</item>
<item>
 <title>Therapeutic Innovations in Parkinson&#039;s and Alzheimer&#039;s Disease: Molecular Mechanisms and Emerging Strategies.</title>
 <link>https://www.alzforum.org/papers/therapeutic-innovations-parkinsons-and-alzheimers-disease-molecular-mechanisms-and-emerging</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Apr 13; Epub 2026 Apr 13&lt;br&gt;Authors: Kasthuri S, Padmavathi S, Jeevitha M, Rajangam J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051097&quot;&gt;42051097&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-innovations-parkinsons-and-alzheimers-disease-molecular-mechanisms-and-emerging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-innovations-parkinsons-and-alzheimers-disease-molecular-mechanisms-and-emerging#comments</comments>
</item>
<item>
 <title>In Silico Design and Evaluation of Diosmin Analogs for Targeting Peroxisome Proliferator-activated Receptor γ (PPAR-γ) Against Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/silico-design-and-evaluation-diosmin-analogs-targeting-peroxisome-proliferator-activated</link>
 <description>Curr Neuropharmacol. 2026 Apr 13; Epub 2026 Apr 13&lt;br&gt;Authors: Sun Y, Chan TW, Liao W, Li M, Mao X, Feng Y, Rong J, Zhao J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051092&quot;&gt;42051092&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/silico-design-and-evaluation-diosmin-analogs-targeting-peroxisome-proliferator-activated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/silico-design-and-evaluation-diosmin-analogs-targeting-peroxisome-proliferator-activated#comments</comments>
</item>
<item>
 <title>Cognitive Testing in Spanish Older Adults: A Scoping Review.</title>
 <link>https://www.alzforum.org/papers/cognitive-testing-spanish-older-adults-scoping-review</link>
 <description>Geriatrics (Basel). 2026 Apr 10;11(2)&lt;br&gt;Authors: Sáez-González L, Martínez LA, Blázquez-Abellán G, de Lara JA, Martinez-Garcia RM, Castro-Vázquez L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042101&quot;&gt;42042101&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cognitive-testing-spanish-older-adults-scoping-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cognitive-testing-spanish-older-adults-scoping-review#comments</comments>
</item>
<item>
 <title>Schisandra chinensis Pomace Attenuates Scopolamine-Induced Cholinergic Dysfunction Associated with Changes in BDNF and JNK Signaling.</title>
 <link>https://www.alzforum.org/papers/schisandra-chinensis-pomace-attenuates-scopolamine-induced-cholinergic-dysfunction-associated</link>
 <description>Curr Issues Mol Biol. 2026 Apr 10;48(4)&lt;br&gt;Authors: Yoon JH, Lim SH, Lee IS, Jang YK, Park SJ, Lee SJ, Im S, Park JH, Park H, Maeng S, Shin J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042048&quot;&gt;42042048&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/schisandra-chinensis-pomace-attenuates-scopolamine-induced-cholinergic-dysfunction-associated#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/schisandra-chinensis-pomace-attenuates-scopolamine-induced-cholinergic-dysfunction-associated#comments</comments>
</item>
<item>
 <title>Deficient Visuospatial Incidental and Intentional Memory in Cognitively Healthy Middle-Aged First-Degree Descendants of Alzheimer&#039;s Disease Patients.</title>
 <link>https://www.alzforum.org/papers/deficient-visuospatial-incidental-and-intentional-memory-cognitively-healthy-middle-aged</link>
 <description>Brain Sci. 2026 Apr 10;16(4)&lt;br&gt;Authors: Álvarez-Huante CG, Rincón-Ortega MF, Palomares-Vallejo EJ, Téllez-Anguiano AD, Junco-Muñoz ML, López-Vázquez MÁ, Olvera-Cortés ME&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041814&quot;&gt;42041814&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deficient-visuospatial-incidental-and-intentional-memory-cognitively-healthy-middle-aged#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deficient-visuospatial-incidental-and-intentional-memory-cognitively-healthy-middle-aged#comments</comments>
</item>
<item>
 <title>From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/lipids-mitochondria-shared-metabolic-alterations-obesity-and-alzheimers-disease</link>
 <description>Cells. 2026 Apr 10;15(8)&lt;br&gt;Authors: Uranga RM, Allani SK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041540&quot;&gt;42041540&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lipids-mitochondria-shared-metabolic-alterations-obesity-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lipids-mitochondria-shared-metabolic-alterations-obesity-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Association Between the Color Kanji Pick-Out Test App Performance and Cognitive Frailty as a Potential Early Screening Marker for Cognitive Decline.</title>
 <link>https://www.alzforum.org/papers/association-between-color-kanji-pick-out-test-app-performance-and-cognitive-frailty-potential</link>
 <description>Geriatrics (Basel). 2026 Apr 9;11(2)&lt;br&gt;Authors: Goda A, Nakano H, Kikuchi Y, Katsurasako T, Mori K, Kubo A, Nonaka K, Iwamoto K, Mitsumaru N, Shimura T, Murata S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042097&quot;&gt;42042097&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-color-kanji-pick-out-test-app-performance-and-cognitive-frailty-potential#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-color-kanji-pick-out-test-app-performance-and-cognitive-frailty-potential#comments</comments>
</item>
<item>
 <title>Integrated Analysis of Cerebral Small Vessel Disease and Facial Soft-Tissue Markers in the Alzheimer&#039;s Disease Continuum.</title>
 <link>https://www.alzforum.org/papers/integrated-analysis-cerebral-small-vessel-disease-and-facial-soft-tissue-markers-alzheimers</link>
 <description>Brain Sci. 2026 Apr 9;16(4)&lt;br&gt;Authors: Bernetti C, Di Gennaro G, Roberti R, Ricci M, Pipitone F, Profilo M, Motolese F, Calandrelli R, Pilato F, Di Lazzaro V, Beomonte Zobel B, Mallio CA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041811&quot;&gt;42041811&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrated-analysis-cerebral-small-vessel-disease-and-facial-soft-tissue-markers-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrated-analysis-cerebral-small-vessel-disease-and-facial-soft-tissue-markers-alzheimers#comments</comments>
</item>
<item>
 <title>Sustained Palmitoylethanolamide Infusion Restores Incentive Motivation and Synaptic Plasticity in the Tg2576 Mouse Model of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/sustained-palmitoylethanolamide-infusion-restores-incentive-motivation-and-synaptic</link>
 <description>Cells. 2026 Apr 9;15(8)&lt;br&gt;Authors: Panuccio A, Yurtsever ZN, Cutuli D, Giacovazzo G, Decandia D, Tortolani D, Landolfo E, Oddi S, Maccarrone M, Petrosini L, Coccurello R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041537&quot;&gt;42041537&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sustained-palmitoylethanolamide-infusion-restores-incentive-motivation-and-synaptic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sustained-palmitoylethanolamide-infusion-restores-incentive-motivation-and-synaptic#comments</comments>
</item>
<item>
 <title>Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications.</title>
 <link>https://www.alzforum.org/papers/immunosenescence-and-inflammaging-drivers-neurodegeneration-cellular-mechanisms-neuroimmune</link>
 <description>Cells. 2026 Apr 8;15(8)&lt;br&gt;Authors: Bertoni G, Ristori S, Monti D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041525&quot;&gt;42041525&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/immunosenescence-and-inflammaging-drivers-neurodegeneration-cellular-mechanisms-neuroimmune#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/immunosenescence-and-inflammaging-drivers-neurodegeneration-cellular-mechanisms-neuroimmune#comments</comments>
</item>
<item>
 <title>Effect of High-Salt Diet on Memory and Behavior in Mice Expressing Human Apolipoprotein Epsilon-4 (APOE4) Allele.</title>
 <link>https://www.alzforum.org/papers/effect-high-salt-diet-memory-and-behavior-mice-expressing-human-apolipoprotein-epsilon-4</link>
 <description>NeuroSci. 2026 Apr 7;7(2)&lt;br&gt;Authors: Abdulmoniem R, Rivers M, Carter G, Khundmiri SJ, O&amp;#039;Neil JN&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042624&quot;&gt;42042624&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-high-salt-diet-memory-and-behavior-mice-expressing-human-apolipoprotein-epsilon-4#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-high-salt-diet-memory-and-behavior-mice-expressing-human-apolipoprotein-epsilon-4#comments</comments>
</item>
<item>
 <title>Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment.</title>
 <link>https://www.alzforum.org/papers/quinolinethiazole-compounds-selective-acetylcholinesterase-inhibitors-synthesis-and</link>
 <description>RSC Med Chem. 2026 Apr 7; Epub 2026 Apr 7&lt;br&gt;Authors: Kurban B, Osmaniye D, Levent S, Özkay Y, Kaplancıklı ZA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037743&quot;&gt;42037743&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quinolinethiazole-compounds-selective-acetylcholinesterase-inhibitors-synthesis-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quinolinethiazole-compounds-selective-acetylcholinesterase-inhibitors-synthesis-and#comments</comments>
</item>
<item>
 <title>mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions.</title>
 <link>https://www.alzforum.org/papers/mtor-signalling-neurodegenerative-disorders-unveiling-key-factors-mechanistic-insights-and</link>
 <description>Cell Physiol Biochem. 2026 Apr 6;60(2):136-174. &lt;br&gt;Authors: Jha NK, Chauhan P, Abomughaid MM, Avinash D, Almutary AG, Lakhanpal S, Singh A, Sulaimani GM, Al-Kuraishy HM, Mohammed HA, Misra J, Thakur K, Kumar D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057546&quot;&gt;42057546&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mtor-signalling-neurodegenerative-disorders-unveiling-key-factors-mechanistic-insights-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mtor-signalling-neurodegenerative-disorders-unveiling-key-factors-mechanistic-insights-and#comments</comments>
</item>
<item>
 <title>Life course neighborhood conditions and change: a 20-year examination of neighborhood context and associations with Alzheimer&#039;s disease biomarkers in late life.</title>
 <link>https://www.alzforum.org/papers/life-course-neighborhood-conditions-and-change-20-year-examination-neighborhood-context-and</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71382. &lt;br&gt;Authors: Clark AL, Hamlin AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029424&quot;&gt;42029424&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/life-course-neighborhood-conditions-and-change-20-year-examination-neighborhood-context-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/life-course-neighborhood-conditions-and-change-20-year-examination-neighborhood-context-and#comments</comments>
</item>
<item>
 <title>Visual memory correlates with AD biomarkers in cognitively unimpaired individuals.</title>
 <link>https://www.alzforum.org/papers/visual-memory-correlates-ad-biomarkers-cognitively-unimpaired-individuals</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71417. &lt;br&gt;Authors: James TA, Zhao L, Xu H, Wu J, Schweidel DA, Goldstein FC, Levey AI, Qiu D, Loring DW, Hanfelt JJ, Lah JJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029420&quot;&gt;42029420&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/visual-memory-correlates-ad-biomarkers-cognitively-unimpaired-individuals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/visual-memory-correlates-ad-biomarkers-cognitively-unimpaired-individuals#comments</comments>
</item>
<item>
 <title>Locus coeruleus degeneration is associated with cortical tau deposition and cognitive decline in older adults at familial risk of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/locus-coeruleus-degeneration-associated-cortical-tau-deposition-and-cognitive-decline-older-0</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71427. &lt;br&gt;Authors: Wearn A, Onuska KM, Shanks HR, Gaurav R, Lehéricy S, Baracchini G, Hughes C, Tremblay-Mercier J, Narayanan S, Breitner J, Poirier J, Schmitz TW, Turner GR, Spreng RN, PREVENT‐AD Research Group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029407&quot;&gt;42029407&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/locus-coeruleus-degeneration-associated-cortical-tau-deposition-and-cognitive-decline-older-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/locus-coeruleus-degeneration-associated-cortical-tau-deposition-and-cognitive-decline-older-0#comments</comments>
</item>
<item>
 <title>Beyond AUC: Clinical interpretability of depression-MRI-machine learning analyses in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/beyond-auc-clinical-interpretability-depression-mri-machine-learning-analyses-alzheimers</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71435. &lt;br&gt;Authors: Deng W, Xie Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029395&quot;&gt;42029395&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-auc-clinical-interpretability-depression-mri-machine-learning-analyses-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-auc-clinical-interpretability-depression-mri-machine-learning-analyses-alzheimers#comments</comments>
</item>
<item>
 <title>Infection of 5xFAD mice with a mouse-adapted SARS-CoV-2 does not alter Alzheimer&#039;s disease neuropathology yet induces widespread changes in gene expression across diverse cell types.</title>
 <link>https://www.alzforum.org/papers/infection-5xfad-mice-mouse-adapted-sars-cov-2-does-not-alter-alzheimers-disease-0</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71394. &lt;br&gt;Authors: Furman S, Zayou L, Tsourmas KI, Javonillo DI, Olivarria GM, Cheng Y, Pachow C, Fernandez K, Le L, Edwards RA, Nicholas DA, Sanchez GP, Baric RS, Green KN, Lane TE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42029189&quot;&gt;42029189&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/infection-5xfad-mice-mouse-adapted-sars-cov-2-does-not-alter-alzheimers-disease-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/infection-5xfad-mice-mouse-adapted-sars-cov-2-does-not-alter-alzheimers-disease-0#comments</comments>
</item>
<item>
 <title>[A &quot;prion mechanism&quot; involved in the progression of Parkinson&#039;s disease: towards innovative therapeutic approaches?].</title>
 <link>https://www.alzforum.org/papers/prion-mechanism-involved-progression-parkinsons-disease-towards-innovative-therapeutic</link>
 <description>Med Sci (Paris). 2026 Apr;42(4):385-388.  Epub 2026 Apr 24&lt;br&gt;Authors: Baron T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028943&quot;&gt;42028943&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prion-mechanism-involved-progression-parkinsons-disease-towards-innovative-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prion-mechanism-involved-progression-parkinsons-disease-towards-innovative-therapeutic#comments</comments>
</item>
<item>
 <title>[Protein aggregation: at the origins of neurodegenerative diseases].</title>
 <link>https://www.alzforum.org/papers/protein-aggregation-origins-neurodegenerative-diseases</link>
 <description>Med Sci (Paris). 2026 Apr;42(4):383-384.  Epub 2026 Apr 24&lt;br&gt;Authors: Baron T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028942&quot;&gt;42028942&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protein-aggregation-origins-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protein-aggregation-origins-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>[Protein aggregation: from the prion exception to a general paradigm of neurodegeneration].</title>
 <link>https://www.alzforum.org/papers/protein-aggregation-prion-exception-general-paradigm-neurodegeneration</link>
 <description>Med Sci (Paris). 2026 Apr;42(4):323-324.  Epub 2026 Apr 24&lt;br&gt;Authors: Beringue V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028928&quot;&gt;42028928&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protein-aggregation-prion-exception-general-paradigm-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protein-aggregation-prion-exception-general-paradigm-neurodegeneration#comments</comments>
</item>
<item>
 <title>Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer&#039;s Disease Research Centers: Current strategies and future directions.</title>
 <link>https://www.alzforum.org/papers/outreach-recruitment-and-engagement-cores-nia-designated-alzheimers-disease-research-centers</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71238. &lt;br&gt;Authors: Chan CK, Glover CM, Parker M, Grill JD, Langbaum JB, Morhardt DJ, Okonkwo O, Farrar-Edwards D, Wang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028802&quot;&gt;42028802&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/outreach-recruitment-and-engagement-cores-nia-designated-alzheimers-disease-research-centers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/outreach-recruitment-and-engagement-cores-nia-designated-alzheimers-disease-research-centers#comments</comments>
</item>
<item>
 <title>Molecular Pathogenesis of Memory Impairment in Parkinson&#039;s Disease: An Exploration of Underlying Mechanisms.</title>
 <link>https://www.alzforum.org/papers/molecular-pathogenesis-memory-impairment-parkinsons-disease-exploration-underlying-mechanisms</link>
 <description>Health Sci Rep. 2026 Apr;9(4):e72024.  Epub 2026 Apr 21&lt;br&gt;Authors: Pourfridoni M, Hakemi Z, Mashayekhi-Sardoo H, Baghcheghi Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028419&quot;&gt;42028419&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-pathogenesis-memory-impairment-parkinsons-disease-exploration-underlying-mechanisms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-pathogenesis-memory-impairment-parkinsons-disease-exploration-underlying-mechanisms#comments</comments>
</item>
<item>
 <title>Structural and biochemical basis of ROC-dependent activation of LRRK2.</title>
 <link>https://www.alzforum.org/papers/structural-and-biochemical-basis-roc-dependent-activation-lrrk2-0</link>
 <description>PNAS Nexus. 2026 Apr;5(4):pgag112.  Epub 2026 Apr 9&lt;br&gt;Authors: Park Y, Wu C, Tennessen K, Wan L, Hoang NC, Hoang CW, Liao J, Hoang QQ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028153&quot;&gt;42028153&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/structural-and-biochemical-basis-roc-dependent-activation-lrrk2-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/structural-and-biochemical-basis-roc-dependent-activation-lrrk2-0#comments</comments>
</item>
<item>
 <title>Endothelial NAD+ depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/endothelial-nad-depletion-drives-vascular-senescence-and-neuroinflammation-mtdna-cgassting</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71423. &lt;br&gt;Authors: Luo QH, Li F, Yang L, Pan HQ, Zhu WP, Hu P, Tao CM, Yin M, Zhang S, Liao QY, Chen ZH, Shu HX, Zhu XY, Yan TF, Liu X, Tu JL, Zhu XG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033099&quot;&gt;42033099&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/endothelial-nad-depletion-drives-vascular-senescence-and-neuroinflammation-mtdna-cgassting#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/endothelial-nad-depletion-drives-vascular-senescence-and-neuroinflammation-mtdna-cgassting#comments</comments>
</item>
<item>
 <title>Differential associations between traumatic brain injury severity and four dementia phenotypes in military veterans.</title>
 <link>https://www.alzforum.org/papers/differential-associations-between-traumatic-brain-injury-severity-and-four-dementia</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71370. &lt;br&gt;Authors: Merritt VC, Valocchi E, Lopez FV, Asimakopoulos G, Clark AL, Kodama L, Jak AJ, Liu L, Chanfreau-Coffinier C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033091&quot;&gt;42033091&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differential-associations-between-traumatic-brain-injury-severity-and-four-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differential-associations-between-traumatic-brain-injury-severity-and-four-dementia#comments</comments>
</item>
<item>
 <title>Tau Oligomers Induce Brain Endothelial Cell Hyperpermeability and Increase NLRP3 Inflammasome Signaling and MMP-9 Activity.</title>
 <link>https://www.alzforum.org/papers/tau-oligomers-induce-brain-endothelial-cell-hyperpermeability-and-increase-nlrp3-inflammasome</link>
 <description>Microcirculation. 2026 Apr;33(3):e70059. &lt;br&gt;Authors: Seplovich G, Muthusamy S, Anderson A, Waithe OY, Kobeissy F, Wang KK, Tharakan B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42035323&quot;&gt;42035323&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tau-oligomers-induce-brain-endothelial-cell-hyperpermeability-and-increase-nlrp3-inflammasome#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tau-oligomers-induce-brain-endothelial-cell-hyperpermeability-and-increase-nlrp3-inflammasome#comments</comments>
</item>
<item>
 <title>Cold Climate and Alzheimer&#039;s Disease: A Narrative Review of Biomedical and Environmental Mechanisms.</title>
 <link>https://www.alzforum.org/papers/cold-climate-and-alzheimers-disease-narrative-review-biomedical-and-environmental-mechanisms</link>
 <description>Acta Neurol Taiwan. 2026 Apr 1;35(2):70-78.  Epub 2026 Apr 24&lt;br&gt;Authors: Abdel-Sater KA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42033804&quot;&gt;42033804&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cold-climate-and-alzheimers-disease-narrative-review-biomedical-and-environmental-mechanisms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cold-climate-and-alzheimers-disease-narrative-review-biomedical-and-environmental-mechanisms#comments</comments>
</item>
<item>
 <title>Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/use-anti-amyloid-v-monoclonal-antibodies-persons-down-syndrome-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71404. &lt;br&gt;Authors: Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043831&quot;&gt;42043831&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/use-anti-amyloid-v-monoclonal-antibodies-persons-down-syndrome-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/use-anti-amyloid-v-monoclonal-antibodies-persons-down-syndrome-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Genetic correlation analysis of Alzheimer&#039;s disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry.</title>
 <link>https://www.alzforum.org/papers/genetic-correlation-analysis-alzheimers-disease-and-stroke-implicates-phlpp1-shared-locus</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71433. &lt;br&gt;Authors: Ray NR, Kurup J, Kumar A, Rajabli F, Wang L, Xu W, Jin F, Yilmaz E, Kizil C, Bertholim-Nasciben L, Moura S, Ramirez AM, Baiyewu O, Griswold AJ, Coker M, Scott KM, Akinwande K, Adams LD, Diala S, Whitehead PG, McCauley JL, Ogunronbi M, Hamilton-Nelson KL, Damasceno A, Zaman AF, Blanton SH, Akpalu A, Cuccaro ML, Wahab K, McInerney KF, Nuytemans K, Obiako R, Mena PR, Okubadejo N, Martinez IM, Zewde YZ, Gugssa SA, Sarfo FS, Kalaria R, Ndetei DM, Williams SM, Caban-Holt A, ADGC, AfDC, Tosto G, Haines JL, Akinyemi RO, Ogunniyi A, Byrd GS, Bush WS, Kunkle BW, Vance JM, Pericak-Vance MA, Reitz C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043782&quot;&gt;42043782&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-correlation-analysis-alzheimers-disease-and-stroke-implicates-phlpp1-shared-locus#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-correlation-analysis-alzheimers-disease-and-stroke-implicates-phlpp1-shared-locus#comments</comments>
</item>
<item>
 <title>Human iPSC-derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer&#039;s disease model.</title>
 <link>https://www.alzforum.org/papers/human-ipsc-derived-gabaergic-interneuron-transplantation-restores-circuit-balance-and</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71378. &lt;br&gt;Authors: Zhang X, Wang G, Chen H, Sun Y, Wangliu Z, Wang L, Sun M, Liu Q, Zhang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42043780&quot;&gt;42043780&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/human-ipsc-derived-gabaergic-interneuron-transplantation-restores-circuit-balance-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/human-ipsc-derived-gabaergic-interneuron-transplantation-restores-circuit-balance-and#comments</comments>
</item>
<item>
 <title>How PM2.5 drives dementia: emerging mechanisms and unanswered questions.</title>
 <link>https://www.alzforum.org/papers/how-pm25-drives-dementia-emerging-mechanisms-and-unanswered-questions</link>
 <description>Life Med. 2026 Apr;5(2):lnag007.  Epub 2026 Feb 2&lt;br&gt;Authors: Defrancesco AD, Yi C, Oliver BG, Chen H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040207&quot;&gt;42040207&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/how-pm25-drives-dementia-emerging-mechanisms-and-unanswered-questions#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/how-pm25-drives-dementia-emerging-mechanisms-and-unanswered-questions#comments</comments>
</item>
<item>
 <title>Feasibility of identifying factors related to Alzheimer&#039;s disease and related dementia in real-world data.</title>
 <link>https://www.alzforum.org/papers/feasibility-identifying-factors-related-alzheimers-disease-and-related-dementia-real-world-0</link>
 <description>JAMIA Open. 2026 Apr;9(2):ooag060.  Epub 2026 Apr 24&lt;br&gt;Authors: Huang Y, Li Q, Chen A, Li Y, Chuang YN, Hu X, Guo SJ, He X, Pang Y, Zhou J, Wu Y, Guo Y, Bian J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040178&quot;&gt;42040178&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/feasibility-identifying-factors-related-alzheimers-disease-and-related-dementia-real-world-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/feasibility-identifying-factors-related-alzheimers-disease-and-related-dementia-real-world-0#comments</comments>
</item>
<item>
 <title>The adherence of memory clinics to consensus recommendations for dementia diagnosis: A multicentric study in Italy.</title>
 <link>https://www.alzforum.org/papers/adherence-memory-clinics-consensus-recommendations-dementia-diagnosis-multicentric-study</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71432. &lt;br&gt;Authors: Festari C, Singh Solorzano C, Orini S, Castagna E, Cotta Ramusino M, D&amp;#039;Antonio F, Di Crosta A, Masòtino A, Massa F, Mazzonetto A, Panigutti M, Ravì N, Pievani M, Bonanni L, Bruno G, Cagnin A, Gatta R, Frisoni GB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036798&quot;&gt;42036798&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adherence-memory-clinics-consensus-recommendations-dementia-diagnosis-multicentric-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adherence-memory-clinics-consensus-recommendations-dementia-diagnosis-multicentric-study#comments</comments>
</item>
<item>
 <title>Sleep duration and amyloid status moderate the association between mood symptoms and amygdalar tau in preclinical Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/sleep-duration-and-amyloid-status-moderate-association-between-mood-symptoms-and-amygdalar</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71447. &lt;br&gt;Authors: Bonta KM, Li JS, Tun SM, Fredericks CA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42036797&quot;&gt;42036797&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-duration-and-amyloid-status-moderate-association-between-mood-symptoms-and-amygdalar#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-duration-and-amyloid-status-moderate-association-between-mood-symptoms-and-amygdalar#comments</comments>
</item>
<item>
 <title>AS1842856 Reduces β-Amyloid Burden via Inhibiting PLA2G4A-Mediated Lysosomal Dysfunction in APP/PS1 Mice.</title>
 <link>https://www.alzforum.org/papers/as1842856-reduces-v-amyloid-burden-inhibiting-pla2g4a-mediated-lysosomal-dysfunction-appps1</link>
 <description>CNS Neurosci Ther. 2026 Apr;32(4):e70910. &lt;br&gt;Authors: He DL, Wu Z, Jia RJ, Wu TY, Qiu YM, Fan YG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047940&quot;&gt;42047940&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/as1842856-reduces-v-amyloid-burden-inhibiting-pla2g4a-mediated-lysosomal-dysfunction-appps1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/as1842856-reduces-v-amyloid-burden-inhibiting-pla2g4a-mediated-lysosomal-dysfunction-appps1#comments</comments>
</item>
<item>
 <title>System changes to empower primary care in Alzheimer&#039;s disease detection and care.</title>
 <link>https://www.alzforum.org/papers/system-changes-empower-primary-care-alzheimers-disease-detection-and-care</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71276. &lt;br&gt;Authors: Phares S, Kremer I, Wall JK, Wood J, Baumgart M, Dickson S, Fickie M, Hubbard T, Jannati A, Monane M, Rivet C, Hirsch G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047299&quot;&gt;42047299&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/system-changes-empower-primary-care-alzheimers-disease-detection-and-care#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/system-changes-empower-primary-care-alzheimers-disease-detection-and-care#comments</comments>
</item>
<item>
 <title>Multiscale metabolic covariance networks uncover stage-specific biomarker signatures across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/multiscale-metabolic-covariance-networks-uncover-stage-specific-biomarker-signatures-across-0</link>
 <description>Alzheimers Dement. 2026 Apr;22(4):e71218. &lt;br&gt;Authors: Chong Chie JA, Persohn SA, Pandey RS, Simcox OR, Carter G, Salama P, Territo PR, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42047294&quot;&gt;42047294&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multiscale-metabolic-covariance-networks-uncover-stage-specific-biomarker-signatures-across-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multiscale-metabolic-covariance-networks-uncover-stage-specific-biomarker-signatures-across-0#comments</comments>
</item>
<item>
 <title>Plasma Biomarkers and Clinical Outcomes in Early-Onset Dementia.</title>
 <link>https://www.alzforum.org/papers/plasma-biomarkers-and-clinical-outcomes-early-onset-dementia</link>
 <description>JAMA Netw Open. 2026 Apr 1;9(4):e269687. &lt;br&gt;Authors: Jang H, Lee SM, Kim HJ, Jung NY, Zetterberg H, Blennow K, Apostolova LG, Moon SY, Kim EJ, Longitudinal Study of Early-Onset Dementia and Family Members (LEAF) Investigators&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054026&quot;&gt;42054026&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-biomarkers-and-clinical-outcomes-early-onset-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-biomarkers-and-clinical-outcomes-early-onset-dementia#comments</comments>
</item>
<item>
 <title>Association Between Serum Adropin Levels and Cognitive Impairment in the Elderly: A Cross-Sectional Study.</title>
 <link>https://www.alzforum.org/papers/association-between-serum-adropin-levels-and-cognitive-impairment-elderly-cross-sectional</link>
 <description>Clin Neuropsychiatry. 2026 Apr;23(2):144-153. &lt;br&gt;Authors: Abousamra S, El Arman MM, Arafa Ghazi H, El-Sobky HS, Hatata E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052221&quot;&gt;42052221&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-serum-adropin-levels-and-cognitive-impairment-elderly-cross-sectional#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-serum-adropin-levels-and-cognitive-impairment-elderly-cross-sectional#comments</comments>
</item>
<item>
 <title>Dynamic trajectories of neuropsychiatric symptoms predict Alzheimer&#039;s disease risk and clinical phenotypes.</title>
 <link>https://www.alzforum.org/papers/dynamic-trajectories-neuropsychiatric-symptoms-predict-alzheimers-disease-risk-and-clinical</link>
 <description>Gen Psychiatr. 2026 Apr;39:e70018.  Epub 2026 Apr 26&lt;br&gt;Authors: Liu W, Wang Y, Shi Y, Huang L, Tan C, Tan L, Xu W, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052139&quot;&gt;42052139&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dynamic-trajectories-neuropsychiatric-symptoms-predict-alzheimers-disease-risk-and-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dynamic-trajectories-neuropsychiatric-symptoms-predict-alzheimers-disease-risk-and-clinical#comments</comments>
</item>
<item>
 <title>The Need for Standardized Data Collection to Improve Harmonization and Pooling of Information About Modifiable Risk Factors for Alzheimer&#039;s Diseases in Italian Clinical Studies: A Systematic Review.</title>
 <link>https://www.alzforum.org/papers/need-standardized-data-collection-improve-harmonization-and-pooling-information-about</link>
 <description>Geriatrics (Basel). 2026 Mar 31;11(2)&lt;br&gt;Authors: Allegra P, Lodico M, Migliazzo C, Tarantino D, Piccoli T, Vanacore N, Salemi G, Maniscalco L, Matranga D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042094&quot;&gt;42042094&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/need-standardized-data-collection-improve-harmonization-and-pooling-information-about#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/need-standardized-data-collection-improve-harmonization-and-pooling-information-about#comments</comments>
</item>
<item>
 <title>Exploring Early Neurodegeneration Through Fasting-Induced Metabolic Signatures and High-Sensitivity Biomarkers.</title>
 <link>https://www.alzforum.org/papers/exploring-early-neurodegeneration-through-fasting-induced-metabolic-signatures-and-high</link>
 <description>Curr Issues Mol Biol. 2026 Mar 28;48(4)&lt;br&gt;Authors: Cacciabaudo F, Agnello L, Gambino CM, Accardi G, Masucci A, Tamburello M, Vassallo R, Ciaccio M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042018&quot;&gt;42042018&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-early-neurodegeneration-through-fasting-induced-metabolic-signatures-and-high#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-early-neurodegeneration-through-fasting-induced-metabolic-signatures-and-high#comments</comments>
</item>
<item>
 <title>Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives.</title>
 <link>https://www.alzforum.org/papers/alpha-lipoic-acid-and-biotin-neurodegenerative-diseases-convergent-mechanistic-insights</link>
 <description>Neurol Int. 2026 Mar 26;18(4)&lt;br&gt;Authors: Aguilera-Méndez A, Aguilera-Manuel K, Saavedra-Molina A, Ríos-Chávez P, Villafaña S, Nieto-Aguilar R, Godínez-Hernández D, Ortega-Cuellar D, Palomera-Sanchez Z, Gauthereau-Torres M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42042751&quot;&gt;42042751&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alpha-lipoic-acid-and-biotin-neurodegenerative-diseases-convergent-mechanistic-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alpha-lipoic-acid-and-biotin-neurodegenerative-diseases-convergent-mechanistic-insights#comments</comments>
</item>
<item>
 <title>Distant Origins of Local Pathologies: Rethinking the Systemic Roots of Alzheimer&#039;s Disease and Beyond.</title>
 <link>https://www.alzforum.org/papers/distant-origins-local-pathologies-rethinking-systemic-roots-alzheimers-disease-and-beyond</link>
 <description>Iran J Med Sci. 2026 Mar;51(3):157-159.  Epub 2026 Mar 1&lt;br&gt;Authors: Ghasemi Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42039220&quot;&gt;42039220&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/distant-origins-local-pathologies-rethinking-systemic-roots-alzheimers-disease-and-beyond#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/distant-origins-local-pathologies-rethinking-systemic-roots-alzheimers-disease-and-beyond#comments</comments>
</item>
<item>
 <title>Non-fluent agrammatic variant of primary progressive aphasia in a bilingual Mandarin/English speaker: a case report.</title>
 <link>https://www.alzforum.org/papers/non-fluent-agrammatic-variant-primary-progressive-aphasia-bilingual-mandarinenglish-speaker</link>
 <description>Arch Clin Neuropsychol. 2026 Feb 27;41(3)&lt;br&gt;Authors: Zhang BY, Ortiz BL, Peery S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42041196&quot;&gt;42041196&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/non-fluent-agrammatic-variant-primary-progressive-aphasia-bilingual-mandarinenglish-speaker#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/non-fluent-agrammatic-variant-primary-progressive-aphasia-bilingual-mandarinenglish-speaker#comments</comments>
</item>
<item>
 <title>Current perspectives on neurodegenerative diseases: from clinical autopsy to precision medicine.</title>
 <link>https://www.alzforum.org/papers/current-perspectives-neurodegenerative-diseases-clinical-autopsy-precision-medicine</link>
 <description>Rev Esp Patol. 2026;59(2):100876. &lt;br&gt;Authors: Rábano A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42031434&quot;&gt;42031434&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/current-perspectives-neurodegenerative-diseases-clinical-autopsy-precision-medicine#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/current-perspectives-neurodegenerative-diseases-clinical-autopsy-precision-medicine#comments</comments>
</item>
<item>
 <title>Lost before forgetting: objective driving metrics track navigation deficits tied to preclinical Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/lost-forgetting-objective-driving-metrics-track-navigation-deficits-tied-preclinical</link>
 <description>Innov Aging. 2026;10(5):igag013.  Epub 2026 Feb 18&lt;br&gt;Authors: Zhu Y, Singh RK, Bekena S, Brown DC, Chen C, Blake M, Trani JF, Babulal GM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028229&quot;&gt;42028229&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lost-forgetting-objective-driving-metrics-track-navigation-deficits-tied-preclinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lost-forgetting-objective-driving-metrics-track-navigation-deficits-tied-preclinical#comments</comments>
</item>
<item>
 <title>From clinical judgment to biology: a clinician&#039;s opinion on the use of blood-based biomarkers in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/clinical-judgment-biology-clinicians-opinion-use-blood-based-biomarkers-alzheimers-disease</link>
 <description>Front Neurol. 2026;17:1804163.  Epub 2026 Apr 8&lt;br&gt;Authors: Medina-Rioja R, Llorente-Vidrio A, Ruiz-Garcia R, Rodríguez-Violante M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028213&quot;&gt;42028213&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-judgment-biology-clinicians-opinion-use-blood-based-biomarkers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-judgment-biology-clinicians-opinion-use-blood-based-biomarkers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Traditional Chinese Medicine for Alzheimer&#039;s Disease: Current Evidence and Chemometric Approaches for Multi-Target Evaluation.</title>
 <link>https://www.alzforum.org/papers/traditional-chinese-medicine-alzheimers-disease-current-evidence-and-chemometric-approaches</link>
 <description>Neuropsychiatr Dis Treat. 2026;22:590661.  Epub 2026 Apr 18&lt;br&gt;Authors: Sun X, Yang L, Wang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42028071&quot;&gt;42028071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/traditional-chinese-medicine-alzheimers-disease-current-evidence-and-chemometric-approaches#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/traditional-chinese-medicine-alzheimers-disease-current-evidence-and-chemometric-approaches#comments</comments>
</item>
<item>
 <title>Effects of exercise on cognitive function in older patients with Alzheimer&#039;s disease: a meta-regression and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/effects-exercise-cognitive-function-older-patients-alzheimers-disease-meta-regression-and</link>
 <description>Front Public Health. 2026;14:1793973.  Epub 2026 Apr 8&lt;br&gt;Authors: Xu F, Zhang Y, Tan D, He Y, Fei Q, Xu K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027916&quot;&gt;42027916&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-exercise-cognitive-function-older-patients-alzheimers-disease-meta-regression-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-exercise-cognitive-function-older-patients-alzheimers-disease-meta-regression-and#comments</comments>
</item>
<item>
 <title>Dementia screening protocol for primary care in South America: a Delphi consensus study.</title>
 <link>https://www.alzforum.org/papers/dementia-screening-protocol-primary-care-south-america-delphi-consensus-study</link>
 <description>Front Public Health. 2026;14:1798111.  Epub 2026 Apr 8&lt;br&gt;Authors: Custodio B, Montesinos R, Caramelli P, Calandri I, Brucki SM, Suemoto CK, Allegri R, Slachevsky A, Parodi JF, Morsch P, Willets C, Cuba Fuentes MS, Custodio N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027915&quot;&gt;42027915&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dementia-screening-protocol-primary-care-south-america-delphi-consensus-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dementia-screening-protocol-primary-care-south-america-delphi-consensus-study#comments</comments>
</item>
<item>
 <title>Research progress on Alzheimer&#039;s disease vaccines: from Aβ-targeted approaches to clinical translation.</title>
 <link>https://www.alzforum.org/papers/research-progress-alzheimers-disease-vaccines-av-targeted-approaches-clinical-translation</link>
 <description>Front Aging. 2026;7:1794820.  Epub 2026 Apr 8&lt;br&gt;Authors: Han Y, Luo G, Huang Y, Cai Z, Su W, Kuang X, Huang L, Wei L, Ming F, He Z, Yang Z, Wang J, Jiang W, Xiao C, Hu Q, Yan J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027759&quot;&gt;42027759&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-progress-alzheimers-disease-vaccines-av-targeted-approaches-clinical-translation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-progress-alzheimers-disease-vaccines-av-targeted-approaches-clinical-translation#comments</comments>
</item>
<item>
 <title>Personalized audiovisual gamma stimulation enhances neural connectivity and entrainment beyond fixed 40 Hz protocols.</title>
 <link>https://www.alzforum.org/papers/personalized-audiovisual-gamma-stimulation-enhances-neural-connectivity-and-entrainment</link>
 <description>Front Neurosci. 2026;20:1787255.  Epub 2026 Apr 8&lt;br&gt;Authors: Jeon JY, Lee H, Ji M, Kim JS, Ahn DH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027686&quot;&gt;42027686&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/personalized-audiovisual-gamma-stimulation-enhances-neural-connectivity-and-entrainment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/personalized-audiovisual-gamma-stimulation-enhances-neural-connectivity-and-entrainment#comments</comments>
</item>
<item>
 <title>The role of nutrition and multimodal lifestyle interventions in Alzheimer&#039;s prevention and management: a mini-review.</title>
 <link>https://www.alzforum.org/papers/role-nutrition-and-multimodal-lifestyle-interventions-alzheimers-prevention-and-management</link>
 <description>Front Nutr. 2026;13:1818913.  Epub 2026 Apr 8&lt;br&gt;Authors: Zhang H, Liu C, Yuan X, Yin H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027570&quot;&gt;42027570&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-nutrition-and-multimodal-lifestyle-interventions-alzheimers-prevention-and-management#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-nutrition-and-multimodal-lifestyle-interventions-alzheimers-prevention-and-management#comments</comments>
</item>
<item>
 <title>Bioactive compounds and exercise in aging and neurodegeneration: mechanistic insights from the gut-brain-metabolic axis.</title>
 <link>https://www.alzforum.org/papers/bioactive-compounds-and-exercise-aging-and-neurodegeneration-mechanistic-insights-gut-brain</link>
 <description>Front Nutr. 2026;13:1781176.  Epub 2026 Apr 8&lt;br&gt;Authors: Feng ZT, Zhang YY, Xue CX&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027568&quot;&gt;42027568&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bioactive-compounds-and-exercise-aging-and-neurodegeneration-mechanistic-insights-gut-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bioactive-compounds-and-exercise-aging-and-neurodegeneration-mechanistic-insights-gut-brain#comments</comments>
</item>
<item>
 <title>Fixel-based analysis and free-water metrics in subjective cognitive decline and cognitive impairment no dementia.</title>
 <link>https://www.alzforum.org/papers/fixel-based-analysis-and-free-water-metrics-subjective-cognitive-decline-and-cognitive</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70308.  Epub 2026 Apr 21&lt;br&gt;Authors: Lee ZL, Tee M, Tan WY, Huang X, Cui J, Billaud CH, Yu J, Hilal S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027252&quot;&gt;42027252&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fixel-based-analysis-and-free-water-metrics-subjective-cognitive-decline-and-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fixel-based-analysis-and-free-water-metrics-subjective-cognitive-decline-and-cognitive#comments</comments>
</item>
<item>
 <title>Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/brain-atrophy-and-clinical-diagnosis-independently-predict-default-mode-network-failure</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70343.  Epub 2026 Apr 21&lt;br&gt;Authors: Alghamdi M, von Wegner F, Chan DK, Green M, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42027251&quot;&gt;42027251&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-atrophy-and-clinical-diagnosis-independently-predict-default-mode-network-failure#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-atrophy-and-clinical-diagnosis-independently-predict-default-mode-network-failure#comments</comments>
</item>
<item>
 <title>Deep medullary vein abnormalities associated with cognitive function and Alzheimer&#039;s disease plasma biomarkers in dementia-free older adults: A population-based study.</title>
 <link>https://www.alzforum.org/papers/deep-medullary-vein-abnormalities-associated-cognitive-function-and-alzheimers-disease-plasma</link>
 <description>Alzheimers Dement (Amst). 2026;18(2):e70320.  Epub 2026 Mar 30&lt;br&gt;Authors: Yin D, Wang J, Li C, Wang X, Wang Y, Xie Q, Tian N, Chen Z, Sun X, Wang Y, Hou T, Cong L, Zhou L, Du Y, Song L, Qiu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040899&quot;&gt;42040899&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deep-medullary-vein-abnormalities-associated-cognitive-function-and-alzheimers-disease-plasma#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deep-medullary-vein-abnormalities-associated-cognitive-function-and-alzheimers-disease-plasma#comments</comments>
</item>
<item>
 <title>Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire.</title>
 <link>https://www.alzforum.org/papers/clinical-staging-swedish-primary-care-using-amsterdam-instrumental-activities-daily-living</link>
 <description>Alzheimers Dement (Amst). 2026;18:e70344.  Epub 2026 Apr 24&lt;br&gt;Authors: Fawad A, van der Landen SM, Tideman P, van der Putten-Toorenburg A, Butterbrod E, Smith R, van Westen D, Calling S, Midlöv P, Mattsson-Carlgren N, Borgström Bolmsjö B, Stomrud E, Nilsson MH, Hansson O, Sikkes SA, Palmqvist S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040886&quot;&gt;42040886&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-staging-swedish-primary-care-using-amsterdam-instrumental-activities-daily-living#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-staging-swedish-primary-care-using-amsterdam-instrumental-activities-daily-living#comments</comments>
</item>
<item>
 <title>MRI evaluation of cerebral perivascular spaces predicts amyloid-related imaging abnormalities risk in preclinical Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mri-evaluation-cerebral-perivascular-spaces-predicts-amyloid-related-imaging-abnormalities</link>
 <description>Front Dement. 2026;5:1719740.  Epub 2026 Apr 9&lt;br&gt;Authors: Bigjahan B, Cavallari M, Barisano G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040755&quot;&gt;42040755&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mri-evaluation-cerebral-perivascular-spaces-predicts-amyloid-related-imaging-abnormalities#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mri-evaluation-cerebral-perivascular-spaces-predicts-amyloid-related-imaging-abnormalities#comments</comments>
</item>
<item>
 <title>Beyond the cut-off: measurement bias, calibration, and fairness in mild cognitive impairment screening.</title>
 <link>https://www.alzforum.org/papers/beyond-cut-measurement-bias-calibration-and-fairness-mild-cognitive-impairment-screening</link>
 <description>Front Med (Lausanne). 2026;13:1814214.  Epub 2026 Apr 10&lt;br&gt;Authors: Jerjes W, Harding D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040570&quot;&gt;42040570&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-cut-measurement-bias-calibration-and-fairness-mild-cognitive-impairment-screening#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-cut-measurement-bias-calibration-and-fairness-mild-cognitive-impairment-screening#comments</comments>
</item>
<item>
 <title>Functional and genetic divergence of aging-related TOMM40 polymorphisms in Alzheimer&#039;s disease: an integrative bioinformatics and systematic review with meta-analysis and trial sequential analysis.</title>
 <link>https://www.alzforum.org/papers/functional-and-genetic-divergence-aging-related-tomm40-polymorphisms-alzheimers-disease</link>
 <description>Front Neurosci. 2026;20:1772368.  Epub 2026 Apr 10&lt;br&gt;Authors: Li S, Luo Y, Shi S, Ding Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040345&quot;&gt;42040345&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/functional-and-genetic-divergence-aging-related-tomm40-polymorphisms-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/functional-and-genetic-divergence-aging-related-tomm40-polymorphisms-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Retraction: Early detection and classification of Alzheimer&#039;s disease through data fusion of MRI and DTI images using the YOLOv11 neural network.</title>
 <link>https://www.alzforum.org/papers/retraction-early-detection-and-classification-alzheimers-disease-through-data-fusion-mri-and</link>
 <description>Front Neurosci. 2026;20:1845919.  Epub 2026 Apr 10&lt;br&gt;Authors: Frontiers Editorial Office&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040334&quot;&gt;42040334&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retraction-early-detection-and-classification-alzheimers-disease-through-data-fusion-mri-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retraction-early-detection-and-classification-alzheimers-disease-through-data-fusion-mri-and#comments</comments>
</item>
<item>
 <title>Sleep phenotypes and subjective cognitive decline in the Hispanic Community Health Study/Study of Latinos.</title>
 <link>https://www.alzforum.org/papers/sleep-phenotypes-and-subjective-cognitive-decline-hispanic-community-health-studystudy</link>
 <description>Sleep Adv. 2026;7(2):zpag032.  Epub 2026 Mar 12&lt;br&gt;Authors: González KA, Membreno R, Tarraf W, Stickel AM, DeCarli C, Marquez F, Agudelo C, Patel SR, Gallo LC, Bubu O, Daviglus M, Testai FD, Sotres-Alvarez D, Penedo FJ, Junco B, González HM, Ramos AR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42040192&quot;&gt;42040192&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-phenotypes-and-subjective-cognitive-decline-hispanic-community-health-studystudy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-phenotypes-and-subjective-cognitive-decline-hispanic-community-health-studystudy#comments</comments>
</item>
<item>
 <title>Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer&#039;s disease therapy.</title>
 <link>https://www.alzforum.org/papers/monoclonal-antibodies-and-small-molecules-cutting-edge-alzheimers-disease-therapy</link>
 <description>Front Cell Dev Biol. 2026;14:1766762.  Epub 2026 Apr 9&lt;br&gt;Authors: Ouro A, Ben-Dor GA, Debasa-Mouce M, Gulkarov S, De Leon J, Castro-Mosquera M, Sobrino T, Bougea A, Reiss AB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42039150&quot;&gt;42039150&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/monoclonal-antibodies-and-small-molecules-cutting-edge-alzheimers-disease-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/monoclonal-antibodies-and-small-molecules-cutting-edge-alzheimers-disease-therapy#comments</comments>
</item>
<item>
 <title>Restoring oscillatory dynamics in Alzheimer&#039;s disease: A laminar whole-brain model of serotonergic psychedelic effects.</title>
 <link>https://www.alzforum.org/papers/restoring-oscillatory-dynamics-alzheimers-disease-laminar-whole-brain-model-serotonergic</link>
 <description>Netw Neurosci. 2026;10(2):303-328.  Epub 2026 Apr 22&lt;br&gt;Authors: Gendra JC, Lopez-Sola E, Castaldo F, Lleal-Custey È, Sanchez-Todo R, Vohryzek J, Salvador R, Andrzejak RG, Ruffini G, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42039100&quot;&gt;42039100&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/restoring-oscillatory-dynamics-alzheimers-disease-laminar-whole-brain-model-serotonergic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/restoring-oscillatory-dynamics-alzheimers-disease-laminar-whole-brain-model-serotonergic#comments</comments>
</item>
<item>
 <title>Research on Alzheimer&#039;s disease MRI image classification based on spatial attention mechanism.</title>
 <link>https://www.alzforum.org/papers/research-alzheimers-disease-mri-image-classification-based-spatial-attention-mechanism</link>
 <description>Front Aging Neurosci. 2026;18:1657578.  Epub 2026 Apr 10&lt;br&gt;Authors: Zhao S, Shi H, Guan C, Zeng Q, Zhang C, Wan Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038702&quot;&gt;42038702&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-alzheimers-disease-mri-image-classification-based-spatial-attention-mechanism#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-alzheimers-disease-mri-image-classification-based-spatial-attention-mechanism#comments</comments>
</item>
<item>
 <title>Neuroprotective effects of isoflavone-enriched soybean leaves (Glycine Max) on scopolamine-induced memory deficits in C57BL/6 mice via antioxidative mechanisms.</title>
 <link>https://www.alzforum.org/papers/neuroprotective-effects-isoflavone-enriched-soybean-leaves-glycine-max-scopolamine-induced</link>
 <description>Front Aging Neurosci. 2026;18:1787268.  Epub 2026 Apr 10&lt;br&gt;Authors: Do YJ, Kim SY, Go Y, Lee YH, Park KH, Oh TW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038699&quot;&gt;42038699&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroprotective-effects-isoflavone-enriched-soybean-leaves-glycine-max-scopolamine-induced#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroprotective-effects-isoflavone-enriched-soybean-leaves-glycine-max-scopolamine-induced#comments</comments>
</item>
<item>
 <title>The therapeutic efficacy of transcranial direct current stimulation in managing Alzheimer&#039;s disease: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/therapeutic-efficacy-transcranial-direct-current-stimulation-managing-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1726469.  Epub 2026 Apr 10&lt;br&gt;Authors: Wang X, Tian L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038695&quot;&gt;42038695&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-efficacy-transcranial-direct-current-stimulation-managing-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-efficacy-transcranial-direct-current-stimulation-managing-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Dysregulated glucose metabolism in the visual cortex of human subjects with mild cognitive impairment and Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/dysregulated-glucose-metabolism-visual-cortex-human-subjects-mild-cognitive-impairment-and</link>
 <description>Front Aging Neurosci. 2026;18:1710075.  Epub 2026 Apr 9&lt;br&gt;Authors: Mjaaseth UN, Hsu MF, Arballo J, Haj FG, Patel V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038694&quot;&gt;42038694&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dysregulated-glucose-metabolism-visual-cortex-human-subjects-mild-cognitive-impairment-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dysregulated-glucose-metabolism-visual-cortex-human-subjects-mild-cognitive-impairment-and#comments</comments>
</item>
<item>
 <title>Pink1 at the crossroads of aging, exercise, and diet in Parkinson&#039;s disease: a mechanistic review.</title>
 <link>https://www.alzforum.org/papers/pink1-crossroads-aging-exercise-and-diet-parkinsons-disease-mechanistic-review</link>
 <description>Front Aging Neurosci. 2026;18:1738559.  Epub 2026 Apr 10&lt;br&gt;Authors: Lin Y, Wen DT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038693&quot;&gt;42038693&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pink1-crossroads-aging-exercise-and-diet-parkinsons-disease-mechanistic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pink1-crossroads-aging-exercise-and-diet-parkinsons-disease-mechanistic-review#comments</comments>
</item>
<item>
 <title>Development of Alzheimer&#039;s disease risk score for future integrated primary care: a white-box approach.</title>
 <link>https://www.alzforum.org/papers/development-alzheimers-disease-risk-score-future-integrated-primary-care-white-box-approach</link>
 <description>Front Aging Neurosci. 2026;18:1759273.  Epub 2026 Apr 10&lt;br&gt;Authors: Wiranto Y, Setiawan D, Watts A, Ashourvan A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038691&quot;&gt;42038691&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/development-alzheimers-disease-risk-score-future-integrated-primary-care-white-box-approach#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/development-alzheimers-disease-risk-score-future-integrated-primary-care-white-box-approach#comments</comments>
</item>
<item>
 <title>Design of a deep learning prediction model for Alzheimer&#039;s and Parkinson&#039;s Disease using MRI images.</title>
 <link>https://www.alzforum.org/papers/design-deep-learning-prediction-model-alzheimers-and-parkinsons-disease-using-mri-images</link>
 <description>Front Artif Intell. 2026;9:1777236.  Epub 2026 Apr 9&lt;br&gt;Authors: K V, Jaisankar N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038539&quot;&gt;42038539&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/design-deep-learning-prediction-model-alzheimers-and-parkinsons-disease-using-mri-images#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/design-deep-learning-prediction-model-alzheimers-and-parkinsons-disease-using-mri-images#comments</comments>
</item>
<item>
 <title>Cynanchum bungei Decne-derived extracellular vesicles alleviate cognitive impairment and pathological damage in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/cynanchum-bungei-decne-derived-extracellular-vesicles-alleviate-cognitive-impairment-and</link>
 <description>Front Cell Neurosci. 2026;20:1798965.  Epub 2026 Apr 10&lt;br&gt;Authors: Hong R, Han J, Dong F, Kalsoom UE, Cao C, Zhou A, Wu Q, Qu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038337&quot;&gt;42038337&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cynanchum-bungei-decne-derived-extracellular-vesicles-alleviate-cognitive-impairment-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cynanchum-bungei-decne-derived-extracellular-vesicles-alleviate-cognitive-impairment-and#comments</comments>
</item>
<item>
 <title>Intestinal inflammation promotes neuroinflammation and PD-associated nigrostriatal pathology independently of LRRK2 G2019S kinase activity.</title>
 <link>https://www.alzforum.org/papers/intestinal-inflammation-promotes-neuroinflammation-and-pd-associated-nigrostriatal-pathology</link>
 <description>Front Cell Neurosci. 2026;20:1794784.  Epub 2026 Apr 10&lt;br&gt;Authors: Merchak AR, Herrick MK, Houser MC, Keating CE, Chang J, Tansey MG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038336&quot;&gt;42038336&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intestinal-inflammation-promotes-neuroinflammation-and-pd-associated-nigrostriatal-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intestinal-inflammation-promotes-neuroinflammation-and-pd-associated-nigrostriatal-pathology#comments</comments>
</item>
<item>
 <title>Correction to: A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment.</title>
 <link>https://www.alzforum.org/papers/correction-passive-and-objective-measure-recognition-memory-mild-cognitive-impairment-using</link>
 <description>Brain Commun. 2026;8(2):fcag147.  Epub 2026 Apr 24&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038258&quot;&gt;42038258&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-passive-and-objective-measure-recognition-memory-mild-cognitive-impairment-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-passive-and-objective-measure-recognition-memory-mild-cognitive-impairment-using#comments</comments>
</item>
<item>
 <title>Depression as an early symptom and risk factor of dementia - a narrative review.</title>
 <link>https://www.alzforum.org/papers/depression-early-symptom-and-risk-factor-dementia-narrative-review</link>
 <description>Front Psychiatry. 2026;17:1786179.  Epub 2026 Apr 10&lt;br&gt;Authors: Permoda-Pachuta A, Obszanski P, Grad Z, Futyma-Jędrzejewska M, Ziemecki P, Dominiak M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42038088&quot;&gt;42038088&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/depression-early-symptom-and-risk-factor-dementia-narrative-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/depression-early-symptom-and-risk-factor-dementia-narrative-review#comments</comments>
</item>
<item>
 <title>Research progress in neuroimaging of sporadic early-onset Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/research-progress-neuroimaging-sporadic-early-onset-alzheimers-disease</link>
 <description>Front Neurol. 2026;17:1788814.  Epub 2026 Apr 10&lt;br&gt;Authors: Zhang X, Yang C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037717&quot;&gt;42037717&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/research-progress-neuroimaging-sporadic-early-onset-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/research-progress-neuroimaging-sporadic-early-onset-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Detecting CSF-validated Alzheimer&#039;s disease from spontaneous speech in German: an interpretable end-to-end machine-learning framework.</title>
 <link>https://www.alzforum.org/papers/detecting-csf-validated-alzheimers-disease-spontaneous-speech-german-interpretable-end-end</link>
 <description>Front Neurol. 2026;17:1780783.  Epub 2026 Apr 9&lt;br&gt;Authors: Wiechmann D, Kerz E, Albrecht M, Qiao Y, Pinho J, Reetz K, Costa AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037712&quot;&gt;42037712&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/detecting-csf-validated-alzheimers-disease-spontaneous-speech-german-interpretable-end-end#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/detecting-csf-validated-alzheimers-disease-spontaneous-speech-german-interpretable-end-end#comments</comments>
</item>
<item>
 <title>Correction: The impact of bright light therapy on non-motor symptoms in patients with Parkinson&#039;s disease: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/correction-impact-bright-light-therapy-non-motor-symptoms-patients-parkinsons-disease</link>
 <description>Front Neurol. 2026;17:1823587.  Epub 2026 Apr 10&lt;br&gt;Authors: Geng J, Yu H, Tan L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037702&quot;&gt;42037702&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-impact-bright-light-therapy-non-motor-symptoms-patients-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-impact-bright-light-therapy-non-motor-symptoms-patients-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Differential associations of NFL and GFAP with neuropsychiatric symptoms by amyloid status across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/differential-associations-nfl-and-gfap-neuropsychiatric-symptoms-amyloid-status-across</link>
 <description>Front Neurol. 2026;17:1782816.  Epub 2026 Apr 10&lt;br&gt;Authors: Wu J, Jiang H, Wang R, Lv X, Tang F, Chai X, Zhu Y, Cheng Z, Wu Y, Tang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037699&quot;&gt;42037699&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/differential-associations-nfl-and-gfap-neuropsychiatric-symptoms-amyloid-status-across#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/differential-associations-nfl-and-gfap-neuropsychiatric-symptoms-amyloid-status-across#comments</comments>
</item>
<item>
 <title>Frailty status and the risk of dementia, Alzheimer&#039;s disease: a meta-analysis of observational studies.</title>
 <link>https://www.alzforum.org/papers/frailty-status-and-risk-dementia-alzheimers-disease-meta-analysis-observational-studies</link>
 <description>Front Neurol. 2026;17:1798080.  Epub 2026 Apr 10&lt;br&gt;Authors: Zhao Y, Zeng M, Zhang S, Peng D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037682&quot;&gt;42037682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/frailty-status-and-risk-dementia-alzheimers-disease-meta-analysis-observational-studies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/frailty-status-and-risk-dementia-alzheimers-disease-meta-analysis-observational-studies#comments</comments>
</item>
<item>
 <title>Targeting VDR-RXR heterodimerization in neurodegenerative diseases: a hypothetical framework for combined vitamin D3 and vitamin A therapy.</title>
 <link>https://www.alzforum.org/papers/targeting-vdr-rxr-heterodimerization-neurodegenerative-diseases-hypothetical-framework</link>
 <description>Front Neurol. 2026;17:1754364.  Epub 2026 Apr 10&lt;br&gt;Authors: Sirajo MU, Obie R, Mukhtar AI, Abdullahi NM, Taniyohwo EM, Oyem JC, Badamasi IM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42037680&quot;&gt;42037680&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-vdr-rxr-heterodimerization-neurodegenerative-diseases-hypothetical-framework#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-vdr-rxr-heterodimerization-neurodegenerative-diseases-hypothetical-framework#comments</comments>
</item>
<item>
 <title>Novel insight into PINK1/parkin-associated autophagy implicated in Parkinson disease.</title>
 <link>https://www.alzforum.org/papers/novel-insight-pink1parkin-associated-autophagy-implicated-parkinson-disease</link>
 <description>Transl Neurosci. 2026 Jan;17(1):20250386.  Epub 2026 Apr 20&lt;br&gt;Authors: Stegmüller J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046651&quot;&gt;42046651&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-insight-pink1parkin-associated-autophagy-implicated-parkinson-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-insight-pink1parkin-associated-autophagy-implicated-parkinson-disease#comments</comments>
</item>
<item>
 <title>Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation.</title>
 <link>https://www.alzforum.org/papers/multi-omic-phenotyping-mapt-v337m-neurons-reveals-early-changes-axonogenesis-and-tau</link>
 <description>NPJ Dement. 2026;2(1):24.  Epub 2026 Apr 25&lt;br&gt;Authors: Mohl GA, Dixon G, Marzette E, McKetney J, Samelson AJ, Serras CP, Jin J, Ariqat N, Keys A, Chavira C, Li A, Boggess SC, Swaney DL, Kampmann M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42046563&quot;&gt;42046563&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-omic-phenotyping-mapt-v337m-neurons-reveals-early-changes-axonogenesis-and-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-omic-phenotyping-mapt-v337m-neurons-reveals-early-changes-axonogenesis-and-tau#comments</comments>
</item>
<item>
 <title>In-tissue structural biology of the brain: A focus on Alzheimer&#039;s disease pathology.</title>
 <link>https://www.alzforum.org/papers/tissue-structural-biology-brain-focus-alzheimers-disease-pathology</link>
 <description>Methods Enzymol. 2026;729:69-106.  Epub 2026 Feb 24&lt;br&gt;Authors: Jenkins J, Gilbert MA, Fatima N, O&amp;#039;Sullivan TJ, Thompson WG, Frank RA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055645&quot;&gt;42055645&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tissue-structural-biology-brain-focus-alzheimers-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tissue-structural-biology-brain-focus-alzheimers-disease-pathology#comments</comments>
</item>
<item>
 <title>How to prepare Alzheimer&#039;s amyloid-β(1-42) oligomer samples with sufficient quantity and quality for biophysical and solid-state NMR measurements.</title>
 <link>https://www.alzforum.org/papers/how-prepare-alzheimers-amyloid-v1-42-oligomer-samples-sufficient-quantity-and-quality</link>
 <description>Methods Enzymol. 2026;729:419-433.  Epub 2026 Feb 24&lt;br&gt;Authors: Dinakarapandian DM, Watzlawik JO, Sudarshan TR, Rosenberry TL, Paravastu AK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055644&quot;&gt;42055644&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/how-prepare-alzheimers-amyloid-v1-42-oligomer-samples-sufficient-quantity-and-quality#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/how-prepare-alzheimers-amyloid-v1-42-oligomer-samples-sufficient-quantity-and-quality#comments</comments>
</item>
<item>
 <title>All-atom MD simulations of amyloid-membrane interactions: Setup, execution, and analysis.</title>
 <link>https://www.alzforum.org/papers/all-atom-md-simulations-amyloid-membrane-interactions-setup-execution-and-analysis</link>
 <description>Methods Enzymol. 2026;729:389-417.  Epub 2026 Mar 9&lt;br&gt;Authors: Bundschuh BF, Kley F, Fatafta H, Strodel B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055643&quot;&gt;42055643&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/all-atom-md-simulations-amyloid-membrane-interactions-setup-execution-and-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/all-atom-md-simulations-amyloid-membrane-interactions-setup-execution-and-analysis#comments</comments>
</item>
<item>
 <title>Application of EPR spectroscopy in the structural studies of Aβ oligomers and fibrils.</title>
 <link>https://www.alzforum.org/papers/application-epr-spectroscopy-structural-studies-av-oligomers-and-fibrils</link>
 <description>Methods Enzymol. 2026;729:361-388.  Epub 2026 Feb 3&lt;br&gt;Authors: Portugal Barron D, Guo Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055642&quot;&gt;42055642&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/application-epr-spectroscopy-structural-studies-av-oligomers-and-fibrils#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/application-epr-spectroscopy-structural-studies-av-oligomers-and-fibrils#comments</comments>
</item>
<item>
 <title>Cryo-EM structure determination of amyloid fibrils: Methodology, insights, and practical tools.</title>
 <link>https://www.alzforum.org/papers/cryo-em-structure-determination-amyloid-fibrils-methodology-insights-and-practical-tools</link>
 <description>Methods Enzymol. 2026;729:35-68.  Epub 2026 Mar 17&lt;br&gt;Authors: Sommerhage S, Lammert J, Camino JD, Schröder GF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055641&quot;&gt;42055641&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cryo-em-structure-determination-amyloid-fibrils-methodology-insights-and-practical-tools#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cryo-em-structure-determination-amyloid-fibrils-methodology-insights-and-practical-tools#comments</comments>
</item>
<item>
 <title>Single-molecule fluorescence spectroscopy and imaging of heterogeneous amyloid β aggregation.</title>
 <link>https://www.alzforum.org/papers/single-molecule-fluorescence-spectroscopy-and-imaging-heterogeneous-amyloid-v-aggregation</link>
 <description>Methods Enzymol. 2026;729:309-332.  Epub 2026 Jan 28&lt;br&gt;Authors: Kim JY, Song E, Aniana A, Louis JM, Chung HS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055639&quot;&gt;42055639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-molecule-fluorescence-spectroscopy-and-imaging-heterogeneous-amyloid-v-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-molecule-fluorescence-spectroscopy-and-imaging-heterogeneous-amyloid-v-aggregation#comments</comments>
</item>
<item>
 <title>Methods for characterizing the individual filament structures of amyloid peptide assemblies using atomic force microscopy.</title>
 <link>https://www.alzforum.org/papers/methods-characterizing-individual-filament-structures-amyloid-peptide-assemblies-using-atomic</link>
 <description>Methods Enzymol. 2026;729:281-308.  Epub 2026 Feb 3&lt;br&gt;Authors: Shahbaz A, Weetman SL, Chitty C, Xue WF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055638&quot;&gt;42055638&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/methods-characterizing-individual-filament-structures-amyloid-peptide-assemblies-using-atomic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/methods-characterizing-individual-filament-structures-amyloid-peptide-assemblies-using-atomic#comments</comments>
</item>
<item>
 <title>Time-resolved solid-state nuclear magnetic resonance studies of amyloid-β oligomer formation.</title>
 <link>https://www.alzforum.org/papers/time-resolved-solid-state-nuclear-magnetic-resonance-studies-amyloid-v-oligomer-formation</link>
 <description>Methods Enzymol. 2026;729:259-280.  Epub 2026 Jan 28&lt;br&gt;Authors: Tycko R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055637&quot;&gt;42055637&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/time-resolved-solid-state-nuclear-magnetic-resonance-studies-amyloid-v-oligomer-formation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/time-resolved-solid-state-nuclear-magnetic-resonance-studies-amyloid-v-oligomer-formation#comments</comments>
</item>
<item>
 <title>Characterizations of the β-amyloid (Aβ)-membrane interaction intermediates.</title>
 <link>https://www.alzforum.org/papers/characterizations-v-amyloid-av-membrane-interaction-intermediates</link>
 <description>Methods Enzymol. 2026;729:231-258.  Epub 2026 Jan 28&lt;br&gt;Authors: Kengwerere MK, Wang T, Qiang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055636&quot;&gt;42055636&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/characterizations-v-amyloid-av-membrane-interaction-intermediates#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/characterizations-v-amyloid-av-membrane-interaction-intermediates#comments</comments>
</item>
<item>
 <title>Opportunities and challenges in the use of pressure-jump NMR to study Aβ and protein oligomerization.</title>
 <link>https://www.alzforum.org/papers/opportunities-and-challenges-use-pressure-jump-nmr-study-av-and-protein-oligomerization</link>
 <description>Methods Enzymol. 2026;729:179-230.  Epub 2026 Feb 4&lt;br&gt;Authors: Gelenter MD, Li T, Anfinrud P, Bax A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055635&quot;&gt;42055635&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/opportunities-and-challenges-use-pressure-jump-nmr-study-av-and-protein-oligomerization#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/opportunities-and-challenges-use-pressure-jump-nmr-study-av-and-protein-oligomerization#comments</comments>
</item>
<item>
 <title>Dynamics studies of side-chains and hydration shells in amyloid-β fibrils using deuterium and oxygen-17 solid-state NMR.</title>
 <link>https://www.alzforum.org/papers/dynamics-studies-side-chains-and-hydration-shells-amyloid-v-fibrils-using-deuterium-and</link>
 <description>Methods Enzymol. 2026;729:145-177.  Epub 2026 Feb 5&lt;br&gt;Authors: Vugmeyster L, Ostrovsky D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055634&quot;&gt;42055634&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dynamics-studies-side-chains-and-hydration-shells-amyloid-v-fibrils-using-deuterium-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dynamics-studies-side-chains-and-hydration-shells-amyloid-v-fibrils-using-deuterium-and#comments</comments>
</item>
<item>
 <title>Cryo-EM methods to study binding between amyloid fibrils and chemical compounds.</title>
 <link>https://www.alzforum.org/papers/cryo-em-methods-study-binding-between-amyloid-fibrils-and-chemical-compounds</link>
 <description>Methods Enzymol. 2026;729:107-144.  Epub 2026 Jan 28&lt;br&gt;Authors: Zhao Q, Liu K, Li D, Liu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055633&quot;&gt;42055633&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cryo-em-methods-study-binding-between-amyloid-fibrils-and-chemical-compounds#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cryo-em-methods-study-binding-between-amyloid-fibrils-and-chemical-compounds#comments</comments>
</item>
<item>
 <title>Amyloid extraction from neurodegenerative disease tissues for structural studies.</title>
 <link>https://www.alzforum.org/papers/amyloid-extraction-neurodegenerative-disease-tissues-structural-studies</link>
 <description>Methods Enzymol. 2026;729:1-33.  Epub 2026 Feb 3&lt;br&gt;Authors: Alhadidy MM, Hinton TV, Ernst KN, Yang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42055632&quot;&gt;42055632&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-extraction-neurodegenerative-disease-tissues-structural-studies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-extraction-neurodegenerative-disease-tissues-structural-studies#comments</comments>
</item>
<item>
 <title>[Efficacy of choline alfoscerate treatment for subjective cognitive impairment in first-degree relatives of patients with Alzheimer&#039;s disease: Results of a comparative 5-year study].</title>
 <link>https://www.alzforum.org/papers/efficacy-choline-alfoscerate-treatment-subjective-cognitive-impairment-first-degree-relatives</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):92-99. &lt;br&gt;Authors: Selezneva ND, Roshchina IF, Gavrilova SI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054337&quot;&gt;42054337&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-choline-alfoscerate-treatment-subjective-cognitive-impairment-first-degree-relatives#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-choline-alfoscerate-treatment-subjective-cognitive-impairment-first-degree-relatives#comments</comments>
</item>
<item>
 <title>[Myoclonus in Alzheimer&#039;s disease].</title>
 <link>https://www.alzforum.org/papers/myoclonus-alzheimers-disease</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):63-69. &lt;br&gt;Authors: Bogolepova AN, Burd SG, Lebedeva AV, Rubleva YV, Kovalenko EA, Machnovich EV, Osinovskaya NA, Pantina NV, Kovaleva II, Bokitko TA, Alexeeva GA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054333&quot;&gt;42054333&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/myoclonus-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/myoclonus-alzheimers-disease#comments</comments>
</item>
<item>
 <title>[Sleep disorders in Alzheimer&#039;s disease].</title>
 <link>https://www.alzforum.org/papers/sleep-disorders-alzheimers-disease</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):56-62. &lt;br&gt;Authors: Kolmakova KA, Lobzin VY, Emelin AY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054332&quot;&gt;42054332&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-disorders-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-disorders-alzheimers-disease#comments</comments>
</item>
<item>
 <title>[Alzheimer&#039;s disease and bilingualism].</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-and-bilingualism</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):40-46. &lt;br&gt;Authors: Syromyatnikov NN, Preobrazhenskaya IS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054330&quot;&gt;42054330&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-and-bilingualism#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-and-bilingualism#comments</comments>
</item>
<item>
 <title>[Alzheimer&#039;s disease: Diagnostic criteria and their evolution].</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-diagnostic-criteria-and-their-evolution</link>
 <description>Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):29-39. &lt;br&gt;Authors: Vorobev SV, Emelin AY, Yanishevskiy SN, Tantasheva AM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42054329&quot;&gt;42054329&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-diagnostic-criteria-and-their-evolution#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-diagnostic-criteria-and-their-evolution#comments</comments>
</item>
<item>
 <title>Brain network analysis in Alzheimer&#039;s disease and mild cognitive impairment using high-density diffuse optical tomography.</title>
 <link>https://www.alzforum.org/papers/brain-network-analysis-alzheimers-disease-and-mild-cognitive-impairment-using-high-density</link>
 <description>Imaging Neurosci (Camb). 2026;4 Epub 2026 Apr 24&lt;br&gt;Authors: Butters E, Collins-Jones L, Mesquita RC, Acharya D, McKiernan E, Laurell AA, Low A, Srinivasan S, O&amp;#039;Brien JT, Su L, Bale G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052506&quot;&gt;42052506&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-network-analysis-alzheimers-disease-and-mild-cognitive-impairment-using-high-density#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-network-analysis-alzheimers-disease-and-mild-cognitive-impairment-using-high-density#comments</comments>
</item>
<item>
 <title>Early detection of Alzheimer&#039;s disease via multimodal MRI and machine learning.</title>
 <link>https://www.alzforum.org/papers/early-detection-alzheimers-disease-multimodal-mri-and-machine-learning</link>
 <description>Front Aging Neurosci. 2026;18:1794982.  Epub 2026 Apr 13&lt;br&gt;Authors: Yuan J, Liu Y, Jin J, Li S, Zhang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052380&quot;&gt;42052380&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-detection-alzheimers-disease-multimodal-mri-and-machine-learning#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-detection-alzheimers-disease-multimodal-mri-and-machine-learning#comments</comments>
</item>
<item>
 <title>Plasma chaperone-mediated autophagy associated protein HSPA8 combined with white matter hyperintensities serves as the predictive marker of early-stage Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/plasma-chaperone-mediated-autophagy-associated-protein-hspa8-combined-white-matter</link>
 <description>Front Aging Neurosci. 2026;18:1753692.  Epub 2026 Apr 13&lt;br&gt;Authors: Yan X, Liang C, Zhou Y, Hong G, Li C, Wang K, Huang Y, Xiao X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052379&quot;&gt;42052379&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-chaperone-mediated-autophagy-associated-protein-hspa8-combined-white-matter#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-chaperone-mediated-autophagy-associated-protein-hspa8-combined-white-matter#comments</comments>
</item>
<item>
 <title>Brexpiprazole for Agitation in Patients with Alzheimer&#039;s Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials.</title>
 <link>https://www.alzforum.org/papers/brexpiprazole-agitation-patients-alzheimers-dementia-and-without-co-occurring-psychosis-post</link>
 <description>Neuropsychiatr Dis Treat. 2026;22:586701.  Epub 2026 Apr 21&lt;br&gt;Authors: Tariot PN, Chumki SR, Wang D, Such P, Palma AM, Zhang Z, Montano CB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42052145&quot;&gt;42052145&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brexpiprazole-agitation-patients-alzheimers-dementia-and-without-co-occurring-psychosis-post#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brexpiprazole-agitation-patients-alzheimers-dementia-and-without-co-occurring-psychosis-post#comments</comments>
</item>
<item>
 <title>Amyotrophic lateral sclerosis and chronic inflammatory demyelinating polyneuropathy coexistence in a patient with a C9orf72 variant: case report.</title>
 <link>https://www.alzforum.org/papers/amyotrophic-lateral-sclerosis-and-chronic-inflammatory-demyelinating-polyneuropathy</link>
 <description>Front Dement. 2026;5:1785124.  Epub 2026 Apr 13&lt;br&gt;Authors: File C, Price AM, Ahmad R, Shanina E, Sun RL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051912&quot;&gt;42051912&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyotrophic-lateral-sclerosis-and-chronic-inflammatory-demyelinating-polyneuropathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyotrophic-lateral-sclerosis-and-chronic-inflammatory-demyelinating-polyneuropathy#comments</comments>
</item>
<item>
 <title>Neutrophil-to-lymphocyte ratio in amyotrophic lateral sclerosis: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/neutrophil-lymphocyte-ratio-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis</link>
 <description>Brain Commun. 2026;8(2):fcag132.  Epub 2026 Apr 11&lt;br&gt;Authors: Eissazade N, Nazemi L, Haghi Ashtiani B, Moradi-Lakeh M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051853&quot;&gt;42051853&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neutrophil-lymphocyte-ratio-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neutrophil-lymphocyte-ratio-amyotrophic-lateral-sclerosis-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Effect of traditional Chinese medicine non-pharmacological interventions on cognitive function in patients with mild cognitive impairment: a systematic review and network meta-analysis.</title>
 <link>https://www.alzforum.org/papers/effect-traditional-chinese-medicine-non-pharmacological-interventions-cognitive-function</link>
 <description>Front Med (Lausanne). 2026;13:1799759.  Epub 2026 Apr 13&lt;br&gt;Authors: Dong Z, Li P, Xu J, Wang S, Li Z, Yang N, Zhang Z, Wu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051696&quot;&gt;42051696&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-traditional-chinese-medicine-non-pharmacological-interventions-cognitive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-traditional-chinese-medicine-non-pharmacological-interventions-cognitive-function#comments</comments>
</item>
<item>
 <title>Oropharyngeal dysphagia and amyloid beta pathology in the TgF344-AD rat model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/oropharyngeal-dysphagia-and-amyloid-beta-pathology-tgf344-ad-rat-model-alzheimers-disease</link>
 <description>Front Behav Neurosci. 2026;20:1812480.  Epub 2026 Apr 13&lt;br&gt;Authors: Cullins MJ, Converse AK, Rowe LM, Hoerst AG, Hibbard WK, Russell JA, Connor NP, Ciucci MR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051629&quot;&gt;42051629&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oropharyngeal-dysphagia-and-amyloid-beta-pathology-tgf344-ad-rat-model-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oropharyngeal-dysphagia-and-amyloid-beta-pathology-tgf344-ad-rat-model-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Interaction between Poly(ADP-ribose) polymerase-1 and α-synuclein pathology in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/interaction-between-polyadp-ribose-polymerase-1-and-synuclein-pathology-parkinsons-disease</link>
 <description>Front Neurosci. 2026;20:1774158.  Epub 2026 Apr 13&lt;br&gt;Authors: Zhang P, Li Q, Diao X, Zeng S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051564&quot;&gt;42051564&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interaction-between-polyadp-ribose-polymerase-1-and-synuclein-pathology-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interaction-between-polyadp-ribose-polymerase-1-and-synuclein-pathology-parkinsons-disease#comments</comments>
</item>
<item>
 <title>APOE4 carriers resistant to cognitive decline show unique relationships between cerebrovascular response to exercise and dual-task cognitive-balance performance.</title>
 <link>https://www.alzforum.org/papers/apoe4-carriers-resistant-cognitive-decline-show-unique-relationships-between-0</link>
 <description>Front Neurosci. 2026;20:1716713.  Epub 2026 Apr 13&lt;br&gt;Authors: Palmer JA, Billinger SA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051551&quot;&gt;42051551&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe4-carriers-resistant-cognitive-decline-show-unique-relationships-between-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe4-carriers-resistant-cognitive-decline-show-unique-relationships-between-0#comments</comments>
</item>
<item>
 <title>Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-and-als-cause-consequence-or-correlation-systematic-review</link>
 <description>Front Neurosci. 2026;20:1774417.  Epub 2026 Apr 13&lt;br&gt;Authors: Chakraborty DK, Roy T, Ngo ST, Al-Chalabi A, Al Khleifat A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051550&quot;&gt;42051550&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-and-als-cause-consequence-or-correlation-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-and-als-cause-consequence-or-correlation-systematic-review#comments</comments>
</item>
<item>
 <title>Deciphering the peripheral immune landscape of Alzheimer&#039;s disease through integrated multi-omics research and cohort validation.</title>
 <link>https://www.alzforum.org/papers/deciphering-peripheral-immune-landscape-alzheimers-disease-through-integrated-multi-omics</link>
 <description>Front Immunol. 2026;17:1648591.  Epub 2026 Apr 13&lt;br&gt;Authors: Lv S, Kuang JY, Wang TW, Zhang LP, Liu J, Wang WD, Yang MF, Ni QB, Sun BL, Sun JY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051535&quot;&gt;42051535&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/deciphering-peripheral-immune-landscape-alzheimers-disease-through-integrated-multi-omics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/deciphering-peripheral-immune-landscape-alzheimers-disease-through-integrated-multi-omics#comments</comments>
</item>
<item>
 <title>Dietary restriction as a potential neuroprotective intervention: a narrative review of its impact on neuroinflammation across neurodegenerative diseases and other neurological disorders.</title>
 <link>https://www.alzforum.org/papers/dietary-restriction-potential-neuroprotective-intervention-narrative-review-its-impact</link>
 <description>Front Nutr. 2026;13:1731416.  Epub 2026 Apr 13&lt;br&gt;Authors: Liu B, Zhang Y, Deng W, Zhou YN, Cao Y, Xiong L, Shen R, Lee SM, Bian J, Bian Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051348&quot;&gt;42051348&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dietary-restriction-potential-neuroprotective-intervention-narrative-review-its-impact#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dietary-restriction-potential-neuroprotective-intervention-narrative-review-its-impact#comments</comments>
</item>
<item>
 <title>Montreal Cognitive Assessment (MoCA) Scale: Strengths, Limitations, and Implication for Clinical Practice.</title>
 <link>https://www.alzforum.org/papers/montreal-cognitive-assessment-moca-scale-strengths-limitations-and-implication-clinical</link>
 <description>Iran J Psychiatry. 2026 Jan;21(1):140-150. &lt;br&gt;Authors: Hadinezhad P, Noroozian M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051279&quot;&gt;42051279&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/montreal-cognitive-assessment-moca-scale-strengths-limitations-and-implication-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/montreal-cognitive-assessment-moca-scale-strengths-limitations-and-implication-clinical#comments</comments>
</item>
<item>
 <title>Cell death detection in iPSC-derived cortical neurons as model of neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/cell-death-detection-ipsc-derived-cortical-neurons-model-neurodegeneration</link>
 <description>Methods Cell Biol. 2026;206:217-233.  Epub 2026 Mar 9&lt;br&gt;Authors: Colasuonno F, D&amp;#039;Eletto M, Bellanca V, Piacentini M, Di Sano F, Rossin F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42062001&quot;&gt;42062001&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cell-death-detection-ipsc-derived-cortical-neurons-model-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cell-death-detection-ipsc-derived-cortical-neurons-model-neurodegeneration#comments</comments>
</item>
<item>
 <title>Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer&#039;s disease via data fusion and machine learning.</title>
 <link>https://www.alzforum.org/papers/interpretable-multivariate-survival-models-improving-predictions-conversion-mild-cognitive</link>
 <description>PLoS One. 2026;21(4):e0321671.  Epub 2026 Apr 30&lt;br&gt;Authors: Rosales-Gurmendi DS, Fumagal-González GA, Orozco J, Farber J, Treviño V, Martinez-Ledesma E, Martinez-Torteya A, Rosales-Gurmendi F, Tamez-Peña J, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42060649&quot;&gt;42060649&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-multivariate-survival-models-improving-predictions-conversion-mild-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-multivariate-survival-models-improving-predictions-conversion-mild-cognitive#comments</comments>
</item>
<item>
 <title>Application of Photostimulation Therapy in Cognitive Function of Alzheimer&#039;s Disease Patients: A Scoping Review.</title>
 <link>https://www.alzforum.org/papers/application-photostimulation-therapy-cognitive-function-alzheimers-disease-patients-scoping</link>
 <description>Clin Interv Aging. 2026;21:600468.  Epub 2026 Apr 24&lt;br&gt;Authors: Xu B, Wan H, Liu P, Zhao Z, Xie Y, Meng J, Qin Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42058736&quot;&gt;42058736&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/application-photostimulation-therapy-cognitive-function-alzheimers-disease-patients-scoping#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/application-photostimulation-therapy-cognitive-function-alzheimers-disease-patients-scoping#comments</comments>
</item>
<item>
 <title>Individualized phenotyping of functional amyotrophic lateral sclerosis pathology in sensorimotor cortex.</title>
 <link>https://www.alzforum.org/papers/individualized-phenotyping-functional-amyotrophic-lateral-sclerosis-pathology-sensorimotor</link>
 <description>Brain Commun. 2026;8(2):fcag127.  Epub 2026 Apr 9&lt;br&gt;Authors: Kalyani A, Northall A, Schreiber S, Brüggemann J, Vielhaber S, Al Dubai M, Bin Ramadan A, Mattern H, Speck O, Reichert C, Kuehn E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42058282&quot;&gt;42058282&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/individualized-phenotyping-functional-amyotrophic-lateral-sclerosis-pathology-sensorimotor#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/individualized-phenotyping-functional-amyotrophic-lateral-sclerosis-pathology-sensorimotor#comments</comments>
</item>
<item>
 <title>Chronic rhinosinusitis and posterior cingulate hypoperfusion on SPECT in dementia diagnosis.</title>
 <link>https://www.alzforum.org/papers/chronic-rhinosinusitis-and-posterior-cingulate-hypoperfusion-spect-dementia-diagnosis</link>
 <description>Front Neurol. 2026;17:1777862.  Epub 2026 Apr 14&lt;br&gt;Authors: Kanazawa M, Hatakeyama M, Imamura T, Kobayashi T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057932&quot;&gt;42057932&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/chronic-rhinosinusitis-and-posterior-cingulate-hypoperfusion-spect-dementia-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/chronic-rhinosinusitis-and-posterior-cingulate-hypoperfusion-spect-dementia-diagnosis#comments</comments>
</item>
<item>
 <title>The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson&#039;s disease progression: a trial protocol.</title>
 <link>https://www.alzforum.org/papers/syn-q-study-detection-cutaneous-phosphorylated-alpha-synuclein-parkinsons-disease-progression</link>
 <description>Front Neurol. 2026;17:1823991.  Epub 2026 Apr 14&lt;br&gt;Authors: Parent JH, Levine T, Freeman R, Gibbons CH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057930&quot;&gt;42057930&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/syn-q-study-detection-cutaneous-phosphorylated-alpha-synuclein-parkinsons-disease-progression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/syn-q-study-detection-cutaneous-phosphorylated-alpha-synuclein-parkinsons-disease-progression#comments</comments>
</item>
<item>
 <title>Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/retrospective-longitudinal-analysis-blood-microrna-7-5p-possible-progression-biomarker-people</link>
 <description>Front Neurosci. 2026;20:1784013.  Epub 2026 Apr 14&lt;br&gt;Authors: Zadegan SA, Hutchinson C, Onuigbo C, Martinez-Lemus JD, Talbot L, Metter EJ, Doursout MF, Tharp E, Suescun J, Shahnawaz M, Ellmore TM, Schiess M, Adams C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42057903&quot;&gt;42057903&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retrospective-longitudinal-analysis-blood-microrna-7-5p-possible-progression-biomarker-people#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retrospective-longitudinal-analysis-blood-microrna-7-5p-possible-progression-biomarker-people#comments</comments>
</item>
<item>
 <title>Unveiling the Neuroprotective Role of Nutritional Supplements in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/unveiling-neuroprotective-role-nutritional-supplements-neurodegenerative-diseases</link>
 <description>Cent Nerv Syst Agents Med Chem. 2025 Dec 4; Epub 2025 Dec 4&lt;br&gt;Authors: Singh S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42051103&quot;&gt;42051103&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unveiling-neuroprotective-role-nutritional-supplements-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unveiling-neuroprotective-role-nutritional-supplements-neurodegenerative-diseases#comments</comments>
</item>
</channel>
</rss>
